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L’aldostérone est produite par les cellules glomérulées du cortex surrénalien en 
réponse à l’angiotensine II (AngII). L’étape limitante de cette stéroïdogenèse est facilitée par 
la protéine StAR, dont l’expression doit être finement contrôlée. Dans ce travail, il a été 
démontré que le facteur de transcription COUP-TF est un répresseur du gène de StAR. Dans 
les cellules glomérulées, l’expression de la protéine COUP-TF s’avère être diminuée en 
présence d’AngII de manière dépendante de la concentration et du temps, et ne nécessite pas 
de néosynthèse protéique. La stabilité de l’ARNm de COUP-TF n’est pas affecté par l’AngII 
qui agit au niveau transcriptionnel pour son effet répresseur. Aussi, la surexpression de 
COUP-TF prévient l’induction par l’AngII de StAR, ainsi que de l’aldostérone. De plus, 
l’interaction directe entre COUP-TF et le promoteur de StAR a été mise en évidence et 
l’AngII lève cette interaction, ce qui a pour résultante de prévenir la répression de COUP-TF 
sur StAR. 
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Various pathological cardiovascular conditions are associated with inappropriate 
circulating levels of aldosterone, the main mineralocorticoid in man, which is crucial for salt 
and water homeostasis and therefore, for blood pressure control. A complete understanding of 
the molecular mechanisms leading to aldosterone biosynthesis is a prerequisite to the 
development of potential therapeutic tools. Aldosterone is synthesized mainly in the zona 
glomerulosa of the adrenal cortex, under the action of three principal activators, angiotensin II 
(AngII), potassium (K+) and, to a lesser extend, adrenocorticotropic hormone (ACTH). AngII 
stimulates acute aldosterone biosynthesis by exerting transcriptional effects on the expression 
of some genes that are fundamental for steroidogenesis, such as the gene coding for the 
Steroidogenic Acute Regulatory (StAR) protein. The control of the expression of the StAR 
protein is the rate-limiting step of aldosterone biosynthesis. Indeed, two crucial transcription 
factors, SF-1 and DAX-1, have been shown to be an activator and a repressor of StAR gene 
expression, respectively. In particular, angiotensin II represses DAX-1 expression, thus 
leading to increased StAR gene transcription and mineralocorticoid production. 
 
Recent studies have shown that yet another transcription factor named COUP-TF, 
for Chicken Ovalbumin Upstream Promoter-Transcription Factor, a member of the orphan 
nuclear receptor family, inhibited the transcriptional activity of SF-1, in addition to being 
inversely correlated with steroid production in adrenocortical tumors. We have thus examined 
in this thesis work whether COUP-TF was involved in the transcriptional activity of the StAR 
gene. 
 
We were able to detect strong levels of COUP-TF protein in our model, bovine 
adrenal glomerulosa cells in primary culture. Moreover, under AngII treatment, COUP-TF 
was repressed in a concentration- and time-dependent manner. Newly synthesized protein was 
not required for AngII-induced repression of COUP-TF expression and AngII did not affect 
COUP-TF mRNA stability. 
 
The role of COUP-TF on StAR gene expression and on mineralocorticoid 
biosynthesis was then analyzed. We have shown that the AngII-induced increase in StAR 
mRNA and protein levels in control cells was markedly reduced or even abolished in cells 
overexpressing COUP-TF, as was the aldosterone response under AngII challenge. These 
results demonstrated an implication of COUP-TF in the regulation of the StAR gene and of 
mineralocorticoid biosynthesis. We then investigated whether COUP-TF directly interacts 
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with the StAR promoter for its repressor effect and we were able to demonstrate a physical 
and direct interaction between COUP-TF and the proximal StAR promoter, using 
electrophoretic mobility shift assays and chromatine immunoprecipitation. Moreover, AngII 
prevented COUP-TF interaction with the StAR promoter. Finally, we have shown that COUP-
TF is part of a multifactorial complex, including various transcription factors, such as SF-1, 
DAX-1 and Sp1. 
 
In summary, we have shown in this work that COUP-TF is a direct repressor of 
StAR gene expression and of mineralocorticoid biosynthesis in bovine adrenal glomerulosa 
cells and that angiotensin II activates aldosterone synthesis by lifting this repression. This 
finding may bear pathophysiological relevance, both in the field of blood pressure control and 
in the field of steroid secreting adrenal tumors in which COUP-TF levels are known to be 
downregulated. 
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Les pays occidentaux, tels que la Suisse, sont fortement touchés par les maladies 
cardio-vasculaires. En effet, ces affections représentent la première cause de mortalité devant 
les cancers, et constituent plus de 40% des causes de mortalité selon l’OFS. A travers le 
monde, le nombre de décès imputables à ces maladies ne cesse, quant à lui, de s’élever au fur 
et à mesure que d’autres pathologies se raréfient, que les populations  vieillissent et qu’elles 
adoptent un mode de vie plus occidental. 
 
L’hypertension est un facteur de risque important dans le développement des 
pathologies cardiovasculaires et sa prévalence en fait une cause majeure de morbidité et de 
mortalité à travers le monde. C’est pourquoi le diagnostic et le traitement de l’hypertension 
sont d’importance fondamentale dans le secteur de la santé publique. 
 
La pression artérielle dépend de facteurs génétiques multiples et de facteurs 
environnementaux. Les valeurs de la pression artérielle varient en fonction de deux variables 
hémodynamiques : le volume sanguin et la résistance périphérique totale. Le rein joue 
également un rôle important dans le maintien de la pression artérielle de trois manières 
différentes : 
 
1. le système rénine-angiotensine-aldostérone (RAA). Des cellules spécialisées 
du rein, soit les cellules juxta-glomérulaires, sont des senseurs de pression 
artériolaire et sécrètent une enzyme, la rénine, lors d’une baisse de pression 
artérielle. La rénine circulante va scinder l’angiotensinogène venu du foie en 
un décapeptide, l’angiotensine I, qui à son tour va subir un clivage par 
l’enzyme de conversion fixée sur la membrane des cellules vasculaires 
endothéliales pulmonaires, pour former l’octapeptide angiotensine II. Ce 
dernier agit sur le volume sanguin et directement sur la résistance périphérique. 
En effet, l’angiotensine II est capable d’induire la vasoconstriction des 
artérioles périphériques et de stimuler la sécrétion d’aldostérone par les cellules 
glomérulées du cortex surrénalien, induisant la réabsorption rénale de sodium 
et donc d’eau. 
 
2. l’homéostasie du sodium. En plus du système RAA, deux autres facteurs 
influencent l’homéostasie du sodium : il s’agit du taux de filtration 
glomérulaire et de l’atriopeptine, un facteur natriurétique provenant des 
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oreillettes du cœur. Le taux de filtration glomérulaire chute en réponse à une 
baisse de volume sanguin, ce qui a pour effet de stimuler la réabsorption rénale 
tubulaire proximale de sodium. L’atriopeptine, quant à elle, est sécrétée en 
réponse à une expansion volumique et a un effet inhibiteur sur la réabsorption 
de sodium dans les tubes distaux et favorise la vasodilatation. 
 
 
3. les vasodilatateurs rénaux. Le rein est le siège de synthèse de nombreux 
facteurs vasodilatateurs, tels que les prostaglandines, le système kallikréine-
kinine urinaire, le facteur activateur des plaquettes et l’oxyde nitrique. 
 
 
Dans le système RAA, l’aldostérone, le minéralocorticoïde principal synthétisé 
dans la zone glomérulée du cortex surrénalien en réponse à ses deux agonistes 
physiologiques, l’hormone octapeptidique angiotensine II (AngII), et le potassium extra-
cellulaire (K+), est synthétisée à partir du cholestérol, le précurseur commun à toutes les 
hormones stéroïdes. Celui-ci est stocké sous forme d’esters de cholestérol dans des 
gouttelettes lipidiques intracellulaires, qui sont hydrolysés par une enzyme, la cholestérol-
ester-hydrolase pour être ensuite transportés vers les mitochondries. L’étape limitante de la 
stéroidogenèse, qui consiste en un transfert du cholestérol de la membrane externe à la 
membrane interne de la mitochondrie, est facilitée par la protéine Steroidogenic Acute 
Regulatory (StAR). À l’intérieur de la mitochondrie, le cholestérol subit une cascade 
enzymatique qui finalement conduira à la formation de l’aldostérone. 
 
L’angiotensine II étant une molécule clef dans le système RAA, elle mérite une 
attention particulière. L’angiotensine II agit par l’intermédiaire de ses deux récepteurs 
membranaires, de type AT1 et de type AT2. Ceux-ci sont des récepteurs à sept domaines 
transmembranaires couplés à une protéine G.  
 
Les récepteurs AT1 représentent le sous-type prédominant et sont impliqués dans 
les actions physiologiques cardio-vasculaires principales de l’angiotensine II. Les récepteurs 
AT1, par l’intermédiaire d’hétérodimères de protéines Gq, activent la phospholipase C (PLC), 
ce qui aboutit à l’hydrolyse du phosphatidylinositol 4-5 bisphosphate (PIP2), la formation 
d’inositol 1,4,5 trisphosphate (IP3) et l’accumulation de diacylglycérol (DAG). La fixation de 
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l’IP3 sur son récepteur localisé dans le réticulum endoplasmique, conduit à la libération de 
calcium  des réserves intracellulaires, aboutissant à la sécrétion d’aldostérone dans les cellules 
corticosurrénaliennes. L’activation de la protéine kinase C (PKC) par le DAG aboutit à la 
phosphorylation de protéines-clefs qui sont impliquées dans la vasoconstriction et dans la 
croissance cellulaire. De plus, l’angiotensine II induit ses actions par l’activation de tyrosine-
kinases qui à leur tour phosphorylent de nombreuses cibles en aval, incluant la cascade 
ras/raf/ERK1/2 et la translocation de ERK1/2 dans le noyau. À l’instar des récepteurs aux 
cytokines, le récepteur AT1 peut activer la voie de signalisation JAK-STAT impliquant ainsi 
une transduction du signal de surface dans le cytoplasme cellulaire et le noyau. 
 
Le récepteur AT2, quant à lui, joue un rôle de modulateur de programmes 
biologiques complexes incluant le développement embryonnaire, la différenciation cellulaire, 
la réparation tissulaire et la programmation de la mort cellulaire. Les voies de signalisation du 
récepteur AT2 sont diverses et peu caractérisées. Dans certains cas ces récepteurs sont 
couplés aux protéines Gi. Dans les neurones, une voie de transduction implique l’activation 
d’une phosphatase sérine/thréonine PP2A qui aboutit à l’activation d’un canal potassique et 
provoque une hyperpolarisation des membranes plasmiques. Une deuxième voie de 
signalisation implique l’activation des phosphotyrosines phosphatases (PTPases) qui sont 
importantes dans l’inhibition de la croissance cellulaire inappropriée. L’angiotensine II active 
également la phospholipase A2 via le récepteur AT2, ce qui résulte en un relargage d’acide 
arachidonique. Une autre voie de transduction du signal du récepteur AT2 implique les 
céramides, qui peuvent induire l’apoptose par l’activation de caspases. Dans certains tissus, 
l’activation du système kinine/NO/GMPc a également été observée. 
 
Comme mentionné plus haut, l’angiotensine II est un stimulateur de la biosynthèse 
de l’aldostérone dont une étape cruciale est facilitée par la protéine StAR. Le rôle 
indispensable de la protéine StAR est corroboré par son implication dans une pathologie 
connue sous le nom d’hyperplasie lipoïde surrénalienne congénitale, dans laquelle une 
mutation C-terminale de la séquence de StAR qui rend la protéine inactive conduit à une 
incapacité totale des cellules à produire des hormones stéroïdes et à une accumulation 
massive de lipides dans le cytoplasme, ce qui entraîne à des lésions irréversibles des glandes 
surrénales. 
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La protéine StAR étant le modulateur de l’étape limitante de la stéroidogenèse, son 
expression doit être finement contrôlée. Dans les cellules glomérulées du cortex surrénalien 
bovin en culture primaire, l’angiotensine II  est un agoniste de l’expression transcriptionnelle 
du gène StAR. Divers éléments de réponse ont été identifiés sur le promoteur de StAR. Deux 
facteurs de transcription critiques appartenant à la superfamille des récepteurs nucléaires sont 
connus pour moduler l’expression du gène StAR de manière opposée. L’un d’eux le facteur de 
transcription DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia congenita critical 
region on the X chromosome, gene 1), est un répresseur de l’expression du gène StAR et est 
inhibé par l’angiotensine II. L’autre, le facteur de transcription SF-1, un activateur du 
promoteur de StAR, n’est pas influencé par l’angiotensine II, mais par la forskoline, un 
mimétique de l’hormone adrénocorticotrope ACTH. Cette dernière a également un effet 
répresseur sur DAX-1. 
 
Un autre candidat potentiel pour une répression du gène StAR est le facteur de 
transcription COUP-TF (chicken ovalbumin upstream promoter-transcription factor), qui est 
présent sous deux isoformes de 46 kDa chacune, COUP-TFI et COUP-TFII. Elles 
appartiennent à la superfamille des récepteurs nucléaires. Aucun ligand ou molécule 
activatrice n’a été identifié à ce jour, et les COUP-TFs sont donc classés parmi les récepteurs 
orphelins. Il a été démontré que les COUP-TFs se lient à des motifs 5’-AGGTCA-3’ en 
répétition directe ou en palindrome, qui correspondent également aux éléments de réponse 
aux récepteurs à l’acide rétinoïque (RAR), les récepteurs au rétinoïde X (RXR), le récepteur à 
la vitamine D3 (VDR), et les récepteurs aux hormones thyroïdiennes (TR). Capables d’inhiber 
la fonction activatrice des récepteurs sus-mentionnés en présence de leurs ligands respectifs, 
les COUP-TFs exercent cette répression principalement par une liaison compétitive à l’ADN 
sur l’élément de réponse commun et par hétérodimérisation avec le partenaire.  
  
Bien qu’ils partagent un haut degré d’homologie dans une espèce animale et entre 
espèces, ces deux facteurs de transcription, COUP-TFI et COUP-TFII, jouent des rôles 
cruciaux totalement opposés. Alors que COUP-TFI est impliqué dans le développement du 
système nerveux fœtal, COUP-TFII est, quant à lui, impliqué dans le développement du 
système cardiovasculaire. En effet, des modèles d’invalidation ont été développés, et les 
souris homozygotes pour le gène COUP-TFI invalidé (-/-) meurent prématurément en période 
périnatale et présentent des altérations de la morphogenèse du système nerveux, notamment 
du développement des nerfs et ganglions crâniens, alors que les souris hétérozygotes (+/-), 
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viables, ne se distinguent pas des souris de type sauvage. Le phénotype est encore plus 
dramatiquement altéré chez les souris dont les deux allèles du gène COUP-TFII ont été 
invalidés. En effet, les embryons meurent in utero et présentent de profondes malformations 
dans le développement cardiaque et dans l’angiogenèse. Les souris hétérozygotes (+/-) sont 
également fortement atteintes et près des deux tiers d’entre elles meurent avant d’être sevrées, 
ce qui indique que, dans le cas de COUP-TFII, la perte d’une seule copie du gène est 
suffisante pour provoquer des malformations cardiovasculaires importantes et une très faible 
viabilité postnatale. 
 
En plus des effets précités sur le développement fœtal, des éléments intéressants 
suggèrent l’implication de ces deux facteurs de transcriptions dans la modulation de 
l’expression du gène StAR et donc de la biosynthèse de l’aldostérone. Il semblerait que les 
COUP-TFs pourraient interagir de manière directe ou indirecte avec le promoteur du gène 
StAR. 
 
Premièrement, des profils d’analyses comparatives d’expression protéique 
montrent que les deux sous-types de COUP-TFs sont co-localisés avec SF-1 et DAX-1 (deux 
facteurs de transcription impliqués dans la stéroidogenèse et dans la modulation du gène 
StAR) dans le noyau des cellules corticosurrénaliennes. De plus, l’expression des protéines 
COUP-TFI et COUP-TFII est modulée dans les adénomes corticosurrénaliens. En effet, par 
comparaison avec des glandes surrénaliennes normales, les taux de protéines COUP-TFI et 
COUP-TFII sont nettement abaissés dans les tumeurs sécrétant des stéroïdes, telles que 
l’adénome producteur de cortisol (CS) et l’adénome producteur de déoxycorticostérone 
(DOC). L’expression des COUP-TFs se présente donc en corrélation inverse avec la 
production de stéroïdes dans les tumeurs cortico-surrénaliennes. 
 
Il a également été démontré dans les cellules Y1 issues d’une lignée de cellules 
tumorales de glandes surrénales de souris que SF-1 et COUP-TF peuvent respectivement 
activer et réprimer la transcription du gène CYP17 bovin codant pour une des enzymes clefs 
de la production des glucocorticoïdes et des androgènes surrénaliens. Une compétition 
similaire entre SF-1 et COUP-TFs a également été relevée dans le cadre de sites de liaison 
composites pour d’autres gènes impliqués dans la stéroïdogenèse, incluant celui de 
l’aldostérone synthase humaine, de l’aromatase et de DAX-1 murin. 
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Tous ces éléments pris en compte soulèvent la question de la possible implication 
des COUP-TFs dans la régulation en tant que répresseur de l’expression du gène StAR. 
 
Travaillant sur le modèle des cellules glomérulées du cortex surrénalien bovin en 
culture primaire, nous avons tout d’abord recherché la présence des COUP-TFs dans ce type 
cellulaire. Effectivement, la protéine COUP-TFI analysée par Western Blot est fortement 
exprimée dans les cellules glomérulées et présente une diminution d’expression sous 
l’influence d’un traitement par l’angiotensine II, l’agoniste physiologique de la 
stéroïdogenèse. Cette répression induite par l’angiotensine II sur les taux protéiques de 
COUP-TFI est dépendante de la concentration d’angiotensine II ainsi que de la durée du 
traitement. On remarque qu’une inhibition de 54% environ est atteinte avec 10 nM 
d’angiotensine II, et qu’une totale abolition de l’expression de COUP-TFI est atteinte après 15 
heures de traitement par comparaison avec les cellules contrôles, les taux de COUP-TFI 
chutant dès la première demi-heure de traitement. Parallèlement à ces résultats, l’analyse par 
dosage radio-immunologique des variations de taux d’aldostérone sécrétée dans le milieu de 
culture, traduit une augmentation de ceux-ci de 20 fois sous traitement à l’angiotensine II 
durant 6 heures.  
 
L’effet inhibiteur de l’angiotensine II est également observé par Northern Blot au 
niveau de l’ARN messager de COUP-TFI puisqu’une diminution de 82% est atteinte après 6 
heures de traitement des cellules glomérulées à l’angiotensine II. De plus, l’angiotensine II ne 
requiert pas de néosynthèse protéique pour son effet inhibiteur sur COUP-TF. En effet, dans 
des conditions de blocage de synthèse protéique par un traitement des cellules à la 
cycloheximide, la réponse de l’expression de l’ARNm ou de la protéine COUP-TF à 
l’angiotensine II reste inchangée. 
 
Dans le même sens, la forskoline utilisée comme un mimétique de l’ACTH, 
hormone corticotrope, activateur de l’adénylyl cyclase et qui emprunte la voie de l’AMP 
cyclique pour son action, se révèle également être un puissant répresseur de l’expression de 
l’ARNm et de la protéine de COUP-TFI.  
 
Afin de déterminer si l’angiotensine II agit au niveau de la stabilité ou au niveau 
de la transcription de l’ARNm de COUP-TFI, les cellules glomérulées bovines ont été 
incubées avec l’actinomycine D, un agent inhibiteur de la transcription, en présence ou en 
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absence d’angiotensine II. L’analyse par Northern Blot a rapidement démontré que la stabilité 
de l’ARNm de COUP-TF n’était pas affectée par l’angiotensine II sur une période de 24 
heures. La demi-vie de l’ARNm de COUP-TFI quant à elle, avoisine les 8 heures en présence 
d’actinomycine D. 
 
À l’aide de vecteurs lentiviraux, il était approprié de surexprimer les protéines 
COUP-TFs dans les cellules glomérulées en culture primaire, par ailleurs difficiles à 
transfecter. Utilisant la technique de lentivecteurs dérivés du virus HIV, les cellules 
quiescentes devenaient facilement infectables, une efficacité de plus de 90% étant atteinte 
avec un vecteur codant pour la GFP (green fluorescent protein) sous le contrôle du promoteur 
de la phosphoglycérate kinase humaine (hPGK), par analyse cytométrique de flux (FACS). 
Ainsi, l’étude de l’expression du gène StAR dans les cellules glomérulées bovines 
surexprimant les protéines COUP-TFI ou COUP-TFII murines, montre-t-elle une prévention 
importante de l’augmentation des taux de l’ARNm de StAR sous traitement par l’angiotensine 
II, en comparaison avec les cellules non infectées ou infectées avec le vecteur vide. 
Parallèlement, l’aldostérone récupérée dans les milieu de culture, présente le même profil, soit 
une prévention significative de l’augmentation des taux d’aldostérone induite par 
l’angiotensine II lors de la surexpression des COUP-TFs. 
 
Afin de préciser la modulation par COUP-TFs sur l’expression du gène StAR, une 
étude de l’activité du promoteur de StAR a été faite en employant une méthode de gène 
raporteur, dans laquelle un plasmide contenant le gène codant pour la luciférase de la luciole 
est placé en aval du promoteur complet de StAR. Trois plasmides ont ainsi été transfectés 
dans les cellules glomérulées bovines : le plasmide contenant la construction du promoteur de 
StAR et la luciférase, un plasmide codant pour COUP-TFI ou II ou le vecteur vide, et un 
plasmide codant pour la luciférase issue du corail Renilla reniformis qui est constitutivement 
active pour normaliser les résultats. Les cellules transfectées avec le vecteur vide présentaient 
une activité basale du promoteur de StAR qui était significativement augmentée lors d’un 
traitement par l’angiotensine II. En revanche, cette augmentation induite par l’angiotensine II 
est totalement abolie dans les cellules surexprimant les COUP-TFs. 
 
Ensuite, l’interaction physique directe entre COUP-TF et le promoteur de StAR a 
été recherchée. La première indication favorable a été fournie par l’utilisation d’un gel de 
retard (EMSA), dans lequel une protéine ou un complexe protéique provoque un retard dans 
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la migration d’une sonde d’ADN marquée. Cette dernière correspond à une séquence 
proximale du promoteur de StAR. Lorsqu’un extrait de protéines nucléaires de cellules 
glomérulées, qui contient de nombreux facteurs de transcription, a été ajouté à la sonde 
marquée, diverses bandes de retard de migration ont été observées. De plus, lorsqu’un 
anticorps spécifique COUP-TFI est ajouté à l’extrait cellulaire, l’une des bandes retardées 
disparaît indiquant une interaction possible entre la protéine COUP-TFI et le promoteur de 
STAR. La confirmation ultime a été apportée par l’application in vivo de la méthode 
d’immunoprécipitation de la chromatine (ChIP), puisque celle-ci a permis de nous fournir la 
preuve incontestable que COUP-TFI interagit avec le promoteur de StAR lorsque l’anticorps 
dirigé contre COUP-TFI a immunoprécipité le fragment d’ADN correspondant au promoteur 
proximal de StAR. De plus, sous condition de traitement des cellules à l’angiotensine II, la 
quantité d’ADN immunoprécipité est réduite, confirmant l’hypothèse que l’angiotensine II 
lève la répression de COUP-TF sur le promoteur de StAR. 
 
En conclusion, les résultats obtenus ont démontré que les facteurs de transcription 
COUP-TFs, connus jusqu’alors pour jouer un rôle dans l’organogenèse, sont également 
impliqués dans la biosynthèse des minéralocorticoïdes, notamment l’aldostérone, par leur 
action répressive sur l’expression du gène de StAR. 
 
Des résultats non publiés indiquent que similairement à l’angiotensine II, le 
potassium extracellulaire, un autre agoniste physiologique de la biosynthèse d’aldostérone, 
exerce également un effet répresseur sur l’expression de COUP-TF. En effet une inhibition de 
40 % de l’expression protéique de COUP-TFI est atteinte lorsque les cellules glomérulaires 
sont incubées dans un milieu contenant 12 mM de KCl. 
 
Afin de déterminer si les voies intracellulaires utilisées par l’angiotensine II pour 
conduire à la synthèse d’aldostérone sont également les voies empruntées pour exercer l’effet 
inhibiteur sur l’expression de COUP-TF, celles-ci ont été interrompues à plusieurs niveaux 
pour observer leurs actions sur COUP-TF. Dans un premier temps, sachant que l’angiotensine 
II active ERK2/1 dans les cellules bovines glomérulaires, la voie des MAP kinases a été 
explorée pour déterminer si celle-ci est mobilisée dans la répression de COUP-TF par 
l’angiotensine II. L’utilisation d’inhibiteurs tels que le U0126, un inhibiteur de MEK1/2, la 
protéine kinase qui phosphoryle et active ERK2/1, ou le SB203580, un inhibiteur de la 
protéine kinase MAP p38, semble indiquer que l’effet répresseur de l’angiotensine II sur les 
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facteurs de transcriptions COUP-TFs n’ est pas affecté par l’interruption de ces deux voies. 
L’action de l’angiotensine II sur COUP-TFs ne passe donc pas par la voie des MAP kinases.  
 
Une autre voie , celle de la protéine kinase C (PKC) induite par la génération de 
1,2 diacylglycerol (DAG) elle-même induite par la phospholipase C (PLC), a également été 
interrompue par l’utilisation de deux inhibiteurs sélectifs de PKC, soit la calphostine C et la 
CGP41251. Les résultats montrent que l’effet répresseur de l’angiotensine II sur COUP-TFI 
reste également insensible à l’interruption de la voie de la PKC. Le mécanisme par lequel 
l’angiotensine II exerce sa répression sur COUP-TF est donc encore inconnu et mérite encore 
d’autres investigations. Parmi les différentes étapes intracellulaires connues de l’activation du 
récepteur membranaire AT1 jusqu’à la biosynthèse de l’aldostérone, la libération des stocks 
intracellulaires de calcium reste encore à être explorée afin de déterminer si l’angiotensine II 
utilise cette voie pour réprimer l’expression de COUP-TF. 
 
Les investigations se sont également tournées vers la possible compétition ou 
interaction du facteur de transcription COUP-TF avec SF-1. En effet, une étude a démontré 
l’existence d’une compétition directe entre COUP-TF et SF-1 pour un demi-site de récepteurs 
nucléaires sur le promoteur de l’aromatase P450 dans les cellules stromales de 
l’endométriose. De plus, l’acide nucléique correspondant à une partie de la séquence 
proximale du promoteur de StAR, utilisé comme sonde dans le gel de retard effectué pour 
montrer l’interaction de la protéine COUP-TF avec le promoteur en question, contient une 
séquence correspondant à l’élément de réponse de SF-1, ce qui laisse supposer une possible 
interaction ou compétition entre les deux protéines sur le promoteur de StAR. La co-
immunoprécipitation de SF-1 et de COUP-TF1 indique une possible interaction physique 
entre les deux facteurs de transcription dans les cellules bovines glomérulaires. Cette 
interaction reste à être localisée et confirmée par d’autres types d’expériences. 
 
Enfin, la régulation de la biosynthèse des minéralocorticoides ne se limite pas à la 
modulation de l’expression de gènes au niveau de la séquence d’ADN, mais il semblerait que 
les profils d’expression des gènes soient également modulés par des modifications survenant 
dans la chromatine. Les mécanismes impliqués dans ce type de modifications impliquent 
entre autres des changement au niveau de la méthylation des histones. En effet, selon l’état de 
condensation de la chromatine, l’accès des facteurs de transcription à l’ADN peut être 
restreint. De plus, des modifications post-transcriptionnelles des histones peuvent altérer la 
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conformation de la chromatine et jouer ainsi un rôle direct sur l’expression de gènes. La 
diversité des structures des histones dépend de plusieurs modifications post-
transcriptionnelles, telles que l’acétylation, la phosphorylation, la méthylation et 
l’ubiquitination.  
 
Afin de déterminer l’éventuel effet des changements de conformations de la 
chromatine sur la répression de COUP-TF par l’angiotensine II, la trichostatine A (TSA), un 
agent capable d'inhiber les histone-désacétylases et de maintenir l'état d'acétylation des 
histones notamment dans les régions d'hétérochromatine a été employée sur les cellules 
glomérulées. Des résultats non publiés montrent, de façon inattendue, un effet potentialisateur 
de la TSA sur la répression induite par l’angiotensine II sur l’expression protéique de COUP-
TFI. Alors que l’angiotensine II abaisse l’expression de COUP-TFI d’environ 50 %, un 
traitement simultané à la TSA, diminue l’expression de 30 % supplémentaire. Il semble donc 
possible que les histones soient des acteurs à part entière de la modulation de l’expression de 
gènes tels que COUP-TF. D’autres interactions et régulations sont à exploiter. Sachant que 1) 
COUP-TFII interagit avec des co-répresseurs appelés N-CoR et SMRT, 2) que ces co-
répresseurs induisent l’inhibition transcriptionnelle induite par COUP-TF sur certains gènes, 
et 3) qu’ils recrutent les histones désacétylases (HDAC) pour activement promouvoir la 
condensation de la chromatine via l’hypoacétylation de la chromatine, il serait intéressant de 
déterminer si les co-répresseurs interagissent avec COUP-TF au niveau du promoteur de 
StAR, et s’ils subissent une influence de l’AngII. Ces résultats ouvrent de nouvelles 
perspectives sur les mécanismes moléculaires et transcriptionnels participant au contrôle de la 
biosynthèse des minéralocorticoïdes. 
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Introduction 
 
 
Cardiovascular diseases (CVD) are responsible for one-third of global deaths and 
are a leading and increasing contributor to the global disease burden. In Switzerland also, 
CVD are the first cause of mortality (Table 1), a long way ahead of the second most 
prevalent cause, cancers. Hypertension (high blood pressure) is an important risk factor for 
cardiovascular disease and its high prevalence in the population makes it a major cause of 
morbidity and mortality all over the world. Therefore diagnosis and treatment of 
hypertension are steps of fundamental importance for public health. 
 
 
1 CARDIOVASCULAR DISEASES 25443 40,665% 
2 TUMORS 15579 24,900% 
3 RESPIRATORY DISEASES 4558 7,285% 
4 ACCIDENTS 3561 5,690% 
5 UNKNOWN ORIGIN 2675 4,275% 
6 DIGESTIVE DISEASES 2256 3,606% 
7 ENDOCRINE DISEASES 1936 3,094% 
8 NERVOUS SYSTEM DISEASES 2235 3,572% 
9 AMBIGUOUS CAUSES 2115 3,380% 
10 INFECTIONS 700 1,119% 
11 URINARY TRACT DISEASES 641 0,759% 
12 OSTEOMUSCULAR DISEASES 475 0,759% 
13 BLOOD DISEASES 167 0,267% 
14 PERINATAL MORTALITIES 163 0,261% 
15 AIDS 63 0,101% 
        
TOTAL   62567 100% 
 
Table 1 : First leading causes of mortality in Switzerland. Office Fédéral de la Statistique (OFS) 2003 
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Hypertension is a baffling condition in several respects: for primary or “essential” 
hypertension”, in about 95% of cases, no cause can be established, and mild to moderate 
essential hypertension is usually associated with normal health and well-being for many 
years.  
Hypertension is becoming an increasingly common health problem worldwide 
because of increasing longevity and prevalence of contributing factors such as obesity, 
physical inactivity and an unhealthy diet. The current prevalence in many developing 
countries, particularly in urban societies, is already as high as those seen in developed 
countries. Worldwide hypertension is estimated to cause 7.1 million premature deaths and 
4.5% of the disease burden (WHO, web site). 
Hypertension plays a major etiologic role in the development of cerebrovascular 
disease, ischemic heart disease, cardiac and renal failure. Treating hypertension has been 
associated with about a 40% reduction in the risk of stroke and about a 15% reduction in the 
risk of myocardial infarction (WHO, web site). Although the treatment of hypertension has 
been shown to prevent CVD and to extend and enhance life, hypertension remains 
inadequately managed everywhere. In addition, hypertension often coexists with other 
cardiovascular risk factors, such as tobacco use, diabetes, hyperlipidemia and obesity, which 
exacerbate the cardiovascular risk attributable to hypertension. Worldwide, these coexistent 
risk factors are inadequately addressed in patients with hypertension, resulting in high 
morbidity and mortality. 
Blood pressure is a complex trait that is determined by the interaction of multiple 
genetic and environmental factors. Therefore it should not be surprising that the pathogenesis 
of hypertension remains an enigma. 
 
The magnitude of the arterial pressure depends on two fundamental 
hemodynamic variables: cardiac output and total peripheral resistance. For the most part, 
total peripheral resistance is accounted for by resistance of the arterioles, predominantly 
related to lumen size. This in turn is determined by the thickness of arteriolar wall and the 
effects of neural and hormonal influences that either constrict or dilate these vessels. 
Vasoconstricting agents are angiotensin II, catecholamines, thromboxane, leukotrienes, and 
endothelin. Vasodilatators include kinins, ANP, prostaglandins, and nitric oxide. Arterial 
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hypertension can best be considered a disease dependent on factors that may alter the 
relationship between blood volume and total arteriolar resistance. 
 
The kidneys play also an important role in blood pressure regulation by at least 
three mechanisms: 
 
- The renin-angiotensin system (RAS). The enzymatic cascade leading to the formation 
of angiotensin II begins through the elaboration of renin by the kidneys. Angiotensin 
II alters blood pressure by increasing both peripheral resistance and blood volume. 
The former effect is achieved largely by its ability to cause vasoconstriction through 
direct action on vascular smooth muscle, the latter by stimulation of aldosterone 
secretion, which increases distal tubular reabsorption of sodium and thus of water. 
 
- Sodium homeostasis. In addition to the RAS pathway, two other renal factors have 
important bearing on sodium homeostasis: the glomerular filtration rate (GFR) and 
GFR-independent natriuretic factor. When blood volume is reduced, the GFR falls; 
this in turn leads to increased reabsorption of sodium by proximal tubules in an 
attempt to conserve sodium and expand blood volume. GFR-independent factors 
include atrial natriuretic peptide (ANP), or atriopeptin, a group of peptides secreted 
by heart atria in response to volume expansion, which inhibit sodium reabsorption in 
distal tubules and cause vasodilatation. 
 
- Renal vasodepressor substances. The kidney produces a variety of vasodepressor or 
antihypertensive substances that presumably counterbalance the vasopressor effects 
of angiotensin.  These include the prostaglandins, a urinary kallikrein-kinin system, 
platelet-activating factor, and nitric oxide. 
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The renin-angiotensin-aldosterone system 
 
 
Juxtaglomerular cells (JC) located at the vascular pole of a nephron in the kidney 
possess a sensor for sodium concentration and renal perfusion pressure in the afferent artery. 
Blood volume, however, is monitored by the sympathetic nervous system, which stimulates 
JC. Any one of the three parameters sensed by JC stimulates the secretion of renin from the 
same cells. Renin is a proteolytic enzyme that converts angiotensinogen, an α2-globulin 
secreted by the liver, to angiotensin I, an inert decapeptide. Then, angiotensin-converting 
enzyme (ACE), removes two amino acids from angiotensin I to form the active angiotensin II 
(Figure 1). ACE is a metalloprotease bound to the plasma membrane of endothelial cells 
throughout the circulation. Angiotensin II is a potent vasoconstrictor and stimulator of 
aldosterone secretion from glomerulosa cells. Thus, low blood pressure, hyponatremia, and 
hypovolemia are corrected. Angiotensin II may also be converted to angiotensin III by a 
specific protease (angiotensinase). Angiotensin III is also active. It is important to remark that 
intracellular renin/angiotensinogen/ACE/angiotensin II systems have been reported in several 
cell systems, including glomerulosa cells (Lumbers ER, 1999). 
 
 
 
 
 
Figure 1: Simple diagram of the RAS pathway. Montani JP et al. 2004 
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The basic mechanism of action of angiotensin II in glomerulosa cells involves 
increased Ca2+ influx, and activation of phospholipase C (Spät A et  al. 2004). This last 
enzyme in turn hydrolyses phosphatidyl inositol 4,5 bisphosphate, which is converted to 
active inositol 1,4,5-trisphosphate (InsP3) and diacylglycerol (DAG). InsP3 releases Ca2+  
from intracellular stores, and DAG activates the  Ca2+ and phospholipid-dependent protein 
kinase (protein kinase C, PKC). Although high Ca2+ concentrations are accepted as mediators 
of angiotensin II-stimulated aldosterone secretion, the involvement of PKC is controversial 
(Maturana AD et al. 1999). 
 
In the adrenal gland, aldosterone formation is not only regulated by AngII and 
corticotropin but also by increased circulating K+. The mechanism of action of increased K+ 
appears to be through the opening of voltage-sensitive Ca2+ channels and thus stimulates 
short-term aldosterone production by a mechanism distinct from that of Ang II and 
corticotropin (Quinn SJ et al. 1992). Indeed, the response elicited by extracellular potassium 
is straightforward, involving opening of plasma membrane calcium channels upon cell 
depolarization, transfer of a part of this calcium into the mitochondria, and stimulation of 
cholesterol conversion into pregnenolone and steroid intermediates. Any interference with one 
of these steps is generally detected on steroid output.( Kojima I et al. 1985, Lalevée N et al. 
2003). 
 
Vasopressin (the antidiuretic hormone, ADH) adrenomedullin, α-melanocyte-
stimulating hormone (α-MSH), and endothelin-1 (ET-1) also stimulate the secretion of 
aldosterone, but to a much lower degree compared to angiotensin II and potassium. However, 
endothelin potentiates angiotensin II- and ACTH-mediated stimulation of aldosterone 
production. The adrenocorticotropic hormone, secreted from the anterior pituitary in response 
to corticotropin-releasing hormone from the hypothalamus, is a potent acute stimulator of 
aldosterone secretion (Spat A et al. 2004). ACTH is the main physiological regulator of 
glucocorticoid biosynthesis, and its secretion is inhibited by high glucocorticoid plasma 
concentration by means of a feedback mechanism at the level of the pituitary gland. Although 
from the physiological point of view there is no clear relationship between ACTH and 
aldosterone, glomerulosa cells express ACTH receptors at a higher concentration 
(receptors/cell), compared to the corresponding fasciculata cells. At high levels, ACTH and 
angiotensin II stimulate aldosterone secretion to a similar degree. However, in long-lasting 
(chronic) exposures, ACTH reduces aldosterone levels, after the initial augmentation, to 
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control levels, or even below control levels. Histological observations have determined that 
after chronic treatment with ACTH, the zona glomerulosa is reduced and the zona fasciculata 
is expanded. This result is not surprising because, for example, ACTH induces 17 α-
hydroxylase in the adrenal glands of cortisol-producing animal species. In addition, the 
pathophysiological importance of ACTH in the regulation of mineralocorticoids is underlined 
by the existence of ACTH-dependent, aldosterone-secreting, adrenal adenomas. The 
mechanism of action of ACTH involves G-protein dependent activation of adenylyl cyclase, 
production of cyclic AMP, and activation of cyclic AMP-dependent protein kinase A (PKA) 
(Foster RH et al. 1997). Other mechanisms involving protein kinase C and extracellular 
calcium influx are well known and accepted. 
 
 
Angiotensin II 
 
 
Angiotensin II (AngII) is the principal effector of the renin-angiotensin system 
(RAS) through its interaction with angiotensin (AT) receptor type 1 and type 2 (AT1 and 
AT2), members of the seven-transmembrane G-protein-coupled receptor family. A vast 
majority of the cardiovascular effects of AngII are mediated by the AT1 receptors (Figure 2).  
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Figure 2: AngII actions that affect blood pressure and fluid volume. Lochard N et al. 2003 
 
 
Alternate biosynthesis of angiotensin II: 
 
There may exist alternate biosynthetic pathways in the formation of AngII that 
have important physiological functions: an enzyme called chymase, which may partially 
substitute for ACE in the generation of AngII in certain tissues, including the heart (Figure 3). 
In addition, other proteases, such as cathepsin D and tonin, exhibit renin-like activity in vitro, 
leading to the suggestion that AngII could be synthesized in some tissues by a renin-
independent mechanism.  
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Figure 3: Alternate pathways of AngII formation and other angiotensin peptides. Montani JP et al. 2004 
 
 
Additional angiotensin peptides: 
 
Although AngII is the major product of the classical pathway of the RAS, this 
pathway also leads to the formation of other angiotensin peptides that may have biological 
roles distinct from those of AngII, beyond the regulation of salt and water balance. 
 
 
Sources of angiotensin peptides: 
 
The biological actions of the RAS are not solely due to the activity of the 
circulating RAS components. Indeed, angiotensin peptides are synthesized within tissues, 
where they might have local actions that are distinct from the known cardiovascular effects of 
the RAS. 
 
Although angiotensins do not readily cross the blood-brain barrier, all of the 
components of the RAS, including AngII receptors, have been identified in brain (Johns EJ, 
2005). Interestingly, the fetal brain is particularly rich in AT2 receptor, which virtually 
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disappears after birth. The pituitary gland has a high concentration of AngII per gram of 
tissue, which has bolstered the suggestion of local angiotensin synthesis. 
 
The messenger RNAs for angiotensinogen, ACE, and AT1 and AT2 receptors are 
also expressed in the heart. Angiotensin receptors have been described in both cardiac 
myocytes and fibroblasts (Regitz-Zagrosek V et al. 1998). In blood vessels, ACE can be 
found in abundance on endothelial cells, and angiotensinogen is particularly abundant in the 
surrounding adipose tissue. 
 
The adrenal gland is the tissue with the highest content of AngII per gram of wet 
weight. Both AngII AT1 and AT2 receptors are expressed in the outer adrenal cortex. AngI, 
AngII and AT1 receptors have also been localized in the reproductive organs, such as in 
Leydig cells and sperm tails (Dufau ML et al. 1989). All of the soluble components of RAS 
have been found in ovarian follicular fluid (Nemeth G et al. 1994). 
 
 
Angiotensin II receptor signaling 
 
 
Angiotensin II receptors are divided in two angiotensin receptor subtypes, AT1 and 
AT2 . The vast majority of the biological functions of AngII are mediated through the AT1 
receptor subtype, whereas the AT2  subtype is essentially involved in developmental and 
remodeling process. The two AngII receptor subtypes also differ in their tissue distribution. 
AT1 receptors are found throughout life in all tissues involved in the cardiovascular actions of 
AngII, i.e., adrenal cortex, brain, liver, kidney, and vascular smooth muscle. In contrast, AT2 
receptors are highly expressed in various tissues in the fetus but their level of expression 
decreases considerably after birth. Interestingly, AT2 receptor expression increases in certain 
tissues (heart, vasculature, and kidney) after injury and wound healing (Capponi AM. 2003). 
 
Both AT1 and AT2 subtypes are classic seven-transmembrane-domain receptors, 
sharing only 30% sequence homology (Mukoyama M et al. 1993). Although they display the 
same binding affinity for AngII, they discriminate among nonpeptidic AngII antagonists, 
losartan, a blocker for AT1 subtype, and PD123177, a compound specifically recognized by 
the AT2 receptor subtype (Capponi AM 2003).  
 - Introduction - 28 
 
The AT1 receptor subtype belongs to the G-protein-coupled receptor (GPCRs) 
family. The message carried by the octapeptide hormone, AngII, that binds to the receptor, is 
transduced to intracellular effectors via heterotrimeric guanosine triphosphate (GTP)-binding 
proteins (G-proteins) composed of three subunits, α, β and γ. The different α, β and γ 
combinations are responsible for conveying the information to a given effector. The AT1 
receptor can couple to more than one G-protein, even within the same cell type.  In adrenal 
glomerulosa cells, the AT1 receptor is coupled to phospholipase C- β via a Gq11 protein and to 
L-type calcium channel via Gi-protein and /or a Go-protein (Maturana AD et al. 1999). 
Besides G-protein-mediated activation of intracellular effectors, direct physical interaction of 
the AT1 receptor with either an effector (mainly cytosolic tyrosine kinase) or an adapter 
protein can also occur, essentially via the C-terminal cytoplasmic tail of the receptor. This 
interaction then triggers kinase cascade within the cell (Hunyady L et al. 2005; Capponi AM 
2003; Marinissen MJ et al. 2001). 
 
The AT2 receptor displays structural features that are related to those of GPCRs 
and it couples to G-proteins of the inhibitory type (Gi). In contrast to the AT1 receptor, the 
major effectors of AT2-mediated angiotensin II action are tyrosine or serine/threonine 
phosphatase. 
 
 
AT1 receptor signaling: 
 
Occupancy of the AT1 receptor subtype triggers most of the known signaling 
processes (Figure 4), leading to activation of various phospholipases and recruitment of the 
calcium messenger system and/or to stimulation of numerous kinase cascades (Figure 5).  
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Figure 4: AngII-AT1 receptor interaction. Hunyady L et al. 2001 
 
 
Indeed, AT1 receptors trigger two distinct phospholipase pathways, a first rapid 
way triggered by phospholipase C (PLC), and a slower cascade sustained by phospholipase D 
(PLD) (Takeuchi K 1999). The result of the combined activation of PLC and PLD is a rapid 
and transient increase in intracellular inositol 1,4,5-trisphosphate (InsP3), accompanied by a 
sustained diacylglycerol production. These two metabolites will in turn activate the calcium 
messenger system and protein kinase C, respectively. Phospholipase A2 is also a major 
effector of AngII action. It releases arachidonic acid from membrane phospholipids, which 
enters then either the cyclooxygenase pathway to be converted into prostaglandins, or the 12-
lipoxygenase pathway, to give rise to 12-hydroxyeicosatetraenoic acid (12-HETE), depending 
on the cell type. 
 
The InsP3  produced upon activation of PLC, binds to tetrameric receptors located 
on some compartments of the endoplasmic reticulum functioning as calcium storage 
organelles. These receptors are channels that, upon InsP3 binding, allow calcium efflux into 
the cytosol (Catt KJ 1988). The emptying of intracellular calcium stores activates a 
capacitative influx of calcium from the extracellular medium, through calcium release-
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activated (CRAC) channels, which will replenish the stores. In addition to activating CRAC 
channels, AngII also modulates positively or negatively the activity of voltage-gated 
membrane calcium channels (L-, N-, and T-types) (Rossier MF et al. 2001), either directly, 
through cell membrane depolarization, or indirectly, via G-proteins or via protein kinase or 
phosphatase. The net result of these various impacts of AngII on regulators of calcium fluxes 
is an important alteration of intracellular calcium homeostasis. The changes in cellular 
calcium concentration elicited by AngII are relayed and even amplified within the 
mitochondrial matrix of the adrenal glomerulosa cells, where most enzymes required for 
aldosterone biosynthesis are located (Brandenburger Y et al. 1996).  
 
The elevation in the membrane of sn-1,2-diacylglycerol resulting from AngII –
induced phospholipases C and D activation, contributes to the recruitment  and anchoring to 
the cell membrane of various isoforms of protein kinase C (PKC). The AT1 receptor bears 
consensus PKC phosphorylation sites in its sequence and PKC-mediated phosphorylation of 
these sites results in receptor desensitization (Capponi AM 1996).  
 
Lastly, various other kinases are mobilized in glomerulosa cells following the 
activation of the first intracellular messengers in response to AngII binding to the AT1 
receptor.  
 
Calmodulin, a calcium-binding protein, senses any rise in intracellular calcium 
concentration elicited by AngII (Foster RH 2004). Calmodulin then interacts with Ca2+ -
calmodulin-dependent kinase II  (CaMKII). 
 
Serine-threonine kinases, such as ERK2/1 or p44/p42 mitogen-activated protein 
(MAP) kinases, are the earliest known kinases activated by AngII. The p38 MAP kinase is 
also activated in response to AngII. MAP kinases are activated by phosphorylation of 
adjacent threonine and tyrosine residues (Eguchi S et al. 2000). 
 
AngII also plays the role of a growth factor. Indeed, AngII binding to AT1 receptor 
triggers autophosphorylation of the Janus kinases (JAKs), members of a family of 
intracellular tyrosine kinases, which then in turn phosphorylate the Stat proteins that belong 
to the family of the transducers and activators of transcription. Phosphorylated Stat proteins 
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form dimers and translocate to the nucleus, inducing specific gene transcription (Touyz RM 
2002). 
 
Many other kinases are yet activated by AngII. These include phosphatidylinositol 
3- kinase (PI3-K) and its effector Akt/protein kinase B, tyrosine kinases, and tyrosine 
phosphatases. 
 
Finally, AngII is known to modulate cAMP production, either through a Gi-
mediated inhibition of adenylyl cyclase or through potentiation of the activity of a Ca2+ -
sensitive adenylyl cyclase involving AngII-induced capacitative Ca2+ influx (Rossier MF et 
al. 2001).  
 
 
 
Figure 5: The AT1 receptor signaling pathway. Capponi AM 2003 
 
 
AT2 receptor signaling: 
 
The AT2 receptors are involved in developmental processes and in vascular and 
cardiac remodeling. AT2 receptors couple to G-proteins as do most of the seven-
transmembrane-domain receptors (Nouet S et al. 2000) (Figure 6). 
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The binding of AngII to AT2 receptors leads to activation of tyrosine or serine-
threonine phosphatases, which then mediate inactivation of the ERK pathway (Nouet S et al. 
2000). 
 
Some of the effects of AngII also involve the generation of nitric oxyde (NO), 
which in turn activates a cytosolic guanylyl cyclase and leads to cyclic guanosine 
monophosphate (cGMP) production (Nouet S et al. 2000). 
 
AT2 receptor activation also triggers the generation of arachidonic acid through 
stimulation of phospholipase A2 (PLA2). Interestingly, arachidonic acid activates then the 
MAP kinase cascade (Nouet S et al. 2000). 
 
 
Figure 6: The AT2 receptor signaling pathway. Capponi AM 2003 
 
 
Effect of Angiotensin II on mineralocorticoid biosynthesis 
 
 
Angiotensin II is one of the main physiological regulators of aldosterone 
biosynthesis in the zona glomerulosa of the adrenal cortex. The hormone stimulates 
intracellular cholesterol mobilization to the mitochondrion for steroid biosynthesis, as 
follows. Plasma low- and high-density lipoproteins are the major source of cholesterol for 
most steroid hormone-producing tissues. The uptake of low density lipoprotein (LDL)-
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derived cholesterol esters (CE) involves binding of the LDL particles to specific cell surface 
receptors followed by internalisation of the lipoprotein-receptor complex and lysosomal 
hydrolysis leading to the release of CE. In contrast, the delivery of CE from high density 
lipoproteins (HDL) takes place through a distinct mechanism termed the “selective pathway”, 
and it involves binding of HDL to the cell surface followed by delivery of CE into the cells 
without internalisation of the lipoprotein particles. The lipid-poor HDL then dissociate from 
the cells and reenter the circulation. In adrenocortical cells, lipoprotein-derived CE are stored 
within lipid droplets. After acute hormonal stimulation, these CE are hydrolyzed to free 
cholesterol by the cytosolic cholesterol ester hydrolase (Cherradi N et al. 2003). Cholesterol 
is then transported to the mitochondrion for its conversion to cortisol and aldosterone 
(Cherradi N et al. 2001; Rhainds D et al. 2004).  
 
The membrane receptor for HDL that mediates cholesterol uptake through a 
selective pathway is termed scavenger receptor class B type I (SR-BI). SR-BI is believed to 
bind to the α-helical repeats of apolipoprotein A-I (ApoA-I). It has been suggested that this 
interaction leads to the formation of a nonaqueous channel through which CE move down 
their concentration gradient to the plasma membrane. Because SR-BI has been shown to bind 
not only HDL but also LDL and modified LDL, it is likely that this receptor may also affect 
LDL metabolism in vivo. Tissue distribution studies revealed that SR-BI is expressed in the 
liver, where it contributes to the clearance of plasma CE in reverse cholesterol transport, and 
in steroidogenic tissues, where it is particularly abundant in the adrenal gland. This expression 
is induced by trophic hormones such as hCG , ACTH, and LH. Also, HDL are significantly 
more effective than LDL in supplying cholesterol for corticosterone production in adrenal 
glands of the rat and mouse. HDL are also a source of cholesterol for steroidogenesis in 
human ovarian cells. Finally, it has been recently shown that Angiotensin II regulates the 
scavenger receptor class B type I-mediated selective transport of HDL cholesterol ester across 
the cell membrane as a major source of precursor for mineralocorticoid biosynthesis in 
adrenal cells (Cherradi N et al. 2001; Rhainds D et al. 2004).  
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Endocrine system and hormones 
 
 
The endocrine system includes all of the endocrine organs that release hormones 
into the bloodstream (Figure 7). Together with the nervous system the endocrine system 
regulates many parameters which must be homeostatically maintained.  
 
The activities of the endocrine system and the nervous system are tightly 
coordinated. The endocrine system uses hormones as chemical messengers to allow one tissue 
or organ in the body to control another tissue or organ while the nervous system uses 
electrical signals (action potentials) to regulate physiological functions. 
 
 
 
 
Figure 7: Major endocrine glands. American Medical Association, www.ama-assn.org 
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The classification of the hormones is based on their chemical structure: 
 
Peptide (protein) hormone = a chain (sequence) of amino acids linked together by peptide 
bonds. 
Steroid hormone = a ring-like structure (cyclopentanoperhydrophenanthrene) that is a 
derivative of cholesterol. 
Amine hormone = a hormone containing a special nitrogen containing chemical group (an 
amine); usually a derivative of the amino acid tyrosine. 
Fatty acid hormone = a hormone derived from a fatty acid. 
Hormones with different chemical structures cause their cellular effects in 
different ways (Figure 8).  
 
Figure 8: Hormones structures and pathways. BioMedical Science 108, Human physiology, 
www.biosbcc.net 
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The adrenocortical hormones 
 
 
The adrenocortical hormones are steroid hormones secreted by the adrenal glands. 
Steroids are hydrophobic hormones and among them are (Table 2): 
 
 
Pregnenolone: produced directly 
from cholesterol, the precursor 
molecule for all C18, C19 and C21 
steroids 
 
Progesterone: a progestin, produced 
directly from pregnenolone and 
secreted from the corpus luteum, 
responsible for changes associated 
with luteal phase of the menstrual 
cycle, differentiation factor for 
mammary glands 
 
Aldosterone: the principal 
mineralocorticoid, produced from 
progesterone in the zona glomerulosa 
of adrenal cortex, raises blood 
pressure and fluid volume, increases 
Na+ uptake 
 
Testosterone: an androgen, male sex 
hormone synthesized in the testes, 
responsible for secondary male sex 
characteristics, produced from 
progesterone 
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Estradiol: an estrogen, the principal 
female sex hormone, produced in the 
ovary, responsible for secondary 
female sex characteristics 
 
Cortisol: dominant glucocorticoid in 
humans, synthesized from 
progesterone in the zona fasciculata 
of the adrenal cortex, involved in 
stress adaptation, elevates blood 
pressure and Na+ uptake, numerous 
effects on the immune system 
 
Table 2: Main steroids structure. Medical Biochemistry, web.indstate.edu 
 
 
The two adrenal glands, each of which weighs about 4 grams in human, lie at the 
superior pole of the two kidneys. Each gland is composed of two distinct parts, the adrenal 
medulla and the adrenal cortex.  
 
The adrenal medulla, the central 20 per cent of the gland, is functionally related to 
the sympathetic nervous system; it secretes the hormones epinephrine and norepinephrine in 
response to sympathetic stimulation. In turn, these hormones cause almost the same effects as 
direct stimulation of the sympathetic nerves in all parts of the body. 
 
The two major types of adrenocortical hormones secreted by the adrenal cortex are 
the mineralocorticoids and the glucocorticoids (Figure 9). In addition to these, small amounts 
of sex hormones are secreted, especially androgenic hormones. The mineralocorticoids have 
gained this name because they especially affect the electrolytes of the extracellular fluids, 
sodium and potassium in particular. The glucocorticoids have gained their name because they 
exhibit an important effect in increasing blood glucose concentration. They have additional 
effects on both protein and fat metabolism. More than 30 steroids have been isolated from the 
adrenal cortex, but only two are of exceptional importance to the normal endocrine function 
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of the human body: aldosterone, which is the principal mineralocorticoid, and cortisol, which 
is the principal glucocorticoid. 
 
 
Figure 9: Synthesis of the various adrenal steroid hormones from cholesterol. Enzymatic steps of 
adrenocorticosteroid biosynthesis. Only the terminal hormone structures are included. 3β-DH is 3 β -
dehydrogenase, P450c11 is 11 β -hydroxylase, P450c17 is 17α-hydroxylase, P450c21 is 21 β -hydroxylase. 
Adapted from Encyclopedia of hormones, AademicPress, 2003 
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Mineralocorticoid biosynthesis 
 
 
Adrenal steroid hormones are thus grouped into three main types, 
mineralocorticoids, glucocorticoids, and androgens (Figure 10). Mineralocorticoids are 
synthesized in the zona glomerulosa, whereas glucocorticoids and androgens are synthesized 
in the zona fasciculata and zona reticularis, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: The various zones of the adrenal cortex 
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Chemistry of the steroid hormones: 
 
Steroids are relatively complex organic molecules with approximately 18-27 
carbon atoms. Steroids are derived from a phenanthrene ring structure to which a pentano ring 
has been attached.  
 
In all cases the biosynthesis of adrenal steroids starts with cholesterol, which is 
incorporated into adrenal cells through binding of cholesterol-enriched lipoproteins to their 
specific cellular membrane receptors. These occupied receptors are then internalized. In 
lipoproteins, cholesterol is largely esterified. Free cholesterol is available for immediate use 
in steroid biosynthesis or is reesterified and stored within intracellular droplets. Cholesterol 
can also be synthesized in the adrenal cells from acetate, although this source does not seem 
to be relevant for steroid biosynthesis under physiological conditions (Phillips MC 1987). 
 
The biosynthesis of aldosterone in adrenal zona glomerulosa cells is usually 
divided into early and late pathways. The early pathway reactions wholly transform 
cholesterol into 11-deoxycorticosterone (DOC); in the late pathway reactions, mitochondria 
transform DOC into aldosterone (Phillips MC 1987). 
 
Free cholesterol, obtained by the action of specific esterases, is incorporated into 
adrenal mitochondria and its side chain is cleaved by mitochondrial inner membrane 
cytochrome P450scc via two hydroxylations at positions C-20 and C-22 of the 27-carbon 
cholesterol molecule; this is followed by excision of a fragment, C-22 to C-26. The product, 
pregnenolone, is a 21-carbon steroid, the precursor from which all C18, C19, and C21 
steroids are produced (Phillips MC 1987). 
 
Two kinds of reactions, hydroxylations and dehydrogenations, occur in the 
metabolic pathways that produce mineralocorticoid hormones from cholesterol. 
Dehydrogenases catalyze the oxidation of the cholesterol molecule through loss of two 
hydrogen atoms, using nicotinamide adenine dinucleotide (NAD) as cofactor; 
dehydrogenases are mainly found in the microsomal subcellular fractions of adrenal cells. 
Enzymes of the cytochrome P450 family mediate hydroxylations. Some of these P450 
cytochromes (P450scc, 11,18-hydrolase/aldosterone synthase, CYP11B1, and CYP11B2) are 
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localized in inner mitochondrial membranes and others (21-hydrolase, 17α-hydrolase) are in 
microsomes (Rainey WE et al. 1999; (Phillips MC 1987). 
 
Cytochrome P450 enzyme systems are protein complexes consisting of an electron 
transfer chain that takes reducing equivalents from the reduced form of NAD phosphate 
(NADPH), which is thus converted to NADP, provoking reduction of intermediate specific 
proteins. These proteins finally pass the electrons to heme group of cytochrome P450. 
Trivalent iron in cytochrome P450 molecules is thereby transformed into the ferrous form, 
which has high affinity for molecular oxygen; divalent iron is then oxidized to the ferric form 
and iron-bound oxygen is reduced. These steps yield water and a hydroxyl group that is 
incorporated into the steroid molecule, provoking its oxidation. This last step takes place at 
the active site of the enzyme (cytochrome P450 protein) (Cozza EN et al. 2003).  
 
 
The ∆4 pathway: 
 
The biosynthetic pathway from pregnenolone to aldosterone is able to occur 
through 3β-ol-∆5 or 3-keto-∆4 pathways, the last one being considered as the normal or main 
pathway. In the ∆4 pathway, pregnenolone leaves the mitochondria and is converted to 
progesterone. The conversion of pregnenolone to progesterone is catalyzed by the enzyme 3β-
hydroxysteroid-dehydrogenase ∆5 /∆4 isomerase (3βHSD); the process consists of 
dehydrogenation at the hydroxyl group of C-3 of pregnenolone, yielding a keto group, with 
subsequent migration of the double bond from C-5-C-6 to C-4-C-5. 3β-ol-dehydrogenase ∆5 
/∆4 isomerase is the key enzyme for switching from the ∆5 to the ∆4 pathway (Cherradi N et 
al. 1995). Recent reports have also demonstrated the presence of 3βHSD within the 
mitochondria (Cherradi N et al. 1997). 
 
Progesterone is then metabolized to 11-deoxycorticosterone; this is accomplished 
by microsomal cytochrome P450scc, which introduces a hydroxyl group at position C-21 of 
the substrate. DOC behaves as a mineralocorticoid, but is not as potent as aldosterone. 
 
The last step of aldosterone production is mitochondrial and involves the 
conversion of DOC to aldosterone by means of three hydroxylations, one on C-11 and two 
subsequent hydroxylations on C-18. The overall result of these three hydroxylations is 
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inclusion of a hydroxyl group at C-11, followed by transformation of the methyl group at C-
18 to an aldehyde group (aldosterone) (Cozza EN et al. 2003). 
 
The enzyme involved in the conversion of DOC to aldosterone is species 
dependent. Bovine and porcine adrenal glands express the cytochrome P450 11β/18-
hydroxylase/aldosterone synthase, whereas human, rat and mouse adrenal glands express 
cytochrome P450 CYP11B2. Both enzymes catalyze the three hydroxylation steps in 
glomerulosa cells of each species, but the difference is that, apparently, cytochrome P450 
11β/18-hydroxylase/aldosterone synthase is also expressed in bovine and porcine adrenal 
fasciculata cells, but without producing aldosterone. In other words, aldosterone synthase 
activity of this enzyme seems to be inhibited in the fasciculata. In contrast, species expressing 
CYP11B2 in glomerulosa cells produce a different cytochrome P450, CYP11B1, for 11 β- 
and 18-hydroxylations of DOC in adrenal fasciculata cells. DOC is thus transformed into 
corticosterone by 11β-hydroxylation and is further hydroxylated at C-18 to yield 18-
hydroxycorticosterone, which is finally 18-hydroxylated once again to produce aldosterone 
(Fisher A et al. 2001; MacKenzie SM et al. 2000; Rang HP et al. 1995).  
 
 
Structure of aldosterone: 
 
The monocyclic form of aldosterone (Figure 11) is obtained by the attack of the 
negatively charged oxygen atom of the hydroxyl group at C-11 on the positively charged 
carbon atom of the carbonyl group of the aldehyde at C-18. As a consequence of this reaction 
11,18-oxygen-bridged monocyclic aldosterone is obtained, with a hydroxyl group at C-18. It 
is important to remark that this form of aldosterone could be considered the 18-hydroxylated 
derivative of 11,18-epoxycorticosterone. In other words, the monocyclic form of aldosterone 
may be obtained directly, without passing through free-aldehyde stage, by hydroxylation at 
C-18 of 18-deoxyaldosterone. 
 
The bicyclic form of aldosterone is then obtained when, similar to the previously 
described process, the oxygen of the hydroxyl group at C-18 of the monocyclic structure of 
aldosterone attacks the carbon of the carbonyl group at C-20. This reaction produces a 
bicyclic form consisting of a C-11-oxygen-C-18 ring, a C-19-oxygen-C-20 ring, and a 
hydroxyl group at C-20. This characteristic formation of cyclic structures is not exclusive to 
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aldosterone; other steroids, such as 18-hydroxycorticosterone (a precursor of aldosterone in 
the main pathway), have the ability to form a C-18-oxygen-C-20 cyclic form, via attack of the 
hydroxyl group at C-18 on the carbonyl group at C-20, also introducing a hydroxyl group in 
the cyclic product. Open forms of 18-hydroxycorticosterone are practically nonexistent in 
ordinary solutions, including biological fluids (Cozza EN et al. 2003). 
 
Of particular interest is the behavior of these steroids in acidic media. Aldosterone 
and 18-hydroxycorticosterone yield dimeric structures when placed in acidic solutions. 18-
Hydroxycorticosterone is also converted to 11,18-epoxycorticosterone under the same 
conditions. All of these products present much higher hydrophobicity, compared to their 
mother compounds. It is possible that less polar forms of these steroids favor their transport 
across cellular membranes (plasmatic, microsomal, and mitochondrial). Acidic conditions in 
vivo may exist in particular regions near proton pumps and/or in some organelles. 
 
The conversion of 18-hydroxycorticosterone to aldosterone is the last step of the 
main biosynthetic pathway. 18-hydroxycorticosterone, the immediate precursor of 
aldosterone, needs a C-18 hydroxylation and dehydration, in order to be converted to the 
mineralocorticoid.  
 
 
 
 
 
 
Figure 11: Structure of aldosterone. Rafestin-Oblin ME et al. 2003 
 
 
Extra-adrenal biosynthesis of aldosterone: 
 
The adrenal zona glomerulosa is the main locus for the biosynthesis of 
aldosterone. However, this mineralocorticoid is also synthesized in other tissues, i.e., in the 
central nervous system (mainly hippocampus, cerebellum, and brain cortex), heart, kidney, 
and vascular system (Connell JM et al. 2005). Because the quantities of aldosterone 
biosynthesized in these tissues are around 100 times lower than in adrenal cortex, it is 
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postulated that the mode of action of the mineralocorticoid in the nonadrenal organs is 
autocrine (acting on the same cell) or paracrine (acting on the closest cells), rather than 
systemic (being secreted to blood). As an example, aldosterone produced by vascular smooth 
muscle cells mediates, in an autocrine manner, angiotensin II-stimulated cell proliferation. 
Independently of the particular role of aldosterone in each case, the general overview of 
aldosterone biosynthesis is that it is believed to be focused on cardiovascular homeostasis 
(Hatakeyama H et al. 1994; Matkovic LB et al. 2003). 
 
The biosynthesis of aldosterone in extra-adrenal tissues has been demonstrated to 
be carried out by the same enzymatic machinery found in the adrenal zona glomerulosa. 
Expression and activity of CYP11B2 in the nervous system, heart, kidney, and vascular 
system have been revealed by different experimental approaches in many animal species. 
 
 
Regulation of aldosterone biosynthesis: 
 
The function of aldosterone is to stimulate sodium absorption from the distal renal 
tubule; water is passively absorbed with sodium. The major stimuli for aldosterone secretion 
are hypovolemia, hyponatremia, and low renal perfusion pressure (Muller J et al. 1998). 
However, none of these stimuli directly affects the zona glomerulosa; instead, they are 
channeled through the kidney, because it has the most to lose if blood pressure falls too much. 
Under this last situation, the kidney is not able to remove wastes from the body. 
 
 
Physiological effects of mineralocorticoid  
 
 
Aldosterone has two major physiological functions: it regulates the total amount of 
sodium in the body and, consequently, the extracellular fluid volume and it regulates 
potassium homeostasis.  Normal plasma sodium concentration is 136-145 mM; normal 
plasma potassium concentration is 3.5-5.0 mM. Changes in sodium levels lead to changes in 
plasma osmolality. Changes in plasma potassium levels alter membrane potential and, 
consequently, have major effects on excitatory tissues, such as those in the muscles, the heart, 
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and the nervous system. Therefore, the levels of sodium and potassium in the plasma must be 
tightly regulated.  
 
In the kidney, the primary target segment of aldosterone is the distal tubule and the 
cortical collecting duct. Mineralocorticoid effects on sodium and potassium transport take 
place in the major cell type of this nephron segment, the principal cells. Sodium enters the 
principal cells from the urine, through luminal sodium channels (EnaC), along the 
electrochemical gradient; it is extruded from the cells by a Na+, K+-ATPase located in the 
basolateral membrane. The basolateral Na+, K+-ATPase also creates the driving force for 
potassium to exit from the cells into urine via luminal K+-selective channels (Alvarez de la 
Rosa D et al. 2000; Verrey F et al. 1999). 
 
Aldosterone stimulates active sodium reabsorption from the urine into the blood 
by a complex action, which results in increased activity of Na+, K+-ATPase as well as in 
increased conductive capacity of luminal sodium channels. 
 
Because water follows passively sodium, an increase in sodium reabsorption 
necessarly results in expansion of extracellular fluid volume and in an increase in blood 
pressure. Therefore, chronic overproduction of aldosterone leads to pathological conditions 
accompanied by hypertension. 
 
Although the main physiological effect of aldosterone is stimulation of Na+ 
reabsorption, aldosterone also regulates potassium excretion by increasing K+ secretion from 
the blood into the tubular lumen. This action takes place predominantly in the principal cells 
of the cortical collecting ducts. Pumping Na+ out of the cell is coupled to increased pumping 
of K+ into the cell. This event creates a favorable electrochemical driving force for K+ to exit 
from the cell into the lumen through K+-selective ion channels. 
 
In addition to its effects on sodium and potassium transport, aldosterone also 
enhances the excretion of H+ ions in the collecting ducts. H+ transport takes place in the 
minor cell type of the collecting duct, the intercalated cells. 
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Mineralocorticoids and hypertension 
 
 
Aldosterone action on blood pressure: 
 
The renal sodium-retaining effects of aldosterone were first described over 50 
years ago. Now it is clear that mineralocorticoids such as aldosterone can induce the synthesis 
of components of Na+, K+-ATPase and can directly increase the apical mucosal membrane 
conductance to sodium by enhancing the open probability for the sodium channel located 
within that membrane. 
 
Mineralocorticoid receptors are found in the distal nephron, principally in the 
cortical collecting tubule. Under physiological conditions, aldosterone affects the 
reabsorption of approximately 3% of the sodium filtered by the glomerulus. Continuous 
exposure to aldosterone results in a state of positive sodium balance and can expand the 
extracellular fluid space sufficiently to produce mild edema and hypertension (Rossier BC et 
al. 1997). The progressive increase in extracellular volume induced by mineralocorticoid 
eventually reaches a limit, however, and renal tubular “mineralocoticoid escape” occurs. The 
escape, mediated largely through a decreased reabsorption of sodium in the proximal tubule, 
allows for sodium balance to be reestablished, but at a new steady state. Even with the 
activation of the escape process and normalization of the extracellular fluid space, the 
hypertension most often persists. Thus chronic mineralocorticoid exposure influences blood 
pressure in non-volume-dependent ways (Melby JC et al.1989). 
 
Mineralocorticoids also do exert specific effects on the arterial vascular network, 
independently of extracellular volume and systemic blood pressure. Vascular smooth muscle 
cells have the ability to directly synthesize minute quantities of aldosterone and angiotensin II 
induces CYP11B2, the enzyme responsible for aldosterone synthesis in vascular tissue 
(Hatakeyama H et al.1994). Aldosterone in turn, augments the vascular effects of angiotensin 
II by directly up-regulating angiotensin II receptor (AT-1 type) number in the vascular 
smooth muscle cells (Gomez-Sanchez CE et al.2001). 
 
Chronic exposure to both angiotensin II and aldosterone promotes the generation 
of type I and type III collagen in the heart and aorta, resulting in an increase in interstitial 
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fibrosis that is independent of blood pressure (Weber KT et al. 1995). Angiotensin II, unlike 
aldosterone, also inhibits collagenase activity, preventing or delaying the breakdown of 
preformed collagen. The net effect of the interstitial fibrosis induced by both aldosterone and 
angiotensin II is to decrease vessel compliance. The diminished arterial compliance is a 
contributing factor in the evolution of systolic hypertension (Gomez-Sanchez CE et al.2001; 
Kornel L et al. 1993). 
 
Mineralocorticoids also exert their effects on blood pressure through actions in the 
brain (Connell JM et al. 2005. This central form of hypertension appears to be mediated by a 
generalized increase in sympathetic tone with an accompanying rise in vascular resistance. 
Concentrations of aldosterone, which would produce no visible systemic effect, can produce 
hypertension when placed directly into the brain. 
 
 
Aldosterone-dependent conditions: 
 
Primary hyperaldosteronism should be considered as a cause of hypertension in 
patients who present with hypokaliemia and metabolic alkalosis (Herpin D et al. 2003). 
Although plasma renin and aldosterone levels are dependent on dietary sodium and position 
(lying versus standing), plasma renin is maximally suppressed in cases of primary 
hyperaldosteronism. Adrenocortical adenoma is among the most common causes of primary 
hyperaldosteronism (Ganguly A. 1998). Adrenal carcinomas are quite rare but also can 
secrete aldosterone. 
 
Bilateral nodular adrenal hyperplasia, or idiopathic hyperaldosteronism, is the next 
most common cause of excess aldosterone secretion (Ganguly A. 1998). In contrast to adrenal 
adenomas, plasma renin may be only partially suppressed. There is some evidence that 
adrenal glomerulosa cells have increased sensitivity to the normal activators of aldosterone 
secretion, including angiotensin II.  
 
Glucocorticoid-remediable hyperaldosteronism is a rare autosomal dominant 
inherited condition in which adrenal glomerulosa cells respond inappropriately to ACTH 
(Dluhy RG et al. 1996). Affected patients exhibit a chimeric gene crossover between the 11β-
hydroxylase and the aldosterone synthase. Treatment with exogenous glucocorticoids such as 
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dexamethasone suppresses the secretion of ACTH from the pituitary gland, thereby 
attenuating the release of aldosterone. 
 
 
Conditions mimicking aldosterone excess: 
 
The syndrome of apparent mineralocorticoid excess was first described in children 
who demonstrated sodium retention, potassium wasting, and hypertension without 
measurable elevations in either renin or aldosterone. This syndrome is associated with MR 
activation and it can be successfully treated with spironolactone, an aldosterone antagonist. 
11β-hydroxysteroid dehydrogenase (11- βHSD2) converts active endogenous glucocorticoids 
to their respective 11-dehydro derivatives and confers aldosterone specificity on the 
mineralocorticoid receptors (MR). The 11-dehydro metabolites of cortisol and corticosterone 
are not able to directly activate mineralocorticoid receptors and induce a primary biologic 
effect. Although increased renal sodium retention was thought to be the principal cause of 
hypertension in this disease, effects of nonmetabolized glucocorticoids in the vasculature due 
to diminished 11- βHSD local tissue activity may also be a factor in the development of 
hypertension (Kitanaka S et al. 1996). Glucocorticoids and mineralocorticoids are known to 
potentiate the vasoconstrictive effects of both catecholamines and angiotensin II. 
Glucocorticoids further amplify the contractile effects of catecholamines and angiotensin II 
when 11- βHSD enzyme activity is inhibited. 
 
 
Liddle’s syndrome: 
 
Dysregulation of sodium channel (ENaC channel) within the epithelial cells of the 
cortical collecting tubule can result in a syndrome that mimics hyperaldosteronism, but 
plasma renin and aldosterone values are maximally suppressed. Liddle’s syndrome, a rare 
autosomal dominant disorder, results from a defective β-subunit of the epithelial sodium 
channel present in the cortical collecting duct cell apical membrane (Warnock DG, 1998). 
This channel is normally activated by mineralocorticoids, but in this case is activated 
independently of hormone stimulation, resulting in sodium retention, potassium secretion, 
metabolic alkalosis, and hypertension. The hormonal response is mediated by altered gene 
expression, leading to an increase in ENaC activity (Shigaev A et al. 2000; Ferrari P 2002).  
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Steroid receptors 
 
 
Steroid receptors are proteins found in the cytoplasm or nucleus of eukaryotic 
cells, which bind to and regulate the transcription of DNA under the regulation of steroid 
hormones. Receptors for the different hormones have strong structural and functional 
similarities which point to an evolution from a common ancestral gene and therefore they are 
considered a gene superfamily. 
The hormone receptor superfamily can be divided into three functionally distinct 
subfamilies. These subfamilies are as follows. Type I are classical steroid hormone receptors, 
which include the glucocorticoid receptors (GR, including cortisol receptor), androgen 
receptors, mineralocorticoid receptors (MR, including aldosterone receptor), and progesterone 
receptor. Type II consists of thyroid hormone related receptors including T3R, RAR, RXR, 
and VDR. Type III is formed by the estrogen receptor (ER) and a few orphan receptors.  
Nuclear receptors bind to only one of two possible consensus sequences half-sites 
on DNA. These two half-sites can combine in various orientations and with different spacing, 
allowing binding of head-to-head, head-to-tail, or tail-to-tail receptor homo- or hetero-dimers. 
However, the diversity of HRE is insufficient to account for the observed spectrum of 
specificity in gene regulation by individual receptors. For instance, the MR, the GR, and the 
androgen and progesterone receptors have identical DNA binding specificity but mediate very 
different biological actions. Thus far no HRE has been identified that can distinguish between 
MR and GR (Funder WF et al. 2003). 
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Mineralocorticoid receptors 
 
 
The mineralocorticoid receptors as mediator of aldosterone action: 
 
The mineralocorticoid receptors (MR) are found in varying abundance in both 
epithelial and nonepithelial tissues. In addition, MR have equivalent affinity for aldosterone, 
the physiologic mineralocorticoid, and the physiologic glucocorticoids such as cortisol and 
corticosterone, which circulate at ~ 1000-fold higher plasma levels. In classical 
mineralocorticoid target tissues, aldosterone access to MR involves the expression of high 
levels of the enzyme 11βhydroxysteroid dehydrogenase type 2 (11βHSD2), which converts 
cortisol and corticosterone to their cognate, receptor-inactive 11-ketosteroids. In several 
nonepithelial tissues, 11βHSD2 is also co-expressed with MR, consistent with such tissues 
(vascular smooth muscle, amygdala, and placenta) also being physiologic aldosterone target 
tissues. In other nonepithelial tissues, MR are unprotected and thus presumably essentially 
always occupied by glucocorticoids. In 11βHSD2 protected tissues, cortisol and 
corticosterone mimic the effect of aldosterone, if and when they can access MR, whereas in 
unprotected tissues, the glucocorticoids appear to function as MR antagonists and 
inappropriate occupancy by aldosterone may have very deleterious effects (Alzamora R et 
al.2000).   
 
Aldosterone exerts its effects through binding to MR, which are intracellular 
receptors. Mineralocorticoids, like other steroids, enter the cell by passive diffusion. Ligand 
binding induces a structural change in the MR. The activated MR then interacts with specific 
regulatory segments, hormone response elements (HRE), on the chromatin. This interaction 
results in an increase (or decrease) of the transcription of specific genes (Figure 12). MR are 
present in target tissues in the renal collecting duct system, the colon, and sweat glands, for 
example; in addition, they can be found in the heart and in the muscular walls of vessels, as 
well as in the brain, where their function is still not clear. 
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Figure 12: Mineralocorticoid receptors signaling. www.neurosci.pharm.utoledo.edu 
 
 
Natural mutations of mineralocorticoid receptors: 
 
Loss-of-function mutations of the MR have been identified in several patients with 
autosomal dominant or sporadic pseudohypoaldosteronism type 1 (Tajima T et al. 2000; 
Viemann M et al. 2001). On the other hand, there has also been a description of a MR 
activating mutation that causes early-onset hypertension exacerbated during pregnancy 
(Geller DS et al. 2000). This mutation modifies the selectivity of the receptor, so that 
progesterone and the antimineralocorticoid drug spironolactone become potent activators of 
the mutant receptor (Lifton RP et al. 2001). This identification of naturally occurring 
activating and inactivating mutations of the MR highlights its central role in the regulation of 
blood pressure. 
 
 
Mineralocorticoid effects on gene expression   
 
 
Mineralocorticoids stimulate Na+ reabsorption by changing the transcriptional 
activity of specific genes. The two most important effector molecules in aldosterone-induced 
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Na+ reabsorption are the epithelial Na channel present in the apical luminal membrane of Na+ 
absorbing cells and the basolateral Na+, K+-ATPase (Berger S et al. 1998). Aldosterone 
increases the expression of both of these proteins. In addition, aldosterone rapidly increases 
the insertion of active epithelial Na channel subunits into the apical membrane and might 
activate these channels already present in the apical membrane (Figure 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Model for the mechanism of aldosterone action in epithelial target cell. During the physiological 
lag phase, the mRNA and protein levels of early aldosterone-induced/repressed gene products are up-regulated. 
K-Ras and SGK are the first early induced regulatory proteins identified as yet that appear to be involved in 
ENaC regulation. Aldosterone has also been shown to rapidly activate or repress the expression of transcription 
factors involved in differentiation or proliferation, respectively, thus tuning genome programming toward 
differentiation. The decrease in c-myc, c-fos and c-jun mRNAs is independent of transcription. In several target 
epithelia, aldosterone also promotes the synthesis of ENaC, Na+,K+-ATPase, and other elements of the Na+ 
transport machinery. Although some of these latter anabolic effects are initiated very early (that is, induction of 
Na,K-ATPase and LAT1 transcription in A6 cells), they functionally belong to the late phase of aldosterone 
action. Verrey F et al. 2000 
 
 
Early aldosterone-induced gene: 
 
Serum- and glucocorticoid-induced kinase (sgk), a serine/threonine kinase, has 
been recently identified as the product of an early-induced, aldosterone-regulated gene. This 
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kinase is capable of increasing epithelial Na channel current and insertion of these channel 
molecules into the plasma membrane and thus is probably an important mediator of the early 
effect of aldosterone on Na+ reabsorption (Verrey F et al. 1999). 
 
 
Nonclassical aldosterone targets: 
 
In addition to its effects on ion transport in epithelial cells, aldosterone, under 
certain conditions, has been shown to have effects on other tissues, such as the brain, the 
heart, and vascular smooth muscle cells (Funder JW et al. 1988 and 2000). These effects 
include elevation of blood pressure following intracerebral ventricular infusion of 
aldosterone, increase in salt appetite, interstitial fibrosis in the heart (Young M et al. 2000), 
and rapid effects on activity of the Na/H exchanger. 
 
 
Mineralocorticoid disorders 
 
 
Mineralocorticoid biosynthesis and metabolism are affected by certain genetic disorders.  
 
Figure 14: Genetic disorders of steroid hormone synthesis and metabolism. Marshall I et al. 2003 
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11β-hydroxylase deficiency: 
 
The most potent corticosteroids are 11β -hydroxylated compounds. In humans, 
two cytochrome P450 isoenzymes with 11β -hydroxylase activity, catalyzing the biosynthesis 
of cortisol and aldosterone, are present in the adrenal cortex. CYP11B1, the gene encoding 
11β -hydroxylase (P450c11), is expressed at high levels in the zona fasciculata and is 
regulated by ACTH. CYP11B2, the gene encoding aldosterone synthase (P450c11Aldo), is 
expressed in the zona glomerulosa under primary control of the renin-angiotensin system. 
Mutations in CYP11B1 cause congenital adrenal hyperplasia (CAH) due to 11β -hydroxylase 
deficiency. This disorder is characterized by androgen excess and hypertension. Mutations in 
CYP11B2 cause congenital hypoaldosteronism (aldosterone synthase deficiency), which is 
characterized by life-threatening salt loss, failure to thrive, hyponatraemia and hyperkalaemia 
in early infancy. Both disorders have an autosomal recessive inheritance (Peter M et al. 
1999). 
 
A deficiency of the enzyme 11β-hydroxylase is caused by inactivating mutations 
in the CYP11B1 gene located on chromosome 8 (White PC et al. 1994). 11β-hydroxylase 
catalyzes the conversion of DOC to corticosterone in the mineralocorticoid pathway and 11-
deoxycortisol to cortisol in the glucocorticoid pathway. A deficiency of the enzyme with 
resultant low plasma cortisol leads to chronic elevation of ACTH, with subsequent increased 
synthesis and secretion of steroid intermediates proximal to the 11β-hydroxylase block and 
their non-11β-hydroxylated products. Accumulation of these precursors produces the typical 
phenotype that characterizes the disorder (Peter M et al. 1999). Excessive production of DOC 
and its metabolites exerts a net mineralocorticoid effect. Sodium retention and volume 
expansion occur, with suppression of renin production. Hypertension occurs in approximately 
two-thirds of untreated patients and is variable in childhood. Hypokaliemia is variable, 
developing concomitantly with sodium retention. Aldosterone production is low, secondary to 
low plasma renin activity and low serum potassium concentrations (Cerame BI et al. 1999; 
Peter M et al. 1999).  
 
The precursors that accumulate in the glucocorticoid pathway are channeled into 
androgen pathway and result in prenatal virilization, with varying degrees of genital 
ambiguity in the affected newborn female. 
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Treatment of 11β-hydroxylase deficiency consists of glucocorticoid replacement; 
this approach is effective because it fulfills systemic steroid requirements, and by providing 
feedback inhibition of ACTH release, it reduces the drive on the adrenal for the synthesis and 
secretion of precursor steroids. 
 
 
Aldosterone synthase deficiency: 
 
Deficiency of the aldosterone synthase enzyme, which catalyses the three steps in 
the conversion of DOC to aldosterone, results from mutations in CYP11B2, the gene that 
encodes this mitochondrial cytochrome P450 enzyme. Two types have been described. Type 
1 results from deficiency of the 18-hydroxylase enzyme and is usually characterized 
biochemically by reduced levels of 18OHB and very low levels of urinary aldosterone 
metabolites. Type 2, which is characterized by increased levels of 18OHB and reduced 
urinary levels of aldosterone metabolites, results from deficiency of 18-oxidase enzyme 
(Peter M et al. 1999). 
 
Aldosterone synthase deficiency presents in infancy with renal salt wasting, which 
can lead to dehydration, shock and even death if not treated. Plasma renin activity is increased 
secondary to low aldosterone levels. Cortisol synthesis is unaffected. 
 
Patients are treated with mineralocorticoid replacement therapy in addition to 
sodium supplementation. Often, replacement therapy is not required after childhood when 
compensatory extrarenal salt-conserving mechanisms mature with age. 
 
 
Glucocorticoid-remediable aldosteronism: 
 
Glucocorticoid-remediable aldosteronism (GRA) is a familial form of low renin 
hypertension, which is inherited as an autosomal dominant disorder. 
 
The disease is characterized by hyperaldosteronism and excessive secretion of two 
normally rare steroids, 18-oxocortisol and 18-hydroxycortisol. The presence of these two 
steroids suggests the simultaneous presence of 17α-hydrolase and aldosterone synthase 
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activities, which are normally limited to the zona fasciculata and the zona glomerulosa, 
respectively (Dluhy RG et al. 1999). Although there are clinical features similar to those 
found in other forms of primary hyperaldosteronism, the unique distinguishing feature of 
GRA is complete and rapid suppression of aldosterone oversecretion by dexamethasone 
(glucocorticoid) administration. 
 
GRA produces a volume-expanding, salt-sensitive form of low renin hypertension. 
Although hypertension is invariably present, hypokaliemia and metabolic acidosis may be 
absent. Additionally, children demonstrate normal growth and development. 
Circadian measurement of plasma steroids in GRA patients has revealed that not only is 
aldosterone produced in excessive amounts, but is also high following ACTH stimulation, 
suggesting a zona fasciculata origin. 
 
Children with GRA are treated with glucocorticoids, and resolution of their 
hypertension usually occurs within 2 weeks after initiation of therapy. Adults often require 
additional use of antihypertensive medications, such as spironolactone, which blocks the 
action of aldosterone at the mineralocorticoid receptor. 
 
 
Pseudo hypoaldosteronism type 1: 
 
Pseudo hypoaldosteronism type 1 is characterized by loss-of-function mutations 
that cause defective sodium transport due to inability of aldosterone to exert its end-organ 
effect. 
 
An autosomal dominant form, also known as mineralocorticoid resistance, is 
caused by mutations in the MR of the kidney (Geller DS et al. 1998). As a result, aldosterone 
has no effect on the MR in the kidney. The disorder presents in infancy with salt wasting, 
dehydration, and failure to thrive. Owing to the absence of responsiveness to aldosterone, 
there is markedly elevated plasma renin activity, with paradoxically elevated plasma and 
urinary aldosterone. Mineralocorticoid resistance is treated with sodium supplementation, 
which can often be discontinued after infancy as the salt loss may improve with age (Kuhnle 
U et al. 1997). 
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A recessive form of pseudo aldosteronism results from loss-of-function mutations 
in one or more of the genes encoding the α-, β-, and γ-subunits of the amiloride sensitive 
sodium channel, which is present in the kidney as well as in the colon, sweat glands, salivary 
glands, and lungs. This disorder presents in early infancy with salt wasting, due to profound 
urinary sodium loss leading to hyponatremia, and is accompanied by hyperkaliemia and 
metabolic acidosis. Biochemically it is also characterized by elevated plasma renin and 
aldosterone levels. Treatment includes lifelong salt supplementation, often with the addition 
of potassium-binding resins to maintain normokaliemia (Jackson SN et al. 1998). 
 
 
The role of StAR protein in steroid biosynthesis 
 
 
The process by which steroids are synthesized is referred to as steroidogenesis, 
which comprises a series of reactions that are identical in the initial stages. Steroidogenesis 
occurs in specialized cells in specialized tissues within an organism and results in the 
production of tissue-specific steroids.  
 
In most cases, steroids are synthesized in response to steroidogenic stimuli. All of 
the steroid hormones are of great physiological importance. Glucocorticoids, produced in the 
adrenal glands, regulate carbohydrate metabolism and stress response; the adrenal glands also 
synthesize the mineralocorticoids, which are necessary to regulate salt balance and maintain 
blood pressure. The sex steroid hormones, estrogen and progesterone, synthesized in the 
ovary and placenta in the female, are essential for reproductive function and for maintaining 
secondary sex characteristics. These same functions are mediated in the male by androgens 
synthesized in testicular Leydig cells. Neurosteroids, another class of steroids, are synthesized 
in the brain and their functions include both stimulation and inhibition of γ-aminobutyric acid 
(GABA)ergic responses, modulation of the response of specific brain cells to excitatory 
amino acids, and enhancement of memory functions. Thus, the steroid hormones have very 
diverse and important physiological functions within the body. 
 
Cholesterol is the substrate for steroid hormone synthesis. Low-density 
lipoproteins (LDL) are the major source of cholesterol, although other lipoproteins and high-
density lipoproteins (HDL) also contribute to the steroidogenic pool. The scavenger receptors 
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class B, type I (SR-BI), highly expressed on cells producing large amounts of steroids, 
mediate uptake and transcytosis of the HDL across the plasma membrane. Excess cholesterol 
accumulated by steroidogenic cells is stored as cholesterol ester in cytoplasmic lipid droplets 
ready for mobilization by cholesterol ester hydrolase, which is activated by protein kinase A 
in response to tropic hormone stimulation (Connelly MA et al. 2004).  
 
The initial step in steroid hormone synthesis is the cleavage of the cholesterol side 
chain to form pregnenolone. This reaction is catalyzed by an enzyme located on the matrix 
side of the inner mitochondrial membrane consisting of cytochrome side chain cleavage 
(P450ssc); adrenodoxin, an iron sulfur protein electron shuttle; and adrenodoxin reductase, a 
flavoprotein that transfers electrons from NADPH to adrenodoxin. Cholesterol must be 
translocated from the relatively cholesterol-rich outer mitochondrial membrane to the inner 
mitochondrial membrane to come into contact with P450ssc, requiring it to traverse the 
aqueous space separating the two membranes (Stocco DM 2000). The acute regulation of 
steroidogenesis is due largely to the increased delivery of the hydrophobic cholesterol to the 
inner mitochondrial membrane. This acute mode of regulation of steroidogenesis is super-
imposed on the long-term control that includes changes in the transcription of genes involved 
in steroid biosynthesis, cellular cholesterol uptake, and intracellular sterol trafficking. The 
acute increase in steroidogenesis requires a short-lived, cycloheximide-sensitive protein that 
is activated or synthesized in response to tropic hormone stimulation. A 30 kDa 
phosphoprotein, called steroidogenic acute regulatory (StAR) protein, stimulated by tropic 
hormones or cyclic AMP (cAMP) analogues, controls the rate-limiting step in 
steroidogenesis. The 30 kDa protein is localized to mitochondria and is derived from a larger 
precursor molecule (Arakane F et al. 1998; Stocco DM 2000).  
 
The following evidences supports the notion that StAR has a critical role in steroid 
hormone synthesis: 
 
1- Expression of StAR in MA-10 Leydig tumor cells correlates with enhanced 
steroidogenesis (Hiroi H et al. 2004). 
 
2- In monkey kidney COS-1 cells, which are not steroidogenic, co-transfection of StAR 
and the cholesterol side-chain cleavage system results in enhanced steroidogenesis. In 
the absence of StAR, COS-1 cells expressing the cholesterol side-chain cleavage 
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system produce substantial amounts of pregnenolone only when a polar hydroxysterol 
precursor that readily enters into mitochondria is provided as an exogenous substrate. 
However, COS-1 cells expressing both StAR and the cholesterol side-chain cleavage 
enzyme are capable of producing large amounts of pregnenolone from endogenous 
cholesterol (Arakane F et al. 1998).  
 
3- Mutations that inactivate StAR cause congenital lipoid adrenal hyperplasia, a rare 
autosomal recessive disorder in which the synthesis of all adrenal and gonadal steroid 
hormones is severely impaired at the cholesterol side-chain cleavage step, resulting in 
massive accumulation of cholesterol in the adrenal cortex and testicular Leydig cells 
(Miller WL et al. 1999). 
 
4- Targeted deletion of murine StAR gene results in a phenotype in nullizygous mice 
that mimics human congenital lipoid adrenal hyperplasia (Christenson LK et al. 
2001). 
 
 
Congenital lipoid adrenal hyperplasia 
 
 
The clinical phenotype of congenital lipoid adrenal hyperplasia includes the onset 
of profound adrenocortical insufficiency shortly after birth, hyperpigmentation reflecting 
increased production of proopiomelanocortin, elevated plasma renin activity as a consequence 
of reduced aldosterone synthesis, and male pseudo-hermaphroditism resulting from deficient 
fetal testicular testosterone synthesis. Early in the disease, the steroidogenic cells of the 
enlarged adrenal cortices in affected individuals are engorged with lipid droplets containing 
cholesterol esters, giving rise to the condition’s name. Administration of adrenocorticotropic 
hormone or human chorionic gonadotropin to subjects with congenital lipoid hyperplasia does 
not elicit the normal acute increase in serum levels of adrenal or gonadal steroid hormones 
(Fujieda K et al. 2003). 
 
Congenital lipoid hyperplasia is a rare disease, except in Japan and Korea, where it 
accounts for 5% or more of all cases of congenital adrenal hyperplasia. Mutations in the StAR 
gene have been identified in more than 60 unrelated patients with congenital lipoid adrenal 
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hyperplasia. Analysis of DNA from the parents of several patients confirmed that this disease 
is inherited in an autosomal recessive pattern. Mutations found in the StAR gene, which is 
composed of seven exons and is located on chromosome 8p11.2, include frameshifts caused 
by deletions/insertions, splicing errors, and nonsense and missense mutations, all of which 
lead to the absence of StAR protein or the production of functionally inactive protein. Several 
nonsense mutations were shown to result in C-terminal truncations of StAR. One of these 
mutations, Q258X, which results in the deletion of the final 28 amino acids of the StAR 
protein, accounts for 80% of the known mutant alleles in the affected Japanese population. 
All of the known point mutations that produce amino acid substitutions occur in exons 5-7 of 
the gene, the exons that encode the C-terminus (Bose HS et al. 1996; Caron KM et al.1997). 
The metabolic defect in congenital lipoid adrenal hyperplasia is progressive, with adrenal and 
gonadal steroidogenesis becoming increasingly impaired with time after birth. A model has 
been proposed to explain the disease process that postulates the existence of some StAR-
independent steroidogenesis prior to severe cellular damage resulting from cholesterol 
accumulation and cholesterol oxidation, which ultimately results in a nonfunctional 
steroidogenic cell (Figure 15) (Bose HS et al. 1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 : Model of the disease process resulting from a nonfunctional steroidogenic cell. Bose HS et al. 
1996 
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Comparison of the clinical course of 46,XX females with congenital lipoid adrenal 
hyperplasia to that of 46, XY subjects reinforced the proposed pathophysiological 
mechanism. 46,XX females underwent spontaneous puberty and secondary sexual 
development, whereas 46,XY patients were unable to undergo spontaneous puberty and had 
insufficient testicular androgen production in utero to masculinize the external genitalia.  
 
 
Structure and activity of StAR protein 
 
 
Human StAR is synthesized as a 285-amino-acid protein in the cytoplasm. The N-
terminus of StAR is characteristic of proteins imported into mitochondria: the first 26 amino 
acid residues are predicted to form an amphipathic helix (Figure 16) (Mathieu AP et al. 
2002). Newly synthesized StAR pre-protein (37 kDa) is rapidly imported into mitochondria 
and processed to the mature 30 kDa form. The pre-protein has a very short half-life (minutes) 
but the mature form is longer-lived (hours). 
 
Figure 16: Human StAR model. Helices in red, strands in blue, and loops in yellow. 
Mathieu AP et al. 2002 
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StAR takes on a molten globule configuration at pH 3.5-4.0, a pH that may be 
generated in the immediate vicinity of mitochondria. The molten globule configuration may 
facilitate the unfolding of StAR in preparation for action on the mitochondria and the 
subsequent movement through the import pore into the mitochondria matrix (Christenson LK 
et al. 2000). 
 
The StAR-related lipid transfer (START) domain, first identified in the 
steroidogenic acute regulatory protein StAR, is involved in intracellular trafficking of lipids. 
It consists of an approximately 210 amino acid residue sequence that forms a compact 
alpha/beta structure, a helix-grip fold, with a hydrophobic tunnel that can accommodate a 
sterol molecule (Tsujishita Y et al. 2000; Strauss JF et al. 2003). START domains can bind 
sterol, facilitate the transfer of cholesterol from sterol-rich unilammelar liposomes to acceptor 
membranes, and stimulate steroidogenesis when expressed in cells co-expressing the 
cholesterol side-chain cleavage system or when added to isolated steroidogenic mitochondria. 
Sixteen human START domain proteins have been identified to date. Of these, StAR and 
MLN64 consist of one subfamily and newly described proteins named StarD4, StarD5, and 
StarD6 represent a closely related second subfamily (Strauss JF et al. 2003, Kishida T et al. 
2004). MLN64 is incorporated into the late endosomal compartment and is involved in the 
movement of cholesterol acquired from endocytosed LDL out of these vesicles. The MLN64-
containing compartment may also deliver cholesterol substrate to mitochondria in 
steroidogenic cells of the placenta, as well as other steroidogenic cells, through transient 
interactions between the MLN64 START domain projecting from the vesicle surface with the 
outer mitochondrial membranes (Zhang et al. 2002). On the other hand, the StarD4 family is 
composed of three proteins of 205–233 amino acid residues that have approximately 30% 
amino acid identity with each other and approximately 20% amino acid identity with the 
StAR and MLN64 START domains (Soccio et al. 2002). In contrast to StAR and MLN64, 
which have N-terminal targeting sequences that direct the proteins to specific organelles, 
StarD4, StarD5, and StarD6 lack consensus targeting domains and are predicted to be 
cytoplasmic proteins (Romanowski et al. 2002; Tsujishita et al. 2000). 
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Phosphorylation of StAR protein: 
 
The mature StAR protein contains two consensus sequences for cAMP-dependent 
protein kinase phosphorylation at serine 57 and serine 195. Tropic hormones act via cAMP-
mediated signaling cascades to rapidly increase the production of steroids. The second-
messenger system activates protein kinase A, which phosphorylates proteins on either 
threonine or serine residues in a specific sequence context. Phosphorylation of StAR protein 
is a mechanism by which preexisting or newly synthesized StAR can be activated. Post- or 
co-translational modification of StAR protein can increase the activity of existing or newly 
made StAR protein, providing a mechanism by which tropic hormones acting through the 
intermediacy of cAMP can rapidly increase steroidogenesis (Arakane F et al. 1997).  
 
 
Tissue-specific expression of StAR protein: 
 
Tissues that express StAR protein at high levels carry out tropic hormone-
regulated mitochondrial sterol hydroxylation through the intermediacy of cAMP. StAR 
mRNA is abundant in human adrenal cortex, ovary, and testis. It is also found in lower 
abundance in kidney and monocytes. The brain also expresses StAR in some species, which 
may reflect a role in neurosteroid production. Recent studies have also shown that StAR 
mRNA is present in neonatal rat cardiomyocytes, is regulated by AngII and its expression is 
increased after myocardial infarction (Casal AJ et al. 2003). 
 
 
The StAR gene and its regulation 
 
 
The abundance of StAR protein in steroidogenic cells is determined primarily by 
the rate of StAR gene transcription. In differentiated cells, StAR gene transcription is rapidly 
(within 15 to 30 min) activated by the cAMP signal transduction cascade. In differentiating 
cells (luteinizing granulosa cells), the induction of StAR gene transcription takes a longer time 
(hours) and requires on-going protein synthesis. StAR gene transcription is controlled, in part, 
by steroidogenic factor-1 (SF-1), also known as Ad4BP, an orphan nuclear receptor (Osman 
H et al. 2002). The human StAR promoter contains three cooperative cis elements that bind 
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SF-1 and are required for cAMP stimulation of StAR transcription. In addition to SF-1, 
CCAAT enhancer-binding protein-β, Sp1, GATA-4, and SREBP-1a (a member of the 
transcription factor family that governs the expression of many genes involved in lipid 
metabolism) contribute to the transcriptional control of StAR expression in a positive fashion, 
whereas DAX-1, another orphan nuclear receptor, inhibits StAR transcription (Figure 17) 
(Silverman E et al. 1999; Osman H et al. 2002). 
 
 
 
Figure 17: Comparison of StAR promoter sequences. Reinhart et al. 1999 
 
 
In the adrenal glomerulosa cell, the expression of the StAR protein is rapidly 
increased by factors that activate mineralocorticoid biosynthesis (Cherradi N et al. 1998). 
Angiotensin II and ACTH have been shown to stimulate StAR expression and to 
concomitantly increase aldosterone production in bovine adrenal glomerulosa cells by 
recruiting the calcium messenger system  (Capponi AM et al. 1988; Capponi AM et al. 
1996), or by activating adenylyl cyclase and generating cAMP as an intracellular messenger 
(Baukal AJ et al. 1994), respectively. 
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StAR protein function 
 
 
StAR protein enhances the desorption of cholesterol from steroid-rich donor 
membranes. The desorption process may involve the binding of cholesterol by the StAR C-
terminus, which forms a hydrophibic tunnel, as predicted from the crystal structure of a 
StAR-like protein (MLN64), that can accommodate cholesterol molecules (Tsujishita Y et al. 
2000; Strauss JF et al. 2003). Although the ability of StAR to bind cholesterol might suggest 
that it functions as a shuttle, the relatively small amount of StAR in cells and its short 
functional life cannot account for the needed flux of cholesterol to P450scc if StAR protein 
can move only one to two moles of sterol per mole of StAR protein (Figure 18). 
Consequently, a catalytic role for the protein is required. 
 
Upon reaching the mitochondria, the StAR C-terminus interacts with the relatively 
sterol-rich outer membrane, causing cholesterol to desorb from the outer membrane and 
transit to the relatively sterol-poor inner membrane, perhaps through preexisting contact sites. 
The import of StAR into the mitochondria and its subsequent processing remove the protein 
from its locus of action, effectively terminating sterol movement from the outer to the inner 
mitochondrial membranes (Christenson LK et al. 2000; Kallen CB et al. 1998; Lin D et al. 
1995; Petrescu AD et al. 2001; Stocco DM et al. 2001; Strauss JF et al. 1999; Tsujishita Y et 
al. 2000).  
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Figure 18: A model of StAR action. The StAR N-terminal mitochondrial targeting sequence binds to one or 
more of the known transmembrane outer (TOM) and inner (TIM) mitochondrial transporters, which link it to the 
importation machinery. Cholesterol desorption model: the C-terminus of the protein (START domain) 
stimulates cholesterol desorption (the biochemically and biophysically preferred model). The importation of the 
START domain removes the protein from its site of action, terminating sterol movement to the inner membrane. 
During or following importation, the StAR pre-protein is processed to yield the mature StAR form. 
Intermembrane shuttle model: the StAR protein is imported into the intermembrane space (the StAR-related 
lipid-transfer (START) domain predicted model), and the targeting sequence is proteolytically cleaved leaving 
the START domain in the intermembrane space where it rapidly oscillates from the outer to inner mitochondrial 
membranes delivering cholesterol one molecule at a time. StAR is removed from the intermitochondrial space 
by an undetermined mechanism, thereby terminating sterol movement. 
Strauss JF et al. 2003 
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Nuclear receptor superfamily 
 
 
Nuclear receptors are members of a superfamily of ligand-inducible transcription 
factors involved in the regulation of specific target genes implicated in biological processes as 
diverse as metabolism, development and reproduction.  
 
A list of classical and orphan hormone receptors and their ligands is shown in the 
following table.  
 
Subfamilies of mammalian 
nuclear receptors  
 Receptor Subtype Denomination Ligand 
Response 
Element 
Monomer, 
Homodimer, 
or 
Heterodimer
Class I TR  , β Thyroid hormone 
receptor 
Thyroid hormone (T3) Pal, DR-
4, IP 
H 
 RAR  , β , γ Retinoic acid 
receptor 
Retinoic acid DR-2, 
DR-5 
H 
     Pal, IP  
 VDR  Vitamin D 
receptor 
1-25(OH)2 vitamin D3 DR-3, IP-
9 
H 
 PPAR  , β , γ Peroxisome 
proliferator 
activated receptor
Benzotriene B4; Wy 
14.643Eicosanoids; 
thiazolidinediones (TZDS); 15-
deoxy-12,41-prostaglandin J2; 
polyunsaturated fatty acids 
DR-1 H 
 PXR  Pregnane X 
receptor 
Pregnanes; C21 steroids DR-3 H 
 CAR/MB67  , β  Constitutive 
androstane 
receptor 
Androstanes; 1,4-bis[2-(3,5-
dichloropyridyloxy)]benzene 
DR-5 H 
 LXR  , β  Liver X receptor Oxysterols DR-4 H 
 FXR  Farnesoid X 
receptor 
Bile acids DR-4, 
IR-1 
H 
 RevErb  , β  Reverse ErbA Unknown DR-2, 
Hemisite 
M, D 
 RZR/ROR  , β , γ Retinoid Z 
receptor/retinoic 
acid-related 
orphan receptor 
Unknown Hemisite M 
 UR  Ubiquitous 
receptor 
Unknown DR-4 H 
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Class II RXR  , β , γ Retinoid X 
receptor 
9-Cis-retinoic acid Pal, DR-
1 
D 
 COUP-TF  , β , γ Chicken 
ovalbumin 
upstream 
promoter 
transcription 
factor 
Unknown Pal, DR-
5 
D, H 
 HNF-4  , β , γ Hepatocyte 
nuclear factor 4 
Fatty acyl-CoA thioesters DR-1, 
DR-2 
D 
 TLX  Tailles-related 
receptor 
Unknown DR-1, 
Hemisite 
M, D 
 PNR  Photoreceptor-
specific nuclear 
receptor 
Unknown DR-1, 
Hemisite 
M, D 
 TR2  , β  Testis receptor Unknown DR-1 to 
DR5 
D, H 
Class III GR  Glucocorticoid 
receptor 
Glucocorticoids Pal D 
 AR  Androgen 
receptor 
Androgens Pal D 
 PR  Progesterone 
receptor 
Progestins Pal D 
 ER  , β  Estrogen receptor Estradiol Pal D 
 ERR  , β , γ Estrogen-related 
receptor 
Unknown Pal, 
Hemisite 
M, D 
Class IV NGFI-B  , β , γ NGF-induced 
clone B 
Unknown Pal, DR-
5 
M, D, H 
Class V SF-1/FTZ-F1  , β  Steroidogenic 
factor 1Fushi 
Tarazu factor 1 
Oxysterols Hemisite M 
Class VI GCNF  Germ cell nuclear 
factor 
Unknown DR-0 D 
Class 0 SHP  Small 
heterodimeric 
partner 
Unknown  H 
 DAX-1  Dosage-sensitive 
sex reversal 
Unknown   
M, monomer; D, homodimer; H, heterodimer; NGF, nerve growth factor; DR, direct repeat; Pal, palindrome; 
IP, inverted palindrome.   
 
Table 3 : Nomenclature of nuclear receptors. Aranda et al. 2001 
 
 
Evolutionary analysis of the receptors has led to a subdivision in six different 
subfamilies. One large family is formed by thyroid hormone receptors (TRs), retinoic acid 
receptors (RARs), vitamin D receptors (VDRs) and peroxisome proliferator-activated 
receptors (PPARs) as well as different orphan receptors. The second subfamily contains the 
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retinoid X receptors (RXRs) together with chicken ovalbumin upstream stimulators (COUPs), 
hepatocyte nuclear factor 4 (HNF4), testis receptors (TR2) and receptors involved in eye 
development (TLX and PNR). The third family is formed by the steroid receptors and the 
highly related orphan receptors estrogen-related receptors (ERRs). The fourth, fifth, and sixth 
subfamilies contain the orphan receptors NGFI-B, FTZ-1/SF-1, and GCNF, respectively 
(Aranda et al, 2001). 
 
 
Mechanism of action of nuclear receptors: 
 
Regulatory ligands for many of the nuclear hormone receptors have not yet been 
identified, and these receptors have been called “orphan receptors”. In the last years ligands 
have been found for several of these orphan receptors. Some of these ligands are products of 
lipid metabolism, and it is now known that compounds such as fatty acids, leukotrienes, 
prostaglandin and cholesterol derivatives, bile acids, pregnanes, or even benzoate derivatives 
can regulate gene expression through their binding to nuclear receptors. Therefore, as 
opposed to classic hormones, other ligands are intracellularly originated as metabolic 
products, which explain their role as regulators of nuclear receptors (Figure 19). Many other 
orphan receptors may have a still unidentified ligand, but others may act in a constitutive 
manner or could be activated by other means, i.e., phosphorylation (Aranda et al, 2001). 
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Figure 19: Mechanism of action of nuclear receptors. Left: the ligand can be generated in three different 
ways: 1) an active ligand or hormone is synthesized in a classical endocrine organ and enters the cell, 2) the 
ligand may be generated from a precursor or prohormone within the target cell, and 3) the ligand may be a 
metabolite synthesized within the target cell. The unliganded receptor may have a nuclear location. However, 
some steroid receptors are cytoplasmic in the absence of ligand due to their association with a large multiprotein 
complex of chaperones, including Hsp90 and Hsp56. Ligand binding induces dissociation of the complex and 
nuclear translocation. Once in the nucleus, the receptors regulate transcription by binding, generally as dimers, 
to hormone response elements (HREs) normally located in regulatory regions of target genes. Right: alternative 
ligand-independent pathways for activation of nuclear receptors exist. Some receptors may be constitutively 
active, and the activity of others is modulated by other means, for instance, phosphorylation mediated by 
hormones and growth factors that stimulate diverse signal transduction pathways. Aranda et al. 2001 
 
 
Functional domains of nuclear receptors: 
 
Nuclear hormone receptors are composed of several functional domains which are 
differentially conserved between the various receptors and have different roles (Figure 20); a 
variable N-terminal region, a conserved DNA binding domain (DBD), a variable hinge 
region, a conserved ligand binding domain (LBD), and a variable C-terminal region (Evans 
RM et al. 1988; Zennaro MC et al. 1995; Moras D et al. 1998). 
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Figure 20: Schematic representation of a nuclear receptor. Aranda et al. 2001 
 
The DBD, the most conserved domain of nuclear receptors, confers the ability to 
recognize specific target sequences, or hormone response elements (HRE), and to activate 
genes. The DNA binding domain contains zinc fingers. Zinc fingers are regions of proteins 
which form a three-dimensional structure in which two cysteines and either two histidines or 
cysteines are oriented so as to bind a zinc atom (Figure 21). The resulting three-dimensional 
protein structure of the zinc finger is shaped so that it can insert between specific base pairs of 
a DNA helix (Moras D et al. 1998). The sequence of DNA base pairs into which it can insert 
is determined by amino acids in and near the zinc bound protein region, and thus such DNA-
protein binding is specific (not random).  
 
 
Figure 21: Structure of the C domain of steroid hormone receptor: Left: Zincs Covalently Bound to 2 
cysteines (solid) and 2 histidines or cysteines (striped) to form zinc fingers. Right: Protein zinc fingers binding 
DNA helix. www.neurosci.pharm.utoledo.edu 
 
The DBD binds as a dimmer with each monomer recognizing a six base pair 
sequence of DNA. The reading helix of each monomer makes sequence specific contacts in 
the major groove of the DNA at each half-site. These contacts allow the dimer to read the 
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sequence, spacing and orientation of the half-sites within its response element, and thus 
discriminate between sequences. These proteins exhibit, however, a flexibility in recognizing 
DNA sequences and also accept a variety of amino acid substitutions in their reading helix 
without abolishing binding (Moras D et al. 1998; Glass et al. 1994). 
 
The LBD is a multifunctional domain that participates in several activities 
including hormone binding, homo- and/or heterodimerization, formation of the heat-shock 
protein complex and transcriptional activation and repression.  The LDBs are formed by 12 
conserved α-helical regions numbered from H1 to H12 (Figure 22). A conserved β-turn is 
situated between H5 and H6. The LDBs are folded into a three-layered, antiparallel helical 
sandwich. A central core layer of three helices is packed between two additional layers to 
create a cavity, the ligand-binding pocket, which accommodates the ligand. The binding of 
the hormone induces conformational changes that seem to control these properties and 
influence gene expression. The conformational changes that accompany the transition 
between the liganded and unliganded forms of the nuclear hormone receptors affect 
dramatically their affinity for other proteins (Wurtz et al. 1996; Mangelsdorf et al. 1995). 
 
 
 
Figure 22: Schematic drawing of the nuclear receptor ligand-binding domain (LBD). On the left, the LBD 
from the crystal structure of the unliganded RXR  is shown. On the right, the ligand-bound LBD of the RAR  
is shown. Cylinders represent -helices that are numbered from 1 to 12. Note the different position of the 
COOH-terminal helix 12 that contains the core AF-2 domain in both situations. Wurtz et al. 1996 
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The receptors also contain regions for transcriptional activation. The hypervariable 
A/F region of many receptors contains an autonomous transcriptional activation function, 
referred to as AF-1, that contributes to constitutive ligand-independent activation by the 
receptor. A second transcriptional activation domain, termed AF-2, is located in the COOH 
terminus of the LBD, but unlike the AF-1 domain, the AF-2 is strictly ligand dependent and 
conserved among members of the nuclear receptor superfamily. 
 
Hormone response elements: 
 
Nuclear receptors regulate transcription by binding to specific DNA sequences in 
target genes known as hormone response elements or HREs. These elements are located in 
regulatory sequences normally present in the 5’-flanking region of the target gene.  
 
 
Figure 23: Binding of receptors to the hormone response elements (HREs). Receptors can bind as 
monomers, homodimers, or RXR heterodimers to DNA. Dimerization is mediated by a strong dimerization 
interface (composed of hydrophobic heptad repeats) present in the LBD, and cooperative binding of receptor 
dimers is facilitated by a DNA-dependent interface that forms between the DBDs. Steroid receptors bind as 
homodimers to palindromic elements spaced by three nucleotides in a symmetrical way. Monomeric binding 
requires the half-core motif preceded by a 5'-flanking A/T-rich sequence. Heterodimers can recognize diverse 
HREs in which half-core motifs can be arranged as palindromes (Pal), direct repeats (DRs), or inverted 
palindromes (IPs). The ability of binding to these different motifs implies that the DBDs can rotate with respect 
to the LBDs that are held together through the dimerization interface. Aranda et al. 2001 
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The analysis of a large number of HREs revealed that a sequence of 6 bp 
constitutes the core recognition motif. Two consensus motifs have been identified: the 
sequence AGAACA is preferentially recognized by steroid class III receptors, whereas 
AGG/TTCA serves as recognition motif for the remaining receptors of the superfamily. Most 
receptors bind as homo- or heterodimers to HREs composed typically of two core hexameric 
motifs. For dimeric HREs, the half-sites can be configured as palindromes (Pal), inverted 
palindromes (Ips), or direct repeats (DRs) (Figure 23) (Giguere V. 1999). 
 
 
Receptor-interacting proteins : 
 
Promoters transcribed by RNA polymerase II are recognized by two types of 
transcription factors: the basal or general transcription factors (GFTs) that interact with the 
core promoter elements, and sequence-specific transcription factors, among which nuclear 
receptors are included, which generally interact with sequences located further upstream.  
Most of the factors involved in formation of the transcriptional initiation complex have been 
characterized. In addition to polymerase II (which is composed of at least 12 subunits), these 
include TFIID, TFIIB, TFIIA, TFIIF, TFIIE, and TFIIH. As with other transcriptional 
regulatory proteins, one aspect of the mechanism by which nuclear receptors affect the rate of 
RNA polymerase II-directed transcription likely involves the interaction of receptors with 
components of the transcription preinitiation complex. This interaction may be direct, or it 
may occur indirectly through the action of coregulators, also termed transcription 
intermediary factors (TIFs), which act as bridging factors (Cavailles V et al. 1994; Halachmi 
S et al. 1994; Lee JW et al. 1995). 
 
 
Coregulators: 
 
The ability of nuclear receptors to alternate between activation and repression in 
response to specific molecular cues, is known to be attributable in large part to a diverse 
group of cellular factors, the coregulators. 
 
Coactivators have the ability to enhance the function of receptors. The most 
abundant of these coactivators are proteins of a molecular mass of 140 and 160 kDa (p140 
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and p160). Their interaction with the receptors is ligand-dependent and they cannot interact 
with transcriptionally inactive receptor mutants or with antagonist-bound receptors (Lee JW 
et al, 2001; Voegel JJ et al. 1996). 
 
Coactivators can be categorized based upon their varied functional properties. 
Classes of coactivators include (Hong H et al. 1996; Onate SA et al. 1995): 
 
- Acetyltransferases, such as members of the SRC/p160 family 
- Ubiquitin ligases, such as E6-AP 
- ATP-coupled chromatin remodeling complexes, such as the SWI/SNF/BRG-1 
complex 
- Protein methylases, such as CARM-1 and PRMT-1 
- RNA transcripts, such as SRA 
- Cell cycle regulators such as cdc 25B 
- RNA helicases such as p72 
- And members of the TRAP/DRIP complex, which foster direct contact with 
components of the basal transcription machinery. 
 
Transcriptional repression by corepressors is in many ways conceptually 
comparable to the mediation of receptor transcriptional activation by coactivators. Their 
recruitment of corepressors, generally occurring in the absence of ligand, depends on a 
critical conformation of the receptor AF-2 domain, as well as upon nuclear box-like helical 
motifs in the corepressor. Moreover, corepressors themselves recruit ancillary enzyme 
activities which help to establish or maintain the repressive state at their target promoters 
(Chen JD et al. 1995; Horlein AJ et al. 1995; Hu X et al. 1999; Lee JW et al, 2001). 
 
In addition to their structural analogies, corepressors and coactivators have 
common functional themes. The acetylation state of nucleosomes on a promoter is related to 
the rate of transcription of the gene. Histone acetylase coactivators increase the rate of 
acetylation, opening the nucleosome to transcription factors; histone deacetylases recruited by 
corepressors reverse this reaction, silencing transcription of the target gene (Heinzel T et al. 
1997; Chen H et al. 1997; Lee JW et al, 2001). 
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The physiological role of coregulators has been implied by knockout studies in 
mice of genes encoding these proteins. The effects of these deletions range from the profound 
effects on viability characteristic of TRAP220, CBP and p300, to the more subtle 
developmental and metabolic phenotypes associated with members of the SRC/p160 family. 
Indeed, coactivators are required for physiological and developmental functions of steroid 
and thyroid hormones in living animals, and corepressors too have crucial roles in the 
development of certain organs (Kamei Y et al. 1996; Chakravarti D et al. 1996; Lee JW et al, 
2001). 
 
A spectrum of post-translational modifications is known to regulate the functional 
relationships between nuclear receptors, their coregulator complexes, and their target gene 
networks. Targeted, reversible enzymatic modifications such as acetylation, methylation, 
phosphorylation and terminal modifications such as ubiquitination have been shown to have a 
variety of effects on coregulator function. Indeed, acetylation and ubiquitination appear to 
alter the half-life of molecules in coactivator complexes. Methylation may potentiate 
coregulator function by targeting histones to complement the activity of other coregulators. 
Recent works suggest that coregulators may serve to integrate nuclear receptor signaling with 
inputs from a variety of other signal pathways, such as those involving MAP kinases, protein 
kinase A, and stress-activated pathways. Phosphorylation of coactivators by cellular kinases 
has a variety of effects: 
 
- It can specify the movement of coactivators from one compartment to another within 
the cell 
- It can enhance coregulator enzymatic activities such as acetylation 
- It can promote the recruitment by one coactivator of another coactivator 
- And phosphorylation cascades can signal the disruption of inhibitory coregulator 
complexes 
 
Coregulators may be viewed as control interfaces for integrating multiple afferent 
stimuli into an appropriate cellular response. One possible scenario is that differential 
phosphorylation of coactivators may direct their combinatorial recruitment into different 
transcriptional complexes at distinct promoters. 
 
 - Introduction - 77 
Nuclear receptors and chromatin: 
 
Nucleosomes, which fold chromosomal DNA, contain two molecules each of the 
core histones H2A, H2B, H3, and H4. Almost two turns of DNA are wrapped around this 
octameric core, which provides a major impediment to transcription. Two different 
mechanisms can alleviate this repression: histones can be posttranslationally modified to 
destabilize chromatin, and nucleosomes can be disrupted through activation of ATP-driven 
machines that can remodel chromatin. Histones can be posttranslationally modified, and this 
modification alters chromatin structure and function. Of these modifications, histone 
acetylation has generated most interest because it provided an early link between transcription 
and chromatin modification. Increased acetylation of lysines in histone tails has been 
correlated with transcriptional activity, whereas hypoacetylation has been associated with 
transcriptional repression.. Acetylation neutralizes the positively charged lysine residues of the 
histone NH2 termini decreasing their affinity for DNA, which causes nucleosome unfolding 
and can increase access of transcription factor to the promoter. It is also probable that the 
acetylation of specific lysine residues in the core histones provides novel recognition surfaces 
to promote the association of positive regulators in the transcription process. Additionally, 
histone tails are involved in nucleosomal-nucleosomal contacts. This suggests that acetylation 
may also disrupt higher order chromatin structure (Heinzel T et al. 1997; Chen H et al. 1997). 
 
There is a strong link between histone acetylation, chromatin remodelling, and 
gene regulation. The relative levels of histone acetylation are known to be determined by the 
enzymatic activities of both histone acetyltransferases (HATs) and histone deacetylases 
(HDACs), and it has been demonstrated that transcriptional activators such as GCN5 (the 
yeast homolog of PCAF) are HATs. Conversely, the mammalian histone deacetylase HDAC1 
(or HD1) is related to the yeast RPD3 repressor, and the deacetylase HDAC2, which is 
homologous with the yeast HDA1, has been found to repress transcription. HDACs and HATs 
are enzymes with no observable preference for a specific DNA sequence. However, they 
associate with coactivators and corepressors, which in turn are brought to DNA through 
binding to sequence-specific transcription factors (Heinzel T et al. 1997; Chen H et al. 1997). 
 
There is evidence that binding of hormone receptors locally alters the chromatin 
structure. Thus the glucocorticoid receptor can disrupt nucleosomes in the absence of DNA 
replication, and the disrupted nucleosome can also rapidly reassemble after hormone 
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withdrawal. In other models, binding of receptors does not remove the histone octamer from 
the promoter but produces more subtle changes that lead to greater accessibility of other 
transcription factors. This is the case of the mouse mammary tumor virus (MMTV) promoter 
that is regulated by steroid hormones through a hormone-responsive region that is organized 
in a positioned nucleosome. Hormone induction leads to a structural change of this 
nucleosome, which makes its DNA more sensitive to cleavage by DNase I and enables 
simultaneous binding of all relevant transcription factors (Fryer CJ et al. 1998). 
 
Coregulators are also implicated in chromatin remodelling. Indeed, some 
coactivators have been shown to possess HAT activity. These proteins can acetylate both free 
histones and nucleosomal histones in vitro. Core histone activation then facilitates nuclear 
receptor-mediated gene expression. Transcriptional repression by a sequence specific DNA-
binding factor can be mediated by the recruitment of a deacetylase (HDAC) to the promoter 
region. One of the mechanisms for the recruitment of HDACs to target genes involves their 
association with corepressor proteins (Figure 24).  
 
 
Figure 24: Coactivator and corepressor complexes and histone acetylation. In the absence of ligand, the 
nuclear hormone receptor heterodimer is associated with corepressor complexes. The corepressors 
(SMRT/NCoR) recruit histone deacetylases (HDACs) either directly or through their interaction with Sin3. 
Many other proteins must belong to these complexes, whose exact composition is still unknown. Deacetylation 
of histone tails leads to chromatin compactation and transcriptional repression. Ligand binding causes the release 
of the corepressor complex and the AF-2-dependent recruitment of a coactivator complex that contains at least 
p160 coactivators (such as p/CIP or SRC-1), CBP/p300, and PCAF. All of these proteins possess histone 
acetyltransferase (HAT) activity that allows chromatin decompactation and gene activation. Multiple protein-
protein interactions exist among the different components: CBP/p300 contacts the receptor, the p160 
coactivators, and PCAF through independent domains. Similarly, the receptor binds CBP/p300, p160 
coactivators, and PCAF, and PCAF can also bind directly to CBP/p300, p160 coactivators, and the receptor. 
Aranda et al. 2001 
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The nuclear receptor corepressors SMRT and NcoR are among the factors that 
associate with HDACs, which are required for repression by unliganded receptors. This 
suggests that the corepressors function by recruiting the HDAC. 
 
 
Chicken Ovalbumin Upstream Promoter-Transcription Factor, COUP-TF: 
 
 
COUP-TF (chicken ovalbumin upstream promoter-transcription factor) is one of 
the most characterized orphan receptors of the steroid/thyroid hormone receptor superfamily. 
Two genes called COUP-TFI (also termed EAR3) and COUP-TFII (also termed ARP-1) have 
been identified in mammals. These are closely related transcription factors that are expressed 
in many places and are involved in the regulation of several important biological processes, 
such as neurogenesis, organogenesis, cell fate determination, and metabolic homeostasis. 
Both genes show an exceptional homology within and between species and overlapping 
expression patterns, suggesting that they may serve redundant functions. However, each 
factor possesses its own distinct expression profile during development.  
 
COUP-TFs homodimerize or heterodimerize with retinoid X receptor (RXR) and a 
few other nuclear receptors and bind to a variety of response elements that contain imperfect 
AGGTCA direct or inverted repeats (Cooney A.J. et al. 1992). Although COUP-TF was 
originally characterized as a transcriptional activator of the chicken ovalbumin gene, COUP-
TFs are generally considered to be repressors of transcription for other nuclear hormone 
receptors such as retinoic acid receptor (RAR), thyroid hormone receptor (TR), vitamin D 
receptor (VDR), peroxysome proliferator activated receptor (PPAR), and hepatocyte nuclear 
factor 4 (HNF4). There are several different mechanisms that account for the repressive 
effects of COUP-TFs, including competition with other nuclear receptors for the occupancy 
of DNA binding sites, active repression of basal level transcription, and titration of the 
common regulator, RXR (Leng X. et al. 1996, Qiu Y. et al. 1996). 
 
Competition for occupancy of the binding sites: 
 
COUP-TFs have been shown to bind to a variety of direct repeats, including DR1, 
DR3, DR4 and DR5 of the AGGTCA motif, which are response elements of PPAR, VDR, 
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TR, and RAR, respectively. COUP-TFs repress the hormonal induction of target genes 
through direct competition with VDR, TR, and RAR for the available binding sites. COUP-
TFs negatively regulate retinoid responses by competing for binding to the retinoid response 
elements of the target reporter. COUP-TFs also interfere with the transactivation of TR, RXR, 
and PPAR through a similar mechanism. In addition, COUP-TFs inhibit the transactivation of 
steroidogenic factor 1 (SF-1) and HNF4 due to mutually exclusive binding to the promoter of 
many genes. Finally, COUP-TFs antagonize ER activation of the lactoferrin and oxytocin 
promoters by binding to a binding site that overlaps with the estrogen response element 
(Pereira FA et al. 1995;  X. Leng et al. 1996; Park JI et al. 2003). 
 
 
Competition for RXR: 
 
RXR is a universal heterodimeric partner of RAR, TR, VDR, PPAR and other 
orphan receptors. Homodimers of RAR, TR, VDR, and PPAR either bind poorly or not at all 
their cognate response elements. The heterodimeric receptors can bind to the cognate 
response elements with high affinity through association with RXR, thus, enhance the 
transactivation potential of this group of receptors. Although COUP-TFs exist as homodimers 
and fail to form stable heterodimers with RXR, they readily form DNA-binding heterodimers 
with RXR. Therefore, COUP-TFs are able to sequester the common heterodimerization 
partner RXR and reduce the available concentrations of RXR. The loss of RXR indirectly 
decreases the DNA-binding affinity of TR, VDR, RAR, and PPAR and thereby interferes 
with the potential of this subgroup of receptors to transacivate their target genes. In addition, 
COUP-TFs form heterodimers with TR and RAR and disrupt their functions. Thus, the ability 
of COUP-TFs to form heterodimers with RXR, TR, and RAR may contribute significantly to 
the negative regulatory role of COUP-TFs in modulating hormone responsiveness of a large 
number of receptors of the TR and RAR subfamily (Pereira FA et al. 1995; X. Leng et al. 
1996; Park JI et al. 2003). 
 
 
Active repression: 
 
Similar to unliganded nuclear hormone receptors, COUP-TFs repress basal 
transcriptional activity of a number of thymidine kinase reporters containing DR3, DR4, or 
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DR5 hormone response elements. In addition, COUP-TFs can function as an active repressor 
in a dose-dependent manner to inhibit transactivation mediated by acidic, glutamine-rich, 
proline-rich, and Ser/Thr-rich transactivators. COUP-TFs interact with a common target, a 
putative corepressor that mediates their repression. Indeed, corepressors are involved in 
COUP-TFI-mediated gene silencing, and both N-CoR and SMRT can function as 
corepressors for COUP-TFI in mammalian cells. Therefore, COUP-TFI can function as a 
repressor in vivo by utilizing corepressors that are common for members of the TR and RAR 
subfamily. In addition, it was also discovered that COUP-TF associates with histone 
deacetylase through its C-terminal repression domain and that this association apparently 
plays an important role in the down-regulation of major histocompatibility complex (MHC) 
class I transcription. Thus, COUP-TFs can repress transcription through a mechanism similar 
to that described for nuclear receptors RAR/ RXR or TR/RXR, which associate with histone 
deacetylase in the absence of their specific ligands (X. Leng et al. 1996; Park JI et al. 2003). 
 
 
Transrepression: 
 
COUP-TFs can also repress transcription by directly binding to the LBD of 
nuclear hormone receptors, a process called transrepression. A mechanism for transrepression 
by COUP-TFs has been proposed in which COUP-TF proteins heterodimerize with other 
nuclear hormone receptors, such as TR, RAR, or RXR. Therefore, COUP-TFs can be tethered 
to DNA in the absence of their cognate response elements via LBD-LBD interactions with 
other receptors such as TR, RAR, and RXR to transrepress the ligand-dependent 
transactivation of the nuclear receptors (X. Leng et al. 1996; Park JI et al. 2003). 
 
 
Activation: 
 
COUP-TFs can also function as positive regulators for many different genes. 
Positive regulation by COUP-TFs can be carried out by at least three different molecular 
mechanisms of activation of gene expression by COUP-TFs. First, COUP-TF activates 
transcription by binding to a nuclear receptor DNA response element and directly activating 
gene expression. Second, COUP-TF activates transcription by binding to a DNA element and 
indirectly influencing expression in the context of several other transcription factors. Finally, 
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COUP-TF activates transcription through protein-protein interaction with a DNA-bound 
factor (X. Leng et al. 1996). 
 
COUP-TFs can act as repressors or activators of gene expression. However, the 
mechanisms underlying functional duality are unknown. Some of this functional duality 
might depend on the repertoire of coregulator proteins, which interact with COUP-TF. In 
addition, the bifunctional activity of COUP-TF may also depend upon the promoter contexts 
of target genes. 
 
 
Roles of COUP-TFs: 
 
COUP-TFs are now well known to be involved in the regulation of several 
important biological processes, such as neurogenesis, organogenesis, cell fate determination, 
and metabolic homeostasis. The expression patterns of the two homologous COUP-TF genes 
(I and II) overlap extensively in development, but each factor possesses its own distinct 
profile (Shibata H et al. 2003; Vlahou A et al. 2000). 
 
COUP-TFI is involved in modulation of axonal growth. Indeed, targeted 
disruption of mouse COUP-TFI gene results in decreased arborisation of spinal nerves, in 
abnormal morphogenesis of the ninth cranial (glossopharyngeal) ganglion and nerve, and in 
defects in the guidance of axons emanating from thalamic neurons that normally project to 
cortical layer IV. Disruption of COUP-TFI results also in improper cerebral cortex 
regionalization. COUP-TFI is thus an essential component in the regulation of neurogenesis 
and cellular differentiation during embryonic development. Finally, COUP-TFI plays a major 
role in bone morphogenesis, such as the development of the occipital bone. COUP-TFI serves 
thus a vital function that is obviously not shared by COUP-TFII (Qiu Y et al. 1997; Zhou C et 
al. 2000). 
 
The embryonic expression of COUP-TFII suggests that it may participate in 
mesenchymal-epithelial interactions required for organogenesis. Targeted deletion of COUP-
TFII gene results in embryonic lethality with defects in angiogenesis, vascular remodeling 
and heart development. COUP-TFII mutants are defective in remodelling the primitive 
capillary plexus into large and small microcapillaries. In the COUP-TFII mutant heart, the 
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atria and sinus venosus fail to develop past the primitive stage. COUP-TFII is probably 
required for bi-directional signalling between the endothelial and mesenchymal compartments 
essential for proper angiogenesis and heart development (Pereira FA et al. 1999; Zhou C et 
al. 2000). 
 
 
 
Steroidogenic Factor 1, SF-1: 
 
 
A nuclear receptor named steroidogenic factor 1 (SF-1), also called AdBP4 
(Parker KL & Schimmer BP, 1995; Morohashi K et al. 1995), has emerged as a key regulator 
of endocrine function within the hypothalamic-pituitary-gonadal axis and adrenal cortex and 
as an essential factor in sex differentiation. SF-1 was first identified as a transcription factor 
with limited tissue distribution that recognized a conserved regulatory motif in the proximal 
promoter regions of genes encoding the cytochrome P450 steroid hydroxylases. SF-1 is 
responsible, at least in part, for the tissue-specific expression of genes involved in steroid 
hormone biosynthesis. Because of its apparent key role in regulating the steroid hydroxylases, 
this protein is designated steroidogenic factor 1 (SF-1) or adrenal 4-binding protein (Ad4BP) 
(Rice DA et al. 1991; Morohashi K et al. 1992). SF-1 knockout mice exhibit adrenal and 
gonadal agenesis, male-to-female sex reversal of the internal and external genitalia, impaired 
gonadotrope function, and ablation of a specific region of the hypothalamus. SF-1 plays 
essential roles in the regulation of the hypothalamic-pituitary-steroidogenic organ axis at 
various levels, as well as in the complex processes of endocrine differentiation. Thus, SF-1 
plays a key role in the development and differentiated function of the adrenal gland and 
gonads. 
 
Recently, it has been suggested that SF-1 binds phosphatidyl inositol second 
messengers and that ligand binding is required for maximal activity (Krylova In et al. 2005). 
Indeed, a 1.5 angströms crystal structure of the SF-1 ligand binding domain is in complex 
with an LXXLL motif from a coregulator protein. The structure reveals the presence of a 
phospholipid ligand in a surprisingly large pocket (approximately 1600 angströms), with the 
receptor adopting the canonical active conformation. The bound phospholipid is readily 
exchanged and modulates SF-1 interactions with coactivators. Mutations designed to reduce 
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the size of the SF-1 pocket or to disrupt hydrogen bonds with the phospholipid abolish SF-
1/coactivator interactions and significantly reduce SF-1 transcriptional activity. These 
findings provide evidence that SF-1 is regulated by endogenous ligands and suggest an 
unexpected relationship between phospholipids and endocrine development and function (Li 
Y et al. 2005). 
 
 
SF-1 and steroid hormone biosynthesis: 
 
SF-1 sequence shares conserved regions that correspond to known functional 
domains of other members of the nuclear receptor family (Evans RM et al. 1988). For 
example, SF-1 contains two zinc finger modules that mediate its binding to DNA. Both of 
these zinc finger modules, including the proximal (P) box in the first zinc finger and the distal 
(D) box within the second zinc finger, and the intervening linker region are absolutely 
conserved among four species, human, cow, rat and mouse (Figure 25). In classic steroid 
hormone receptors, the P box determines the DNA sequence recognition for half-sites of the 
hormone-responsive elements, whereas the D box forms a dimerization interface that 
determines the appropriate spacing of these half-sites (Umesomo K et al.1989). Interestingly, 
each SF-1 sequence contains a hybrid P box that combines residues characteristic of 
glucocorticoid and estrogen receptor subclasses of nuclear receptors. A subset of nuclear 
receptors, including SF-1, NGFI-B, ROR, ERR1, and ERR2, interact as monomers with 
AGGTCA recognition motifs (Mangelsdorf DJ et al. 1995). Several of these receptors share 
an additional 30-amino acid carboxyl-terminal extension adjacent to the second zinc finger 
motif, designated the FTZ-F1 or A box, that recognizes additional bases 5' to the AGGTCA 
hexamer (Wilson TE et al. 1992; Ueda H et al. 1992). The 30 amino acids comprising the A 
box are conserved absolutely in human, cow, rat, and mouse SF-1 proteins (Figure 25). 
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In addition to the conserved regions that mediate DNA binding, SF-1 cDNAs from 
various mammalian sources also show homology in C-terminal regions that form the ligand-
binding domain of ligand-activated nuclear receptors. In particular, the AF-2 transactivation 
domain is found at the carboxyl terminus of many ligand-inducible nuclear receptors, forming 
an amphipathic -helix that apparently is essential for transcriptional activation. This region is 
conserved absolutely in all SF-1 proteins (Danielian PS et al. 1992; Voegel JJ et al. 1996; 
Bourguet W et al. 1995). To the extent that the AF-2 motif identifies ligand-activated 
receptors, the conservation of this domain raises the exciting possibility that a ligand may 
mediate SF-1-dependent transactivation. There are other highly conserved regions of SF-1 for 
which functional roles have not yet been defined. 
 
 
 
 
 
Figure 25: Sequence conservation in different regions of SF-1. The functional domains of SF-1 in human, 
cow, rat, and mouse are drawn to scale. The numbers above each region indicate the percentage of identity in 
each region relative to the human sequence. The numbers at the carboxyl terminus indicate the total number of 
amino acids for each species. The positions of the zinc fingers (black), the A box (stippled), hinge region, 
Regions II and III (grey), and the AF-2 transactivation domain (cross-hatched) are indicated. Pro, The proline-
rich sequence in the hinge region; PKA, the motif matching the consensus for phosphorylation by cAMP-
dependent protein kinase. Wong M et al. 1996 
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Sites of SF-1 expression: 
 
The expression pattern of SF-1 in adult tissues generally correlates with its 
proposed roles in regulating the steroid hydroxylases (Ikeda Y et al.1993). SF-1 transcripts are 
present in adrenocortical cells, testicular Leydig cells, ovarian theca and granulosa cells. 
These sites correspond to the tissues containing proteins that interact with SF-1-responsive 
elements and correlate with the known profiles of expression of the cytochrome P450 steroid 
hydroxylases (Miller WL et al. 1988). 
 
SF-1 is also expressed in embryonic development (Ikeda Y et al. 1994). In mouse 
embryos it was shown by in situ hybridization, that SF-1 transcripts at embryonic day 9 were 
localized to the urogenital ridge, which ultimately contributes cells to the adrenal cortex, 
gonads, and the mesonephros. At this early time, SF-1 was detected in a single population of 
cells. Later, the SF-1-expressing cells resolved into two discrete populations: a group of cells 
adjacent to the dorsal aorta that represent adrenocortical precursors and a larger group of cells 
adjacent to the coelomic epithelium that represent the gonadal precursors. 
 
Mouse embryos reveal SF-1 transcripts within a discrete region of the developing 
diencephalon (Ikeda Y et al. 1994). Later in development, the SF-1 signal localizes to regions 
that represent the hypothalamic precursor and then finally localizes to neurons within a 
discrete hypothalamic nucleus, the ventromedial hypothalamic nucleus [VMH] (Ikeda Y et al. 
1995; Shinoda K et al. 1995; Roselli CE et al. 1997). Within the VMH, the expression of SF-
1 is predominantly within the dorsomedial part, although some expressions are also seen in 
the ventrolateral region. 
 
 
SF-1 target genes in steroidogenic cells: 
 
SF-1 plays a key role in regulating the expression of steroidogenic enzymes and 
other proteins involved in the control of reproductive tissues. The stimulation of transcription 
of some genes encoding steroidogenic enzymes by cAMP is also dependent upon SF-1. 
 
SF-1 was first identified and isolated as a critical regulator of the steroid 
hydroxylases within adrenocortical cells. This role for SF-1 was subsequently extended to 
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other steroidogenic cells, strongly suggesting that SF-1 truly acts as a global regulator of the 
cell-specific expression of the cytochrome P450 steroid hydroxylases (Parker KL et al. 1997). 
SF-1 has also been shown to regulate genes encoding 3β-hydroxysteroid 
dehydrogenase, the ACTH receptor (Naville D et al. 1998), StAR protein (Sugawara T et al. 
1996), and the high density lipoprotein receptor SR-B1 (Lopez D et al. 1999) by binding to 
cAMP-responsive sequences. Indeed, studies have implicated SF-1 as a key regulator of non-
cytochrome P450 components of the steroidogenic complex within steroidogenic cells. The 
non-cytochrome P450 enzyme, 3ß-hydroxysteroid dehydrogenase (3ß-HSD), is also required 
for the biosynthesis of all major classes of steroids, and SF-1 has been reported to regulate the 
Type II isozyme of 3ß-HSD, which is expressed only in the adrenal cortex and gonads (Leers-
Sucheta S et al. 1997). 
Similarly, recent studies have indicated that SF-1 also regulates the expression of 
the Steroidogenic Acute Regulatory (StAR) Protein, a mitochondrial protein that plays a 
critical role in cholesterol delivery to the mitochondria where the initial reactions in 
steroidogenesis are catalyzed by P450scc (Sugawara T et al. 1996; Caron KM et al. 1997). 
SF-1 has been shown to efficiently transactivate the StAR gene in various cell types. In fact, 
SF-1 is involved with basal StAR gene transcription in the mouse and human genes (Caron 
KM et al. 1997; Sugawara T et al. 1997). Five SF-1 binding sites have been characterized in 
the rat StAR gene promoter. Both high and low affinity SF-1 motifs are used by SF-1 to 
mediate rat StAR gene transcription, both at a basal level and in response to stimulation with 
cAMP (Sandhoff TW et al. 1998). The bovine gene for the steroidogenic acute regulatory 
(StAR) protein comprises three cis elements corresponding to the binding motif for the 
transcription factor SF-1, an estrogen receptor half-site, at –100, -240, and –1190 from the 
transcription start site (Rust W et al. 1998). Other studies have demonstrated that mutation of 
SF-1 element localized at –95 abolishes both cAMP- and angiotensin II-induced human StAR 
promoter activity (Clark BJ et al. 1999) rather indicating that transcriptional activity of the 
StAR gene by a SF-1-dependent mechanism may represent a common pathway for ACTH 
and angiotensin II action in stimulating steroid production in adrenal glomerulosa cells. 
Although the extent of SF-1 involvement in the regulation of StAR gene expression may 
present species- and cell type- dependent differences (Silverman E et al. 1999), it appears that 
activation of the cAMP-signaling pathway leads to increased phosphorylation (Gyles SL et al. 
2001) and/or expression of SF-1 (Aesoy R et al. 2002). Indeed, whereas AngII is without 
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effect on SF-1 expression, forskolin significantly increased its expression (Osman H et al. 
2002). 
Finally, recent studies have suggested that SF-1 regulates the expression of the 
ACTH receptor within adrenocortical cells (Cammas FM et al. 1997). Collectively, these 
studies point to a pivotal role in the maintenance of differentiated function and steroidogenic 
capacity in steroidogenic cells of the adrenal cortex and gonads. 
 
The role of SF-1 in vivo: 
SF-1 plays an important role in sexual differentiation. Genotypic analysis of 
offspring of heterozygous +/- mice show that SF-1 knockout mice are born at the expected 
frequency of 1:4, establishing that SF-1-encoded transcripts are not required for survival in 
utero. All SF-1 knockout mice have female external genitalia irrespective of genetic sex. 
Within 12 h after birth, the SF-1 knockout mice show evidence of volume depletion and begin 
to die. Most animals die within 3 days, and all are dead within 8 days. The SF-1 knockout 
mice have significantly diminished corticosterone levels and elevated ACTH levels and can 
be kept alive by injection of a glucocorticoid/mineralocorticoid cocktail, proving that the 
cause of their death is adrenocortical insufficiency (Luo X et al. 1995). 
The features of the SF-1 knockout mice—male-to-female sex reversal of external 
genitalia and adrenocortical insufficiency—are consistent with the proposed roles of SF-1 in 
androgen and corticosteroid biosynthesis (Figure 26) (Sadovsky Y et al. 1995; Luo X et al. 
1994). Both male and female SF-1 knockout mice have normal oviducts, uterus, and vagina, 
indicating that male internal genitalia are sex-reversed. In SF-1 knockout embryos, the lack of 
expression of SF-1 leads to the onset of programmed cell death within the developing gonads 
and adrenal gland at discrete developmental stages. 
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Figure 26: Current concepts of mammalian sexual determination and differentiation. Diagrammed are the 
processes by which genetic sex is translated into gonadal sex, which then mediates phenotypic sexual 
differentiation. SRY, Sex-determining region Y chromosome; MIS, Müllerian-inhibiting substance; DHT, 
dihydrotestosterone; 5αR, steroid 5α-reductase; SF-1, steroidogenic factor 1. Parker KL et al. 1997 
 
 
The expression of SF-1 in the anterior pituitary and hypothalamus suggests that the 
SF-1 knockout mice might also exhibit abnormalities at these sites. Within the anterior 
pituitary, a number of cell lineages are apparently unaffected, as normal immunoreactivities 
for GH, PRL, TSH, and corticotropin are observed (Ingraham HA et al. 1994). In fact, the 
expression of POMC, the precursor of ACTH, is elevated 3-fold, consistent with the loss of 
negative feedback regulation by glucocorticoids. In contrast, in SF-1 knockout mice, two 
separate markers of gonadotropes, LH and FSH, are not detected in the pituitary cell type that 
expresses SF-1 (Shinoda K et al. 1995; Ingraham HA et al. 1994). 
 
Significant effects of the SF-1 knockout also are observed in the VMH, the 
hypothalamic region where SF-1 normally is expressed. The VMH is virtually ablated in the 
SF-1 knockout mice, demonstrating that SF-1 also plays essential roles within this 
hypothalamic nucleus (Ikeda Y et al. 1995; Shinoda K et al. 1995). 
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Dosage Sensitive Sex Reversal-Adrenal Hypoplasia Congenita Critical Region on the X-
Chromosome, gene 1, DAX-1: 
 
The DAX-1 (also known as AHC) gene encodes an unusual member of the nuclear 
receptor superfamily, and the gene product plays a pivotal role during gonadal and adrenal 
differentiation. Mutations of the human DAX-1 gene cause X-linked adrenal hypoplasia 
congenita associated with hypogonadotropic hypogonadism.  
A gene (AHCH) structurally belonging to a nuclear receptor superfamily was 
identified as the gene responsible for X-linked adrenal hypoplasia congenita (AHC) 
associated with hypogonadotropic hypogonadism (HH) (Zanaria et al. 1994; Muscatelli et al. 
1994). Indeed, Ahch gene disrupted mice display structural and functional defects in the 
adrenal cortex and gonads (Yu et al. 1998a). Although the defects are not completely 
identical with those seen in human patients, the phenotype of the mice strongly supported a 
notion that Ahch is the responsible gene for the diseases. In addition, the same chromosomal 
region on Xp21.3 is also known as a critical region for dosage sensitive sex reversal (DSS) 
(Bardoni et al. 1994). Therefore, the AHCH gene is also known as DAX-1 (DSS-AHC critical 
region on the X chromosome, gene 1). The latter possibility that the DAX-1 gene induces XY 
sex reversal by gene duplication is supported by a transgenic study in which delayed 
testicular development was induced by over-expressing Dax-1 in the fetal testes (Swain et al. 
1998). 
Based on its structure, DAX-1 has been classified as a member of the nuclear 
receptor superfamily (Zanaria et al. 1994). Indeed, DAX-1 contains ligand-binding domain at 
the carboxyl terminal half, which is a common structure in members of the superfamily. 
Interestingly, however, DAX-1 has an unusual repeat sequence at the amino terminus instead 
of a Zn-finger DNA binding domain, which is another common structure in the superfamily. 
Therefore, it seems that DAX-1 cannot bind to double-stranded DNAs in a sequence-specific 
manner. In contrast, it has been reported that DAX-1 can bind to DNAs forming a stem-loop 
structure (Zazopoulos et al. 1997) as well as to RNAs (Lalli et al. 2000). Functions of DAX-1 
have been investigated from the view that it might act as a regulator of transcription mediated 
by nuclear receptors. In fact, simultaneous expression of DAX-1 with RARα (NR1B1) 
(Zanaria et al. 1994), Ad4BP/SF-1 (NR5A1) (Ito et al. 1997; Crawford et al. 1998), and ERα 
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(NR3A1) and ERβ (NR3A2) (Zhang et al. 2000), is associated with suppression of their 
transcriptional activities. Thus, it is accepted that DAX-1 acts as a suppressor. 
The mechanisms underlying regulation of the DAX-1 gene have been investigated 
at the transcriptional level, because of the functional significance of DAX-1. Reporter gene 
analyses of the DAX-1 gene promoter revealed that Ad4BP/SF-1 (Burris et al. 1995; Ikeda 
et al. 1996; Vilain et al. 1997; Yu et al. 1998b; Kawabe et al. 1999) and WT-1 (Kim et al. 
1999) activate the transcription, whereas COUP-TF (Yu et al. 1998b) suppresses it. The 
function of Ad4BP/SF-1 as the upstream regulator was further confirmed by an in vivo study 
with Ad4 BP/SF-1 gene disrupted mice (Kawabe et al. 1999). Dax-1 gene expression was 
hardly detectable in the gene disrupted mice, indicating that Ad4BP/SF-1 is an essential 
upstream factor for the expression of Dax-1. Although these studies revealed that Ad4BP/SF-
1 is the main contributor of the DAX-1 gene transcription, it is likely that other factors are 
implicated in fine-tuning the DAX-1 gene expression as reported for Wt-1 (Kim et al. 1999). 
This notion was supported by observations that DAX-1 and Ad4BP/SF-1 show similar but 
distinct expression profiles (Kawabe et al. 1999; Ikeda et al. 2001), indicating that the 
temporal and spatial expression of Dax-1 could not be elucidated by Ad4BP/SF-1 alone. 
The expression of DAX-1 in the adrenal cortex shows sexual dimorphism. The 
exact timing of the sex-related differential expression of DAX-1 from foetal life to adult age 
has been examined. Analyses of DAX-1 expression at both protein and mRNA levels 
revealed that the difference emerges during puberty and continues thereafter to adult age 
(Mukai T et al. 2002). Further analyses clearly showed that the regional distribution of DAX-
1 is quite different between the two sexes. The main difference was seen in the zona 
fasciculata (ZF) and zona reticularis (ZR), in which Dax-1 was expressed in the female but 
not in the male. In contrast, the expression was not different in the zona glomerulosa (ZG) 
(Mukai T et al. 2002). The distribution of DAX-1 expression in the adrenal glands has been 
controversial. Two studies showed that DAX-1 is expressed in most of the cortical region 
(Swain et al. 1996; Ikeda et al. 1996), while other studies have previously reported that the 
expression is restricted to the ZG (Kawabe et al. 1999). The discrepancy could be explained 
by the results of the latter study that Dax-1 expression in the adult adrenal glands is sex-
dependent; i.e. the differences observed in the above studies were probably due to the use of 
adrenal glands prepared from different sexes. 
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In recent studies it has been shown that sex steroids secreted from the gonads 
affect the expression of the Dax-1 gene (Mukai T et al. 2002). The experiments involving 
gonadectomy and sex steroid replacement demonstrated that steroid hormones are clearly 
involved in the regulation of Dax-1 expression. Indeed, androgen down-regulates Dax-1 gene 
transcription in ZF. In addition to the role of androgens on Dax-1 gene regulation, the gene 
expression is also influenced by estrogens. Indeed, estrogens activate Dax-1 gene expression 
probably through estrogen receptors (Mukai T et al. 2002, Saunders et al. 1997, Kuiper et al. 
1997, Albrecht et al. 1999). 
 
 
Absence of Dax-1 in the fetal adrenal gland: 
 
It is well known that the fetal adrenal cortex consists of both fetal and permanent 
(adult) areas, which form the major component of the inner part and minor component of the 
outer part of the tissues, respectively. After birth, the cells constituting the permanent zone 
increase in number to form three distinct adult zones, whereas the fetal zone degenerates 
gradually. Previous studies have shown that the persistent presence and structural alteration of 
the fetal zone are largely distinct among mouse strains and highly dependent on the sex of the 
animal (Howard-Miller 1927; Tanaka et al. 1995). Other studies clearly showed that DAX-1 
is not expressed in particular cells although Ad4BP/SF-1 is present. 
 
There is a general agreement that deficiency of the DAX-1 gene during 
embryogenesis leads to adrenal hypoplasia (AHC), which is characterized by adrenal 
insufficiency due to abnormal development of the adult zones and persistent presence of fetal-
type cells (Zanaria et al. 1994; Muscatelli et al. 1994).  
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In recent studies COUP-TFs have been shown to have a possible implication in 
steroidogenesis. Indeed, the protein expression profiles and immunolocalization of COUP-
TFs and other orphan members of the nuclear hormone receptor superfamily such as SF-1 and 
DAX-1 have been analyzed in human normal adrenal gland, cortisol- and 
deoxycorticosterone-producing adrenocortical adenomas. Immuno-histochemical study 
showed the nuclear orphan receptors COUP-TFs, SF-1 and DAX-1 to be colocalized in the 
nuclei of the normal human adrenocortical cells, but not in the adrenal medulla. This co-
localization of COUP-TF, SF-1 and DAX-1 in normal adrenal gland is lost in adrenocortical 
tumors, suggesting that these nuclear receptors play an important role in the regulation of 
steroidogenesis in adrenals. Moreover, in cortisol-producing adenomas causing Cushing 
syndrome, expressions of COUP-TFs and DAX-1 are greatly decreased and in 
deoxycorticosterone-producing adenomas COUP-TFs and SF-1 are strongly decreased 
(Figures 27-30) (Shibata H et al. 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Western blot analysis of the nuclear orphan receptors in normal adrenals (NL), cortisol-
producing adenomas (CS), and deoxycortisone-producing adenomas (DOC), and graph of quantified 
immunodensities of these receptors. Shibata et al. 2001. 
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Figure 28: Immunohistochemistry for COUP-TF, DAX-1, and SF-1 in the normal adrenal gland. 
Immunoreactivities of COUP-TF, DAX-1 and SF-1 were detected in the nuclei of most adrenocortical cells. HE: 
hematoxylin and eosin staining; G: zona glomerulosa; F: zona fasciculata; R: zona reticularis. Shibata et al. 2001 
 
 
Figure 29: Immunohistochemistry for COUP-TF, DAX-1, and SF-1 in cortisol-producing adenomas. 
COUP-TF and DAX-1 expressions are very low in tumor cells.  Immunoreactivity for SF-1 is found in most of 
tumor cells. Shibata et al. 2001 
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Figure 30: Immunohistochemistry for COUP-TF, DAX-1, and SF-1 in deoxycorticosterone-producing 
adenoma. Immunoreactivities for COUP-TF, DAX-1 and SF-1 were observed in most of the tumor cells of 
DOC. DAX-1 immunoreactivities are moderately high and staining intensity of SF-1 is slightly lower. Shibata et 
al. 2001 
 
 
 
Other studies also reported that COUP-TFII immunoreactivity was marked in 
aldosteronoma, modest in nonfunctioning adenoma and adrenocortical carcinoma, and low in 
Cushing adenoma ( Suzuki T et al. 2000). The expression patterns of COUP-TFI and COUP-
TFII may be different and likely to be differentially regulated in human adrenal cortex and 
tumors. 
 
Moreover, COUP-TFs have been shown to negatively regulate the transcriptional 
activity of SF-1 (Shibata H et al. 2003), which is involved in the biosynthesis of the 
mineralocorticoids since it activates the transcription of the StAR gene. Indeed, the StAR 
protein facilitates the rate-limiting step of steroidogenesis, in promoting intramitochondrial 
cholesterol transfer in all steroidogenic tissues (Stocco DM et al. 1996).  
 
The aim of the present work was therefore to examine whether the transcription 
factor COUP-TF is involved in the transcriptional regulation of basal and AngII- or ACTH 
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(mimicked by forskolin)-induced aldosterone biosynthesis in bovine adrenal glomerulosa 
cells in primary culture.  
 
According to the suggestion that COUP-TF could function as a repressor of 
steroidogenesis, the mechanism of action of physiological activators of steroid production, 
such as AngII or ACTH, could operate, in part, through a reduction of COUP-TF expression. 
The first step analysed in this work was therefore the expression profile of COUP-TF protein 
under steroid production activators induction. 
 
The role of COUP-TF on basal and activator-induced StAR expression and 
aldosterone production was then analysed. And finally, a possible interaction of this 
transcription factor with the StAR promoter was investigated. 
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Bovine adrenal zona glomerulosa cell culture and treatments: 
 
Bovine adrenal glands were obtained from a local slaughterhouse. Zona 
glomerulosa layer (0.5 mm) was cut with a Staddie-Riggs microtome, minced with scissors 
into small fragments, and placed in medium 199 containing 120 mM NaCl, 15 mM NaHCO3, 
and 3.5 mM KCl and supplemented with 10 mg/ml dispase, 10 mg/ml BSA, and 
approximately 0.1 mg/ml DNAse. Isolated cells were obtained by enzymatic digestion (two 
periods of 30 min at 37°C) and mechanical dispersion. For cell culture, all procedures were 
performed under sterile conditions. Medium 199 and Dulbecco’s modified essential medium 
(DMEM) were supplemented with 200 U/ml penicillin, 200 µg/ml streptomycin, and 200 
µg/ml gentamycin. After dispersion, the cells were filtered on 70 µm nylon gauze and washed 
twice in medium 199. The cells were then gently layered on top of a preformed Percoll 
density gradient (obtained by centrifugation of 45% Percoll in medium 199 for 30 min in a 
fixed angle Ti60 Beckman rotor at 29’000 rpm) and spun for 15 min at 1’250 x g. The 
purified glomerulosa cells were then collected from the gradient and washed twice in DMEM, 
counted, and resuspended at a concentration of 1 x 106 cells/ml in the same medium 
supplemented with 2% fetal calf serum and 10% horse serum. 
 
The cells were grown in 10-cm petri dishes (1x107 cell/dish) and incubated 
overnight at 37°C in 5% CO2. The next day, the medium was removed and replaced with 
serum-free DMEM for 24 h before experiments, which were performed on the third day of 
culture. Cells were then washed and incubated at 37°C in serum-free medium containing 
various agents, for varying periods of time as appropriate. At the end of the incubation period, 
the media were collected for aldosterone production determination and cells were processed 
for protein or total RNA extraction as described hereafter.  
 
 
Protein extraction: 
 
Nuclear extracts were prepared according to the following protocol. Typically, 
7-10 x 106 glomerulosa cells were first washed in ice-cold phosphate-saline buffer (PBS) and 
pelleted by centrifugation at 5000 x g for 15 sec.  The cell pellet was resuspended in 400 µl 
cold buffer A (10 mM HEPES pH 7.9; 10 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA; 1 mM 
DTT; 1 mM PMSF) by gentle pipetting in a yellow tip. The cells were allowed to swell on ice 
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for 15 min, after which 25 µl of a 10% solution of Nonidet NP-40 (Fluka) was added and the 
tube was vigorously vortexed for 10 sec. The homogenate was then centrifuged for 30 sec at 
top speed. The nuclear pellet was resuspended in 50 µl ice-cold buffer C (20 mM HEPES pH 
7.9; 0.4 M NaCl; 1 mM EDTA; 1 mM EGTA; 20 % glycerol; 1 mM DTT; 1 mM PMSF) and 
the tube was vigorously rocked at 4°C for 15 min on a shaking platform. The nuclear extract 
was centrifuged at top speed for 5 min at 4°C and the supernatant was frozen in aliquots at –
70°C. 
 
Mitochondrial extracts, on the other hand, were prepared as follows. Ten 
millions glomerulosa cells were homogenized with a Potter-Elvejhem homogenizer (1200 
rpm, 35 strokes) in 5 mM Tris-HCl buffer, pH 7.4, containing 275 mM sucrose. The 
homogenate was centrifuged at 200 x g for 15 min to remove large debris and nuclei. Further 
centrifugation of the supernatant at 10’000 x g for 10 min yielded the mitochondria. The 
mitochondrial pellet was washed twice at 8’000 x g with the same buffer. 
 
Proteins were quantified using a protein microassay (Bio-Rad, Munich, Germany) 
in a Beckman Coulter DU 800 spectrophotometer (Beckman Coulter Inc., Fullerton, CA, 
USA). 
 
 
Western blot analysis:  
 
The proteins to be analysed were resolved by Sodium Dodecyl Sulfate-
Polycrylamide Gel Electrophoresis (SDS-PAGE), in which a strongly anionic detergent is 
used in combination with a reducing agent. Equal amounts of protein (15 - 20 µg) were 
resuspended and boiled for 5 min in a dissociation buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 
5% β-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue) in order to dissociate the 
proteins into their individual polypeptides. Samples were then centrifuged for 5 min at 3’000 
rpm and run on a 10-12% SDS-PAGE at 150 V for 1 h. The gel could then be used to 
establish a Western blot or stained with Coomassie Brilliant Blue.  
 
In western blotting, electrophoretically separated components are transferred from 
a gel to a solid support and probed with reagents that are specific for particular sequences of 
amino acids. The probes are antibodies that react specifically with antigenic epitopes 
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displayed by the target protein attached to the solid support. Western blot is therefore useful 
for the identification and quantification of specific proteins. An individual immunoglobulin 
may preferentially recognize a particular conformation of its target epitope (denatured or 
native). Consequently, not all monoclonal antibodies are suitable for use as probes in western 
blots, where the target proteins are thoroughly denatured. Polyclonal antisera, on the other 
hand, are undefined mixtures of individual immunoglobulins, whose specificity, affinity, and 
concentration are less known. 
 
The polypeptides samples to be assayed were thus separated by SDS-PAGE and 
transferred onto a polyvinylidene difluoride (PVDF) membrane at 100 V for 2 h at 4°C. The 
membrane was incubated in blocking buffer (PBS containing 0.4% Tween 20 and 5% nonfat 
dry milk) for 1 h at room temperature. Western blot analysis of proteins was then carried out 
for 2 h either with a rabbit antiserum directed against COUP-TF (kindly provided by Prof. 
Ming-Jer Tsai, Houston, TX, USA and Dr M. Dufau, Bethesda, MD, USA) or with a rabbit 
antiserum against StAR (kindly provided by Dr. D.M. Stocco, Lubbock, TX, USA). The 
membrane was thoroughly washed with the same buffer without milk (3x 10 min) and then 
incubated for 1 h with horseradish peroxidase HRP-labeled goat anti-rabbit IgG (Covalab, 
Oullins, France). The membrane was washed 6x as described above, and immunoreactive 
proteins were visualised by the enhanced chemiluminescence method (ECL, Amersham 
Pharmacia Biotech, Dübendorf, Switzerland) and quanified by densitometry using a 
Molecular Dynamics (Sunnyvale, CA) Computing Densitometer. The membranes were all 
normalized using TF2Eα antibody for hybridisation after cleaning the membranes with a 
srcub solution (0.985% Tris-HCl, 2% SDS, 0.715% β-mercaptoethanol) for 30 minutes at 
60°C. 
 
 
Antibody purification: 
 
General considerations: 
 
In order to improve the antibodies specificity, it was necessary to purify COUP-
TFI antibody. Although many techniques have been developed to purify IgG molecules, the 
method of choice is adsorption to, and elution from, beads coated with protein A, a 
component of the cell wall of S. aureus. For reasons that are not known, this protein (Mr = 42 
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000) binds strongly to sites in the second and third constant regions of the Fc portion of the 
immunoglobulin heavy chain. Each IgG molecule therefore contains two binding sites for 
protein A. Because protein A itself has four potential sites for binding to IgG, it is possible to 
form multimeric complexes of the two types of protein. Since only the Fc region is involved 
in binding protein A, the Fab region is available for binding antigen. Not all immunoglobulins 
bind to protein A with the same affinity.  
 
Protein A coupled to a solid support by cyanogen bromide (protein A Sepharose 
CL-4B, Pharmacia Biotech, Sweden) has been used to isolate and purify immunoglobulins 
from antiserum. Each milliliter of swollen gel can bind approximately 10-20 mg of IgG 
(equivalent to 1-2 ml of antiserum). Antibodies bind to protein A chiefly by hydrophobic 
interactions that can be disrupted at low pH. Protein A can also be treated with high 
concentrations of denaturing agents such as urea, guanidine hydrochloride, or potassium 
isothiocyanate without permanent damage. 
 
Adaptations to the present work: 
 
First, the protein A Sepharose gel has been prepared. Freeze-dried powder was 
suspended in distilled water (1 g powder gives about 4-5 ml final volume of gel). It then was 
washed several times with distilled water on a sintered glass filter. A slurry was then prepared 
with binding buffer (50 mM Tris buffer pH 7.0) in a ratio of 75% settled gel to 25% buffer. 
The slurry was then poured onto an equilibrated column and packed for 15 minutes at 4°C. 
Antiserum containing COUP-TFI antibody was loaded on the column, and the column was 
washed with the same previous buffer. The antibody was then eluted from protein A 
Sepharose with 0.1 M glycine buffer pH 3.0, and purified COUP-TFI antibody was collected 
in 500 µl fractions in microfuge tubes containing 100 µl of 1 M Tris pH 9.0. The fractions 
containing the immunoglobulins were identified by measuring their absorbance at 280 nm, 
using the elution buffer as a blank. Finally, a small aliquot is run on SDS PAGE gel, followed 
by a coomassie staining. Purification of good quality gives a sharp band at about 150 kDa 
position with non or very faint trace amount of denatured heavy chain at about 55 kDa. The 
light chain, due to its small size, is hardly seen. 
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Electrophoretic Mobility Shift Assay, EMSA: 
 
General considerations: 
 
EMSA is a central method to studying gene regulation and determining 
protein:DNA interactions. This method is used to study sequence-specific DNA-binding 
proteins such as transcription factors. The assay is based on the observation that complexes of 
protein and DNA migrate through a non denaturing polyacrylamide gel more slowly than free 
DNA molecules. The gel shift assay is performed by incubating a purified protein, or a 
complex mixture of proteins such as nuclear or cell extract preparation, with a 32P end-
labelled DNA fragment containing the putative protein binding site.  
 
Nonspecific competitor DNA such as poly(dI•dC) or poly(dA•dT) is included in 
the binding reaction to minimize the binding of nonspecific proteins to the labelled target 
DNA. These repetitive polymers provide an excess of nonspecific sites to adsorb proteins in 
crude lysates that will bind to any general DNA sequence. Non-denaturing TBE-
polyacrylamide gels or TAE-agarose gels are used to resolve protein:DNA complexes from 
free DNA. The gel percentage required depends on the size of the target DNA and the size, 
number and charge of the protein(s) that bind to it. Polyacrylamide gels in the range of 4-8% 
are typically used. Gels are pre-run to remove all traces of ammonium persulfate at a constant 
voltage until the current no longer varies with time.  
 
While there are characteristic shifts caused by the binding of specific protein(s) to 
the target DNA, the change in relative mobility does not identify the bound protein. 
Identification of the DNA-bound protein is frequently accomplished by including an 
antibody, specific for the DNA-binding protein in question, to the binding reaction. Addition 
of a specific antibody to a binding reaction can have one of several effects. If the protein that 
forms the complex is recognized by the antibody, the antibody can either block complex 
formation, or it can form an antibody-protein-DNA ternary complex and thereby specifically 
result in a further reduction in the mobility of the protein-DNA complex what is called a 
supershift. Supershift reactions need not be limited to antibodies, but can include other 
secondary or indirectly bound proteins as well.  
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Adaptations to the present work: 
 
In the experiments of the present work, double-stranded DNA (5’gat CAC AGC 
CTT CAG CTG GAG GTA TTT annealed with 5’gatc AAA TAC CTC CAG CTG AAG 
GCT GTG) corresponding to nucleotides -49 to -26 of the bovine StAR promoter according to 
the sequence published by Rust W et. al, was [α-32P]dATP- labelled by Klenow (Promega 
Corporation, Madison, WI, USA) fill-in.  
 
Nuclear protein extracts (15 µg) were incubated for 20 min at room temperature 
with 30 000 cpm/min of labelled probe and 2 µg of poly[d(IC)] in EMSA binding buffer (50 
mM KCl, 20 mM HEPES pH 7.5, 20% glycerol, 0.05% nonidet NP40, 0.078% β-
mercaptoethanol). The reaction mixture was loaded onto a non-denaturing 5% 
polyacrylamide gel for 2h at 200 V in a cold room. Gels were dried and exposed to 
autoradiography films (Kodak Biomax MR, Sigma-Aldrich GmbH, Germany) for 72 h. In 
supershift experiments, 1 µg of purified rabbit polyclonal anti-COUP-TFI (kindly provided by 
Dr. M. Dufau, Bethesda, MD, USA) or anti-SF-1(kindly provided by Prof. K. Morohashi, 
Okasaki, Japan) antibodies was added to the mixture 30 min prior to the labelled probe. 
 
 
Co-immunoprecipitation of proteins: 
 
General considerations: 
 
The topic of co-immunoprecipitation (Co-IP) is best preceded by a discussion of 
immunoprecipitation (IP) to help frame an understanding of the principles involved. 
Immunoprecipitation is one of the most widely used methods for antigen detection and 
purification. An important characteristic of IP reactions is their potential to deliver not only 
the target protein but also other macromolecules that interact with the target. 
 
The principle of an IP is the following (Figure 31): An antibody (monoclonal or 
polyclonal) against a specific target antigen is allowed to form an immune complex with that 
target in a sample, such as a cell lysate. The immune complex is then captured on a solid 
support. The process of capturing this complex from the solution is referred to as 
precipitation. Any proteins not “precipitated” by the immobilized support are washed away. 
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Finally, components of the bound immune complex (both antigen and antibody) are eluted 
from the support and analyzed by SDS-PAGE (gel electrophoresis), often followed by 
Western blot detection to verify the identity of the antigen. 
 
Co-immunoprecipitation (Co-IP) is a technique for protein interaction discovery. 
Co-IP is conducted in essentially the same manner as an IP. However, in a co-IP the target 
antigen precipitated by the antibody “co-precipitates” a binding partner/protein complex from 
a lysate, i.e., the interacting protein is bound to the target antigen, which becomes bound by 
the antibody that becomes captured on the gel support. The assumption that is usually made 
when associated proteins are co-precipitated is that these proteins are related to the function 
of the target antigen at the cellular level. This is only an assumption, however, that is subject 
to further verification. 
 
Adaptations to the present work: 
 
The source of antigen used for immunoprecipitation was obtained from total 
protein extract from bovine adrenal glomerulosa cells. Antibody-conjugated beads were 
prepared as follow: Thirty microliters of 50% divinyl-sulphone-activated agarose, Mini Leak 
slurry (purchased from Kem Em Tec, Copenhagen, Denmark) were first washed three times 
in distilled water, and incubated with 4 µl specific COUP-TF1 antibody (2ZH8132L, PPMX 
Perseus Proteomics Inc., Tokyo, Japan), or SF-1 antibody (Ad4BP/SF-1 kindly provided by 
Prof. KI Morohachi, Okasaki, Japan) in 350 µl NaCl 0.9% and 100 µl polyethylene glycol 
30% of 20000 Da molecular mass (6% final concentration of PEG 20000) at 4°C over night. 
The mixture was then incubated with 500 µl 0.1M NaCl for 15 minutes at 4°c, centrifuged at 
4000 g for 5 minutes. The supernatant containing unbound antibodies was aspirated and the 
pellet was mixed with 0.2 M ethaloamine pH 9.0 for 5 hours at 4°C. Beads were then washed 
once with 1 ml 0.1M K2HPO4 pH 11.0 and once with 1 ml 0.1 M glycine pH 3.0. The slurry 
was finally stocked in 0.1 M NaCl.  
 
Bovine glomerulosa total protein extract was incubated with RIPA buffer (10 mM 
NaH2PO42H2O, 1% Triton, 1% Na deoxycholate, protease inhibitors) for 10 minutes on ice, 
vortexed and again 10 minutes on ice, centrifuged 5 minutes at 12000 rpm. The supernatant 
containing the proteins was quantified with a spectrophotometer (Beckman Coulter DU 800, 
Beckman Coulter Inc., Fullerton, CA, USA) and 200 µg were adjusted to a volume of 400 µl 
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RIPA buffer. These proteins were incubated with the antibody-slurry complexes at 4°C over 
night while mixing end over end in a tube rotator.  
 
Finally, the mixture was washed with RIPA buffer and centrifuged 5 minutes at 
4000 g. This step was repeated four times. Immunoprecipitates could then be processed for 
subsequent analysis such as electrophoresis with specific antibody in order to confirm 
interaction between two proteins. Thirty microliters of Western blot dissociation buffer (60 
mM Tris-HCl, pH 6.8, 2% SDS, 5% β-mercaptoethanol, 10% glycerol, 0.01% bromophenol 
blue) was mixed to the pellet and boiled for 5 minutes. The sample was ready to use for 
performing a Western Blot analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: Various steps of the Co-IP 
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Chromatin Immunoprecipitation, ChIP:  
 
General considerations: 
 
The aim of this method is to evidence in vivo on genes of interest, either 
transcription factor-bound promoter sites or the acetylation status of nucleosomes-bound 
histones (Figure 32). Cellular proteins are cross-linked to DNA by adding formaldehyde. 
DNA is then fragmented by sonication down to ~500 bp in lengh. The protein of interest, 
which is bound to the genomic DNA, is immunoprecipitated and isolated. Genes of interest 
are then identified by PCR with specific primers. The advantages of this technique are that it 
is performed on living cells; more accurate than an in vitro test by gel shift assay for example. 
It also allows to visualize transcription factors-bound genomic sites on promoters in response 
to a specific treatment, but also post-transcriptional modifications of transcription factors, 
depending on the antibody used. Moreover, anti-acetylated histone antibodies are now very 
well developed and this technique allows a good view of the general acetylation status of a 
specific promoter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Various steps of the ChIP assay 
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Adaptations to the present work: 
 
Chromatin cross-linking was performed here by adding 1% formaldehyde to forty 
million bovine glomerulosa cells at room temperature for 8 minutes. Reaction was stopped by 
adding glycine to a final concentration of 0.2 M. Cells were then washed twice with ice-cold 
phosphate-buffered saline (PBS), collected in 5 ml PBS, and harvested by brief 
centrifugation. Cells were resuspended in ice-cold cell lysis buffer (10 mM Tris-HCl pH 8.0, 
1mM EDTA, 0.5% nonidet NP-40, protease inhibitors), incubated on ice for 5 minutes, and 
briefly centrifugated. Cells were then resuspended in nuclear lysis buffer (10 mM Tris-HCl 
pH 8.0, 1 mM EDTA, 1% Triton X-100, 0.5% NaDOC, 0.5% sarcosyl, 0.5 M NaCl, protease 
inhibitors), incubated at room temperature for 5 minutes while vortexing vigorously several 
times and washed in PBS. Sonication of the cells was performed 30 times for 30 seconds in 
TEN buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 100 mM NaCl) with a Branson 250 
sonifier, followed by centrifugation 15 minutes at maximal speed. Supernatant was collected 
and diluted 5 folds in dilution/incubation buffer (20 mM HEPES pH 8.0, 0.2 M NaCl, 2 mM 
EDTA, 0.1% NaDOC, 1% Triton X-100, 100 µg/ml salmon sperm DNA, 1 mg/ml BSA, 
protease inhibitors) followed by immunoclearing with 20 µl protein A Sepharose CL-4B 
(Pharmacia Biotech AB, Uppsala, Sweden) for 30 minutes at room temperature, to which 5 µl 
of specific antibody anti-COUP-TFI was added for overnight incubation at 4°C. The mixture 
was then cleared from precipitated material by centrifugation at 10 000 rpm for 10 minutes. 
Supernatant was incubated with 12 µl Protein A Sepharose (Amersham Biosciences, Uppsala, 
Sweden) for 1 hour at room temperature. Precipitate was recovered by centrifugation at 3000 
rpm for 1 minute and washed 7 folds in RIPA buffer (50 mM HEPES pH 7.6, 1 mM EDTA, 
0.5 M LiCl, 0.7% NaDOC, 1% Nonidet NP-40), once in TE buffer (10 mM Tris-HCl pH 8.0, 
1 mM EDTA) and extracted twice with 100 µl elution buffer (100 mM Tris-HCl pH 8.0, 1% 
SDS). Eluates were pooled, treated with proteinase K (100 µg/ml) for 2 hours at 42°C, heated 
at 65°C overnight to reverse the formaldehyde cross-linking, and followed by phenol 
extraction and ethanol precipitation. DNA pellet was dissolved in 10 µl of TE buffer. Five µl 
of DNA was used for real-time PCR.  
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Total RNA extraction: 
 
Total RNA from adrenal glomerulosa cells was extracted according to the TRIzol 
reagent protocol (Life Technologies, Cergy Pontoise, France). Cells of a 3.5 cm dish were 
first washed twice with phosphate-buffered saline solution (PBS: 137 mM NaCl, 1.47 mM 
KH2PO4, 8.9 mM Na2HPO4, pH 7.4), then homogenised with 1 ml TRIzol, which is a mono-
phasic solution of phenol and guanidine isothiocyanate that maintains the integrity of the 
RNA while disrupting cells and dissolving cell components. The sample volume should not 
exceed 10% of the volume of TRIzol used for homogenisation. An insufficient amount of 
TRIzol may result in contamination of the isolated RNA with DNA. The homogenised 
sample was then incubated for 5 minutes at room temperature to permit the complete 
dissociation of nucleoprotein complexes. Addition of 0.2 ml chloroform followed by 
centrifugation separated the solution into a colorless upper aqueous phase and a lower red 
organic phase. RNA remained exclusively in the aqueous phase. After transfer of the aqueous 
phase into a fresh Eppendorf tube, the RNA was recovered by precipitation with 0.5 ml 
isopropyl alcohol. If very small quantities of cells were used for RNA isolation, 10 µg 
RNAse-free glycogen was added as carrier to the aqueous phase prior to precipitating the 
RNA with isopropyl alcohol. The glycogen co-precipitates with the RNA, but it does not 
inhibit PCR. The RNA pellet was then washed once with 1 ml of 75% ethanol. At the end of 
the procedure, the RNA pellet was briefly air-dryed and dissolved in RNAse-free water. 
 
After removal of the aqueous phase, the organic phase was saved if desired and 
the DNA and proteins could be recovered by sequential precipitation. Precipitation with 
ethanol yielded DNA from the interphase, and an additional precipitation with isopropyl 
alcohol yielded proteins from the organic phase. This was useful for normalising aldosterone 
production assessed in the medium. 
 
Total RNA concentration was evaluated by spectrophotometry at 260 nm, 
knowing that one absorption unit at 260 nm corresponds to 40 µg/ml of RNA. The A260/A280 
ratio allows to estimate the nucleic acid purity and should be between 1.8 and 2.0. 
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Primer design: 
 
General considerations: 
 
In order to perform PCR, the following parameters should be considered for 
primer design. Whenever possible, primers of 15-30 bases in length should be selected in a 
region with a G/C content of 30-80%. Regions with an excess of G/C content may not 
denature well during thermal cycling, leading to a less efficient reaction. In addition, G/C-rich 
sequences are susceptible to non-specific interactions that may reduce reaction efficiency and 
produce non-specific signal in particular in SYBR Green I assays. For this same reason, 
primer sequences containing runs of four or more G bases should be avoided. A/T-rich 
sequences require longer primer sequences in order to obtain the recommended melting 
temperature Tm. Selecting primers with the recommended Tm is one of the factors that allows 
the use of universal thermal cycling parameters. The last five bases on the 3’ end of the 
primers should contain no more than two C and/or G bases, which is another factor that 
reduces the possibility of non-specific product formation. Maximum amplicon size should not 
exceed 400 bp. Smaller amplicons give more consistent results because PCR is more efficient 
and more tolerant of reaction conditions. To avoid false-positive results due to amplification 
of contaminating genomic DNA in cDNA preparation, it is preferable to have primers 
spanning exon-exon junctions in the cDNA sequence. This way, genomic DNA will not be 
amplified. The melting temperature (Tm) should range between 58-62°C. Its value can be 
calculated with the following formula: Tm = 2°C x (number of A and T bases) + 4°C x 
(number of G and C bases). Primers should be designed with similar Tm values. 
 
 
Semi-quantitative reverse transcriptase-polymerase chain reaction, RT-PCR:  
 
General considerations: 
 
PCR is a procedure for in vitro enzymatic amplification of a specific segment of 
DNA. Two oligonucleotides are used as primers for a series of synthetic reactions that are 
catalysed by a DNA polymerase. These oligonucleotides typically have different sequences 
and are complementary to sequences that lie on opposite strands of the template DNA and 
flank the segment of DNA that is to be amplified. DNA to be amplified is denatured by 
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heating the sample. In the presence of DNA polymerase and excess dNTPs, oligonucleotides 
that hybridize specifically to the target sequence can prime new DNA synthesis under a lower 
temperature. The cycle of denaturation, annealing, and DNA synthesis is then repeated many 
times. The first cycle is characterised by a product of indeterminate length. The second cycle 
produces the discrete short product, which accumulates exponentially with each successive 
round of amplification. This can lead to the many million-fold amplification of the discrete 
fragment over the course of 20 to 30 cycles. PCR can be adapted to RNA templates, via 
production of a cDNA copy of the RNA by reverse transcriptase. 
 
Adaptations to the present work: 
 
RT-PCR was used to evaluate StAR and COUP-TF mRNA abundance in 
response to various treatments. Total RNA (100 ng) was amplified by one-step RT-PCR 
Access system (Promega Corp., Madison, USA) according to the instructions of the 
manufacturer. This one-tube, two-enzyme system uses AMV Reverse Transcriptase (AMV 
RT) from Avian Myeloblastosis Virus for first strand DNA synthesis and the thermostable Tfl 
DNA Polymerase from Thermus flavus for second strand cDNA synthesis and DNA 
amplification. Specific primers are used for strands synthesis. Specific primers anneal only to 
defined sequences and can be used to synthesise cDNA from particular mRNAs rather than 
from the entire mRNA population in the sample. To differentiate between amplification of 
cDNA and amplification of contaminating genomic DNA, primers may be designed to anneal 
to sequences in exons on opposite sides of an intron. An amplification product derived from 
genomic DNA will be much larger than the product of the RT-PCR reaction. This size 
difference can be analysed by gel electrophoresis. 
 
The primers were: bovine StAR 5’-TGA AGA GCT TGT GGA GCG CA-
3’(forward) and 5’-TGC GAG AGG ACC TGG TTG AT-3’(reverse), corresponding to 
positions +538-557 and +902-921, respectively (NCBI, GenBankTM, accession number 
Y17259); mouse COUP-TFI 5’-ATG CAC TCA CAA ACG GGG AT-3’ (forward) and 5’-
ACT GTG CGA AGA GAG GGC AAT-3’ (reverse), corresponding to positions +514-533 
and +1121-1141 respectively (NCBI, GenBankTM, accession number U07625); mouse 
COUP-TFII 5’-AAG CTG TAC AGA GAG GCA GGA-3’ (forward) and 5’-AGA GCT TTC 
CGA ACC GTG TT-3’ (reverse), corresponding to positions +475-495 and +1106-1125 
respectively (NCBI, GenBankTM, accession number X76653); GAPDH 5’-ATG GTG AAG 
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GTC GGA GTG-3’ (forward) and 5’-TGC AGA GAT GAT GAC CCT C-3’ (reverse), 
corresponding to positions +82-99 and +426-444 (NCBI, GenBankTM, accession number 
NM002046). Primers yielded products of the expected size corresponding to 362 bp for 
GAPDH, 383 bp for StAR, 627 bp for COUP-TFI and 650 bp for COUP-TFII. Ten 
microliters of the PCR products were analysed on 1.2 % agarose gel and quantified by 
densitometry using a Molecular Dynamics (Sunnyvale, CA) Computing Densitometer. All 
mRNA levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA.  
 
 
Quantitative real-time transcriptase-polymerase chain reaction, real-time PCR: 
 
General considerations: 
 
Real-time PCR quantitates the initial amount of the template most specifically, 
sensitively and reproducibly, and is a preferable alternative to other forms of quantitative 
PCR that detect the amount of final amplified product at the end-point. In real-time PCR, a 
fluorescent reporter is used to monitor the PCR reaction as it occurs. The fluorescence of the 
reporter molecule increases as products accumulate with each successive round of 
amplification. The point at which the fluorescence rises appreciably above background has 
been called the threshold cycle. There is a linear relationship between the log of the starting 
amount of template and the corresponding threshold cycle during real-time PCR. Given 
known starting amounts of the target nucleic acid, a standard curve can be constructed by 
plotting the log of starting amount versus the threshold cycle. This standard curve can then be 
used to determine the starting amount for each unknown template, based on its threshold 
cycle. 
 
With the use of DNA-binding dyes such as SYBR Green I, a melt-curve profile 
can be generated. The iCycler iQ system records the total fluorescence generated by SYBR 
Green I binding to double-stranded DNA as temperature changes, and plots the fluorescence 
in real time as a function of temperature. The first derivative of this plot, dF/dT, is the rate of 
change of fluorescence in the reaction, and a significant change in fluorescence accompanies 
the melting of the double-stranded PCR products. A plots of –dF/dT vs. temperature will 
display these changes in fluorescence as distinct peaks. The melting temperature (Tm) of each 
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product is defined as the temperature at which the corresponding peak maximum occurs. This 
analysis can confirm the specificity of the chosen primers as well as reveal the presence of 
primer-dimers. Because of their small size, primer-dimers usually melt at lower temperatures 
than the desired product. Additionally, nonspecific amplification may result in PCR products 
that melt at temperatures above or below that of the desired product. The presence of 
secondary nonspecific products and primer-dimers can severely reduce the amplification 
efficiency. Primer-dimers can also limit the dynamic range of the desired standard curve due 
to competition for reaction components during amplification. Therefore, melt-curve analysis 
is essential in designing an efficient and specific quantitative PCR assay. 
 
Adaptations to the present work: 
 
The DNA (5 µl) was amplified with the qPCR Core Kit for SYBR GreenI 
(Eurogentec, Seraing, Belgium) according to the instructions of the manufacturer. The 
primers were located on the proximal part of the bovine StAR promoter :  forward 5’-AGA 
CTC CTG GTG AGG CAA TC-3’ and reverse 5’-CTG CGG CCA GAT GAT GTG TT-3’, 
corresponding to positions +1807-1826 and +1925-1944, respectively (NCBI, GenBankTM, 
accession number Y17260), and yielding an amplification product of 137 bp. 
 
 
Northern blot analysis:  
 
General considerations: 
 
Specific sequences in RNA preparations can be detected by blotting and 
hybridisation analysis using techniques very similar to those originally developed for DNA. 
Fractionated RNA is transferred from an agarose gel to a membrane support. The resulting 
blot is studied by hybridisation analysis with labelled DNA or RNA probes. Because they are 
single-stranded, most RNAs are able to form secondary structures by intramolecular base 
pairing and must therefore be electrophoresed under denaturing conditions if good separations 
are to be obtained. Denaturation is achieved either by adding formaldehyde to the gel and 
loading buffers or by treating the RNA with glyoxal and dimethyl sulfoxide (DMSO) prior to 
loading. The first solution is the quickest and most reliable method for northern analysis of 
specific sequences in RNA extracted from eukaryotic cells. 
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Adaptations to the present work: 
 
For Northern blot analysis, 30 µg RNA were thus size-fractionated on a 1% 
formaldehyde agarose gel, vacuum-transferred onto Hybond-N+ nylon membranes 
(Amersham Biosciences, Bucks, UK) for 3 hours, and fixed by UV cross-linking (Spectro 
Linker, XL-100) for 1 min. The integrity of the 18 S and 28 S RNA was checked by ethidium 
bromide staining of the gel. Hybridization was performed using the previously cloned 1.5-kb 
mouse COUP-TF cDNA. The cDNA was labeled with [α32P]dCTP using the Rediprime II 
random primer labeling kit from Amersham. Northern blots were prehybridized in Rapid 
Hybridization Buffer (Amersham Biosciences) at 65°C for 30 min. The α32P-labeled probe 
(specific activity: 2 × 106 cpm/ng DNA) was then added and the incubation was continued for 
2.5 h at 65°C. Blots were washed for 5 min and 15 min successively at room temperature in 2 
× saline sodium citrate (SSC), 0.1% SDS, and then for 15 min in 1 × SSC, 0.1% SDS. The 
final wash was performed at 65°C for 15 min in 1 × SSC, 0.1% SDS. RNA-cDNA hybrids 
were visualized on Hyperfilms (Amersham Biosciences) after a 12- to 14-h exposure period. 
Blots were stripped and reprobed with mouse glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) cDNA (Ambion, Lugano, Switzerland) to assess RNA loading. 
 
 
Plasmids:  
 
General considerations: 
 
Plasmids are self-replicating, extrachromosomal DNA molecules found in 
virtually all bacterial species. Most prokaryotic plasmids are double-stranded circular DNA 
molecules. The size of plasmids varies widely, from several kilobases to hundreds of 
kilobases. Replication of plasmids depends on host-cell proteins but also may require 
plasmid-encoded functions. Plasmids carry genes that specify a wide variety of functions 
including: resistance to antibiotics, resistance to heavy metals, sensitivity to mutagens, 
sensitivity or resistance to bacteriophages, production of restricition enzymes, determination 
of virulence, etc. 
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Starting in the 1970s, vectors for propagation, manipulation, and delivery of 
specific DNA sequences were constructed with fragments from naturally occurring plasmids, 
primarily Escherichia coli plasmids. All plasmid vectors contain three common features: a 
replicator, a selectable marker, and a cloning site. The replicator is a stretch of DNA that 
contains the site at which DNA replication begins (the origin of replication, ori), and that also 
includes genes encoding whatever plasmid-encoded RNAs and proteins are necessary for 
replication. The selectable marker, necessary for following and maintaining the presence of 
the plasmid in cells, is usually dominant and is usually a gene encoding resistance to some 
antibiotic. The cloning site is a restriction endonuclease cleavage site into which foreign 
DNA can be inserted without interfering with the plasmid’s ability to replicate or to confer 
the selectable phenotype on its host. 
 
Introduction of plasmid DNA into E. coli (transformation of E. coli) can be 
achieved in several different ways. One of these methods uses calcium chloride, gives good 
transformation efficiencies and allows storage of competent cells. In this system, E. coli cells 
are grown to log phase. Cells are then concentrated by centrifugation and resuspended in a 
solution containing calcium chloride. Exposure to calcium ions renders the cells able to take 
up DNA, or competent. Plasmid DNA is mixed with the cells and presumably adheres to 
them. The mixture of DNA and cells is then heat shocked, which allows the DNA to 
efficiently enter the cells. The cells are grown in nonselective medium to allow synthesis of 
plasmid-encoded antibiotic resistance proteins, then plated on antibiotic-containing medium 
to allow identification of plasmid-containing colonies. 
 
If considerably higher transformation efficiencies are needed, another system 
using electroporation should be used. Indeed, electroporation with high voltage is the most 
efficient method for transforming E. coli with plasmid DNA. This system may be used to 
transform freshly prepared cells or to transform cells that have been previously grown and 
frozen. 
 
Adaptations to the present work: 
 
The plasmids used for overexpressing COUP-TFs proteins were prepared as 
follows: COUP-TFI- and II- encoding 1.5 kb fragments were excised out of the original 
mouse plasmids pCDNA3-COUP-TFI and pCDNA3-COUP-TFII with BamHI and XhoI 
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restriction enzymes. The digested fragments were separated on agarose gel and subsequently 
purified (JetQuick extraction kit, Genomed GmbH, Germany). COUP-TFs cDNAs were then 
inserted into the pRRL-sin-ppt-hPGK vector digested with BamHI and SalI. These vectors 
were then electroporated into HB 101 bacteria strains and plated on LB (Luria-Bertani) agar 
petri dishes supplemented with antibiotics. 
 
In order to prepare electrocompetent bacteria, they were first grown overnight in 
50 ml LB medium without antibiotics at 37°C. Two erlenmeyer flasks of 500 ml LB medium 
each were then inoculated with 10 ml of precultured bacteria (dilution 1/50), and incubated at 
37°C until reaching an OD600 ranging between 0.6 – 0.7. Bacteria were then placed on ice for 
30 minutes, centrifuged 15 min at 3500 g at 4°C, and washed twice with sterile ice-cold 
water. This washing step was then repeated twice with water containing 10% glycerol, and 
bacteria were finally ressuspened in a 2 ml volume and aliquots of electrocompetent bacteria 
were immediately frozen in liquid nitrogen.   
 
Electroporation of bacteria was performed using a BIORAD MicroPulser. Five 
microliters of ligated DNA were added to 50 µl electrocompetent bacteria and incubated for 
one minute on ice. The mixture was transferred into an E. coli Pulser cuvette (Bio-Rad 
Laboratories, CA, USA) to receive adequate pulse. One milliliter SOC media (20mM glucose 
in SOB media: bacto-tryptone 20g, bacto-yeast extract 5g, NaCl 0.5g for 950 ml H2O, with 10 
ml 250mM KCl and 5 ml 2M MgCl2)  was used to rinse the cuvette in order to facilitate 
recovery of bacteria. The mixture was incubated for 20 minutes at 37°C before a short 
centrifugation (5 minutes at 3500 g). Transformed bacteria were then allowed to grow on LB 
agar dish containing antibiotics. 
 
HB 101 strain is a highly transformable E. coli K12 x E. coli B hybrid. It is an A 
recombination-deficient (recA) suppressing strain commonly used for large-scale production 
of plasmids. One colony of the freshly grown bacteria was amplified overnight in LB agar 
(Luria-Bertani Medium) in an Erlenmeyer flask at 37°C. Plasmid DNA were then purified 
with the NucleoBond PC 500 kit (Macherey-Nagel AG, Oensingen, Switzerland). This 
system uses a silica-based anion-exchange resin. This resin consists of hydrophilic, macro-
porous silica beads coupled to a methyl-ethylamine functional group. The functional group 
provides a high overall charge density that permits the negatively charged phosphate 
backbone of plasmid DNA to bind with high specificity to the resin. Bacterial cell pellets are 
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first lysed by an alkaline/SDS solution. Both chromosomal and plasmid DNA are denatured 
under these alkaline conditions. Potassium acetate is then added to the denatured lysate, 
which causes the formation of a precipitate containing chromosomal DNA and other cellular 
compounds. The potassium acetate buffer also neutralizes the lysate. Plasmid DNA, which 
remains in solution, can revert to its native supercoiled structure. Plasmid DNA is then bound 
to an anion-exchange resin and finally eluted. After precipitation of the eluted DNA it can 
easily be dissolved in TE buffer for further use. 
 
 
Dual Luciferase reporter assay system: 
 
General considerations: 
 
The North American Firefly, Photinus Pyralis, uses a photoprotein to signal to 
other members of the colony with flashes of luminescence. 
 
When expressed in mammalian cells, luciferase molecules produce luminescence 
in direct proportion to their number. Expressed under the control of a genetic regulatory 
element, the promoter, firefly luciferase reports the activity of that promoter.  
 
Dual Luciferase Reporter (DLR) Assay System provides an efficient means of 
performing two reporter assays. Indeed, in the DLR Assay, the activities of firefly (Photinus 
pyralis) and Renilla (Renilla reniformis) luciferases are measured sequentially from a single 
sample. The firefly luciferase reporter is measured first by adding a luciferase reagent to 
generate a luminescent signal lasting at least one minute. After quantifying the firefly 
luminescence, this reaction is quenched, and the Renilla luciferase reaction is initiated 
simultaneously by adding another reagent to the same sample. In the DLR Assay System, 
both reporters yield linear assays with attomole (<10-18) sensitivities and no endogenous 
activity of either reporter in the experimental host cells.  
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Adaptations to the present work: 
 
The StAR-luc reporter construct was kindly provided by Dr. D. Stocco, Lubbock, 
TX, USA. Briefly, the 1.3 kb full length human StAR promoter region was cloned into the 
plasmid vector pGL2 (Promega) which contains firefly luciferase as a reporter gene (Figure 
33).  
 
 
 
 
 
Figure 33: StAR-luc reporter construct 
 
Other plamids used in these experiments included the pGL2 basic vector as a 
negative control, which contains no promoter sequence; pGL2 control used as a positive 
control, which places the luciferase gene under the control of the SV40 promoter; pRL-SV40 
vector, which places the Renilla luciferase under the control of the SV40 promoter was used 
as an internal control; and pCR3.1 vector in which murine COUP-TFI or COUP-TFII cDNA 
were subcloned under the control of the CMV promoter (kindly provided by Prof. MJ Tsai, 
Houston, TX, USA).  
 
Bovine glomerulosa cells were co-transfected with the various vectors according 
to the manufacturer’s protocol (Effectene Transfection Reagent kit, Qiagen GmbH, Hilden, 
Germany). Cells were harvested 48 h after transfection, and extracts were made in Passive 
lysis buffer (Promega, Madison, USA). Luciferase and Renilla activities were quantified 
using a Luminoskan Ascent (Labsystems, Catalys AG). The luciferase assay results were 
normalised to Renilla activity to compensate for variations in transfection efficiency. Each 
treatment group contained at least triplicate cultures. 
 
 
StAR promoter luciferase 
pGL2 
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Generation of lentiviral vectors and infection of bovine adrenal glomerulosa cells: 
 
General considerations: 
 
Lentiviruses are enveloped viruses carrying two copies of single-strand positive 
RNA and are considered the ethiologic agent of acquired immunodeficiency syndromes 
(AIDS) for a broad range of animal species, such as humans, primates, cats, horses, etc. Such 
syndromes develop in multiorgan disease and share a long period of incubation and a fatal 
outcome. The name lentiviruses (from Latin, lenti, slow) originated from the uniquely 
prolonged incubation period (from months to years) needed for the infecting virus to induce 
the disease. Lentiviruses belong to the Lentiviridae subfamily of the Retroviridae family, 
which also includes the Oncoviridae, for the most part viruses inducing cell transformation, 
and the Spumaviridae viruses establishing persistent as well as non-pathogenic infections. 
Lentiviral vectors can mediate the efficient delivery, integration and stable expression of 
transgenes in both dividing and nondividing cells. HIV-1 based lentiviral vector is the best-
studied and well-developed lentiviral vector system that has shown high transduction 
efficiencies targeting many human and experimental animal cell types. They have a relatively 
large capacity, allowing for the transfer of up to 10 kilobases of sequence. 
 
Transducing lentiviral vectors that transfer the exogenous gene(s) into target cells 
are typically defective for viral replication because at least some of the trans-acting sequences 
encoding the viral proteins have been deleted. To propagate vector virus, the viral proteins are 
supplied either by transient transfection of plasmids expressing the viral proteins or by using 
packaging cell lines, which contain the viral expression plasmids stably integrated into their 
cell genome. Safety elements are built into the system using lentiviral vectors (particularly 
those derived from human immunodeficiency virus type 1) including dispensing with most of 
the genes encoding viral accessory and regulatory proteins while still retaining the ability of 
the vector to effectively transduce target cells. Three generations of HIV-based packaging 
plasmids have been successively developed for production of lentivectors by transient 
transfection (Figure 34) (Trono D 2001). The first generation encompasses all HIV-1 genes 
beside the envelope. The second generation is additionally deleted in all viral auxiliary genes, 
as vpr, vif, vpu and nef. The third generation comprises only gag, coding for the virion main 
structural proteins, pol, responsible for the retrovirus-specific enzymes, and rev, which 
encodes a post-transcriptional regulator necessary for efficient gag and pol expression. The 
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vector itself is the only genetic material transferred to the target cells. It typically comprises 
the transgene cassette flanked by cis-acting elements necessary for its encapsidation, reverse 
transcription and integration. Advantage is taken of the reverse transcription to engineer self-
inactivating HIV-1-derived vectors, which lose the transcriptional capacity of the viral long 
terminal repeat (LTR) once transferred to target cells. This minimises the risk of emergence 
of replication competent recombinants and avoids problems linked to promoter interference. 
 
 
 
Figure 34: the various generations of HIV-based packaging plasmids. Trono D 2001 
 
 
Adaptations to the present work: 
 
The lentiviral particles were generated by co-expressing the virion packaging 
elements and the vector genome in 293T human embryonic kidney cells used as producers, 
involving transient transfection procedures. Titers of lentiviral vectors obtained in 293T cells 
are generally higher than those observed in other cell lines. The core and the enzymatic 
components of the virion are HIV-1 derived, whereas the envelope is derived from a 
heterologous virus, vesicular stomatitis virus (VSV), chosen for its high stability and broad 
tropism of its G protein. We used the second generation LV packaging system deleted in all 
viral auxiliary genes, which are essential virulence factors in vivo but not necessary for viral 
replication in vitro.  
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The lentiviral vectors were obtained by transient transfection of 293T human 
embryonic kidney cells as follows: A total of 2 x 106 293T cells were seeded in 10-cm petri 
dishes 24 h before transfection, in DMEM containing 10% fetal calf serum (FCS) and 
glutamine, in the presence of chloroquine (final concentration, 25 µM) and in a 5% CO2 
atmosphere. Twenty microgram of plasmid DNA were used for the transfection of one 10-cm 
dish using the calcium-phosphate precipitation method: 2.5 µg envelope-coding plasmid 
pMDG, 7.5 µg packaging plasmid pCMV∆R8.91 (which expresses Gag, Pol, Tat and Rev), 
and 10 µg of either COUP-TFI- or COUP-TFII-expressing pRRL-sin-ppt-hPGK plasmid 
(Figures 35 + 36). The cells were washed with phosphate-buffered saline (PBS) after 14 to 16 
h and were incubated in serum-free DMEM in a 10% CO2 atmosphere. The conditioned 
medium was collected after another 24 h and filtered through 0.45 µm pore-size 
polyvynilidene difluoride (PVDF) filters. The vectors were concentrated 100-fold by one 
round of centrifugation at 50 000 x g for 90 min and resuspended for 20 min at room 
temperature in PBS. Titers of HIV vectors were determined by p24 antigen ELISA. Titers 
were found to range from 5x106 to 107 infectious units per milliliter. Stock of vectors was 
stored at –80o C until used for stable transduction of the bovine glomerulosa cells. All 
transductions were performed in 12-well plates, with 200’000 glomerulosa cells per well, and 
500 ng of p24 were used for each COUP-TF. 
 
Packaging plasmid and envelope-coding plasmid maps: 
 
 
Figure 35: Packaging plasmid and envelope-coding plasmid maps 
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PRRL-plasmid map in which COUP-TFs have been inserted: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: pRRL-sin-ppt-hPGK -plasmid map 
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 Flow cytometric analysis, FACS: 
 
General considerations: 
 
Flow cytometry is a method for quantitating components or structural features of 
cells primarily by optical means. The cells may be alive or fixed at the time of measurement, 
but must be in monodisperse (single cell) suspension. They are passed single-file through a 
laser beam by continuous flow of a fine stream of the suspension. Each cell scatters some of 
the laser light, and also emits fluorescent light excited by the laser. The cytometer typically 
measures several parameters simultaneously for each cell:  
 
• low angle forward scatter intensity, approximately proportional to cell diameter  
• orthogonal (90 degree) scatter intensity, approximately proportional to the quantity of 
granular structures within the cell  
• fluorescence intensities at several wavelengths  
 
Green fluorescent protein, GFP, is a spontaneously fluorescent protein isolated 
from coelenterates, such as the Pacific jellyfish, Aequoria victoria. Its role is to transduce, by 
energy transfer, the blue chemiluminescence of another protein, aequorin, into green 
fluorescent light. When expressed in mammalian cells fluorescence from wild type GFP is 
typically distributed throughout the cytoplasm and nucleus, but excluded from the nucleolus 
and vesicular organelles. Furthermore, GFP fluorescence is stable and species-independent 
and does not require any substrates or cofactors. GFP fluoresces maximally when excited at 
400 nm with a lesser peak at 475 nm, and fluorescence emission peaks at 509nm.  
 
Adaptations to the present work: 
 
Of the various constructs we have tested for the transduction of glomerulosa cells 
using the lentivectors system, the pRRL-sin-ppt-hPGK plasmid gave the highest levels of 
fluorescence when GFP gene was sub-cloned, and the least cell mortality. Indeed, 
transduction efficiency rose up to 91% in glomerulosa cells. 
 
In our experiments, cell preparation for FACS analysis was the following. The 
cells were first detached with Trypsin-EDTA for 10 min at 37°C and suspended with a same 
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volume of DMEM containing fetal calf serum to stop the enzymatic activity. After 
centrifugation for 3 min at 150 g, the pellet was washed once with FACS buffer containing 
phosphate-saline buffer (PBS) or NaCl 0.9%, fetal calf serum 2% and NaN3 0.1%, before 
another centrifugation. The cell pellet was finally well resuspended with 7-Amino-
actinomycin D (7-AAD) at 1:200 dilution in FACS buffer. Since 7-AAD intercalates into 
double-stranded nucleic acids, it is excluded by viable cells but can penetrate cell membranes 
of dying or dead cells. It is thus used as a marker of cell viability. Cells were then analysed on 
a single laser flow cytometer (Becton Dickinson FACSCalibur). 
 
 
Determination of aldosterone production by radioimmunoassay, RIA:  
 
General considerations: 
 
RIA (radioimmunoassay) is a highly sensitive and specific assay method that uses 
the competition between radio-labeled and unlabelled substances (e.g. hormones) in an 
antigen-antibody reaction to determine concentration of the unlabelled substance. The 
technique of RIA was first described by Yalow and Berson (1960) for measuring insulin in 
the plasma. The amounts of antibody and of radioactive hormone are constant. Any increase 
of unlabeled (cold) hormone swept a decrease in levels of labelled hormone, which fixes to 
the antibody. Indeed, unlabelled antigen competes for the binding sites of the antibody and 
therefore displaces the radioactive antigen. To perform a hormonal assay, a standard binding 
curve is first established. It shows the decrease in percentage of the labelled hormone that 
binds to the antibody in the presence of a known and progressively increasing amount of 
unlabelled hormone. The samples to be assayed can then be loaded. 
 
Adaptations to the present work: 
 
This procedure is a solid-phase radioimmunoassay, in which the aldosterone-
specific antibodies are coupled to the inner walls of a polypropylene tube (Morwell 
Diagnostics, Egg, ZH, Switzerland). Aldosterone content of 100 µl media incubated for 3 h 
on a shaking table at room temperature with 500 µl 125I isotope, was measured by direct radio 
immunoassay using a commercially available kit (Diagnostic Systems Laboratories, Webster, 
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TX) on a Packard multi-gamma radiation counter. Aldosterone production was normalized 
and expressed per microgram cellular protein. 
 
 
Analysis of data:  
 
Results are expressed as means ± SEM. The mean values were compared by 
ANOVA using Fisher’s test. A value of P < 0.05 was considered as statistically significant. 
Quantification of immunoblots and autoradiograms was performed using a Molecular 
Dynamics (Sunnyvale, CA) Computing Densitometer. 
 
 
Other materials used: 
 
Solutions: 
 
- Coomassie Blue staining solution: per liter: 2.5 g Commassie Brilliant Blue R-250 in 
250 ml methanol, 100 ml acetic acid, volume adjusted with H2O, storage temperature 
15-25°C. 
- Coomassie Blue destaining solution: per liter: 450 ml methanol, 100 ml acetic acid, 
volume adjusted with H2O, storage temperature 15-25°C. 
- EMSA binding buffer: 50 mM KCl, 20 mM HEPES pH 7.5, 20 % glycerol, 0.05 % 
nonidet NP40, 0.078 % β-mercaptoethanol, volume adjusted with H2O, storage 
temperature -20°C. 
- Gel-loading buffer (6x buffer) for DNA: 0.25% bromophenol blue, 0.25% xylene 
cyanol FF, 30% glycerol in water, storage temperature 4°C. 
- LB Medium (Luria-Bertani Medium): per liter: 10 g bacto-tryptone, 5 g bacto-yeast 
extract, 10 g NaCl, 950 ml H2O deionised, pH 7.0, autoclaved. 
- MOPS, concentrated stock solution 10x: per liter: 41.85 g 3-
morpholinopropanesulfonic acid, 25 ml sodium acetate 2 M, 20 ml EDTA 0.5 M pH 
8.0. 
- PBS, phosphate-saline buffer: 137 mM NaCl, 1.47 mM KH2PO4, 8.9 mM Na2HPO4, 
pH 7.4, storage temperature 4°C. 
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- RNA loading buffer: 50% glycerol, 1 mM Na2EDTA, 0.4% Bromophenol Blue in 
H2O, storage temperature –20°C. 
- Sample buffer for RNA: 250 µl formamide, 100 µl formaldehyde 37%, 75 µl MOPS 
10x. 
- Scrub solution for PVDF membrane, for 100 ml: 985 mg Tris-HCl, 2 g SDS, 715 µl β-
mercaptoethanol, pH 6.7. 
- SDS gel-loading buffer (3x buffer): 
- SSC, saline sodium citrate, concentrated stock solution 20x : per liter: 175.3g NaCl, 
78.93g di-Na-H-citrate in water, pH 7.0, storage temperature 15-25°C. 
- TAE, Tris-acetate electrophoresis buffer, concentrated stock solution 50x: per liter: 
242 g Tris base, 57.1 ml glacial acetic acid, 40 ml EDTA 0.5 M pH 8.0. working 
solution 1x: 0.04 M Tris-acetate, 0.001M EDTA  
- TBE, Tris-borate electrophoresis buffer, concentrated stock solution 5x: per liter: Tris 
base 54g, boric acid 27.5g, EDTA 0.5 M 20 ml pH 8.0. working solution 0.5x: Tris-
borate 0.045 M, EDTA 0.001 M.  
- TE: 10 mM Tris-Cl (pH 8.0), 1 mM EDTA (pH 8.0), storage temperature 15-25°C. 
 
 
Radioactivity: 
 
- 32P, a phosphorous isotope emitting β particles was used in Northern Blot analysis and 
Gel Shift assay (32P t1/2 = 14 days). 
- 125I, a iodine isotope emitting γ rays was used in radio immuno assay (125I t1/2  = 60 
days). 
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Various pathological cardiovascular conditions are associated with inappropriate 
circulating levels of aldosterone. Indeed, aldosterone, the main mineralocorticoid in man, 
regulates salt and water homeostasis and blood pressure. Since the StAR protein facilitates 
the rate-limiting step in the biosynthesis of aldosterone, its expression must be finely 
regulated. We have shown in our published work that the transcription factor COUP-TF is 
involved in the transcriptional regulation of the StAR gene elicited by the octapeptide 
hormone, angiotensin II. The results have demonstrated that COUP-TF exerts a tonic 
inhibition on steroidogenesis by repressing StAR gene transcription. We have also shown that 
angiotenin II markedly reduces COUP-TF expression in a time- and concentration-dependent 
manner.  
 
In the second part of this work, we have analyzed the putative pathways involved 
in the control of COUP-TF expression elicited by angiotenin II in the adrenal glomerulosa 
cells and we have also focused our interests on the possible interaction between COUP-TF 
and other transcription factors known to modulate StAR transcription. 
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Extracellular potassium represses COUP-TF expression 
 
Several factors modify aldosterone secretion – the most important are angiotensin 
II (AngII) and extracellular potassium (K+). Thus, the effect of K+ on COUP-TF expression 
was also analysed in this work. Our results indicate that similarly to AngII, K+ also exerts a 
strong effect on COUP-TF expression. When bovine glomerulosa cells were challenged for 6 
h with 12 mM K+, a decrease in COUP-TFI protein levels was observed, an inhibition down 
to 60.5 ± 0.8% of control levels being reached with 12 mM KCl (n = 3; P < 0.01; Fig. 38). 
 
 
A 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
Figure 38: AngII and KCl repress COUP-TFI protein levels. Representative Western blot (A) and 
densitometric analysis (B) of COUP-TFI. Bovine adrenal glomerulosa cells were stimulated for 6 h with 10-8 M 
AngII, 12 mM KCl and/or 10-5 M U0126. COUP-TFI was determined in nuclear extracts. TFIIEα antibody was 
used to normalize the experiment. Values are means ± SEM from three separate experiments. **, P < 0.01 vs 
control. 
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Are kinase pathways involved in COUP-TF repression? 
 
To address pathways involved in AngII or KCl regulation of COUP-TFI 
expression, their various signalling pathways were interrupted with pharmacological 
inhibitors and the effect on COUP-TF expression was observed. We first focused on the 
mitogen-activated protein kinases (MAPK) signaling pathway was, as MAPK are linked to 
AngII receptor (AT1) activation in glomerulosa cells (Osman H et al. 2002). Pretreatment of 
cells with U0126, a specific inhibitor of MAPK extracellular signal-regulated kinase (ERK) 
1/2 activation, did not affect AngII- or KCl-mediated repression of COUP-TFI protein 
expression (n = 3; Figure 38). This suggests that ERK1/2 is not involved in AngII- or KCl- 
induced COUP-TFI repression. 
 
Pretreatment of the cells with SB203580, a specific inhibitor of p38 mitogen-
activated protein kinase (p38 MAPK), neither affected AngII-mediated repression of COUP-
TFI (n = 3; Figure 39), indicating that the p38MAPK pathway is not involved in this 
inhibition. 
A 
 
 
 
 
B  
 
 
 
 
 
 
 
 
Figure 39: p38 MAPK is not involved in AngII- mediated COUP-TFI repression. Representative Western 
blot (A) and densitometric analysis (B) of COUP-TFI. Bovine adrenal glomerulosa cells were stimulated for 6 h 
with 10-8 M AngII w/o 10-6 M SB203580. COUP-TFI was determined in nuclear extracts. Values are means ± 
SEM from three separate experiments. **, P < 0.01 vs control. 
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Since stimulation of aldosterone synthesis in bovine adrenal zona glomerulosa cells 
by AngII is believed to be mediated by the phospholipase C (PLC) pathway that results in the 
increase of cytosolic free calcium concentration and in the activation of protein kinase C 
(PKC) (Bodart V et al. 1995), glomerulosa cells were pretreated with inhibitors of PKC (CGP 
41521 and calphostin C) in order to determine whether the PKC pathway was involved in 
AngII mediated COUP-TFI repression. As shown in Figure 40 (n = 3), neither of these 
specific inhibitors had an effect on AngII-induced inhibition of COUP-TFI expression, 
suggesting that the PKC pathway is not implicated in the repression of COUP-TF mediated 
by AngII. 
 
A 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
Figure 40: The protein kinase C (PKC) pathway is not involved in AngII mediated COUP-TFI repression. 
Representative Western blot (A) and densitometric analysis (B) of COUP-TFI. Bovine glomerulosa cells were 
stimulated for 6 h with 10-8 M AngII, w/o 10-6 M calphostin C or 10-6 M CGP 41521. COUP-TFI was 
determined in nuclear extracts. Values are means ± SEM from three separate experiments. **, P < 0.01 vs 
control. 
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These results indicate that AngII mediated COUP-TFI repression does not involve 
either mitogen-activated protein kinases ERK-1/2, or the p38MAPK pathway. Moreover, the 
protein kinase C pathway seems also not to be implicated in the COUP-TFI inhibition.  
 
Another possible pathway is the cytosolic calcium signal. Recent studies have 
demonstrated that AngII stimulates aldosterone production in adrenal glomerulosa cells by 
mobilizing the calcium messenger system (Lalevee N et al. 2003). This response requires 
calcium influx across the plasma membrane, followed by calcium uptake into the 
mitochondria. The effect of the calcium pathway on COUP-TF repression by AngII has thus 
been analysed. As shown in Figure 41 (n = 3), neither calcium depletion with EGTA, nor a 
rise in cytosolic calcium generated with the calcium ionophore, ionomycin, (Python CP et al. 
1995) affects COUP-TFI expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41: The calcium pathway is not linked to COUP-TFI repression. Representative Western blot and 
densitometric analysis of COUP-TFI : Bovine glomerulosa cells were stimulated for 3 h in Krebs medium with 
or without 0.2 mM EGTA, 2 µM ionomycine, 1 mM calcium or 2 mM calcium. COUP-TFI was determined in 
nuclear extracts. Values are means ± SEM from three separate experiments. 
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We have thus excluded that ERK1/2, p38MAPK and PKC contribute to AngII-
elicited COUP-TF repression. Other pathways such as the PI3K/Akt pathway remain to be 
studied. 
 
 
Interaction between COUP-TF and other transcription factors 
 
Having shown by ChIP that COUP-TFI directly interacts with the proximal StAR 
promoter, repressing its activity, we have hypothesized and examined a possible competition 
or interaction between the transcription factors COUP-TF and SF-1 on the StAR promoter. 
Indeed, studies have shown evidence for a direct competition between SF-1 and COUP-TF 
for occupancy of a nuclear receptor half-site (NRHS, AGGTCA) on the aromatase P450 
(P450arom) promoter, to which SF-1 bound with a higher affinity in stromal cells of 
endometriosis (Zeitoun K et al. 1999). Moreover, as shown in the published work, a gel shift 
assay performed with a small nucleotide sequence corresponding to the proximal promoter of 
the StAR gene and containing an SF-1 response element, showed the presence of an 
interaction of COUP-TFI transcription factor with the probe (Buholzer CF et al. 2005). These 
elements suggesting a possible interaction or competition between COUP-TF and SF-1, led us 
to perform a co-immunoprecipitation in which COUP-TFI was immunoprecipitated with a 
monoclonal antibody (2ZH8132L, PPMX, Tokyo, Japan), as was SF-1 with a polyclonal 
antibody (kindly provided by Prof. Morohashi, Okasaki, Japan), from a total glomerulosa cell 
protein extract. The immunoprecipitates were then analysed by Western blot using COUP-
TFI antibody.  
 
In addition, two other transcription factors, DAX-1 and Sp1 were also analysed 
by co-immunoprecipitation. Indeed, DAX-1 is a repressor of StAR gene expression 
(Zazopoulos E et al. 1997), and Sp1 is known to physically interact and cooperate with SF-1 
in controlling human StAR promoter activity (Sugawara T et al. 2000). As shown in Figure 
42 (n = 3), SF-1, Sp1 or DAX-1 co-immunoprecipitated with COUP-TFI and thus are indeed 
physically linked to COUP-TFI in bovine adrenal glomerulosa cells. These co-
immunoprecipitation experiments suggest that COUP-TF is part of a complex involving 
various factors in adrenal cells. 
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Figure 42: In vivo physical interaction between COUP-TFI, SF-1, Sp1 and DAX-1 in bovine glomerulosa 
cells. Representative Western blot of COUP-TFI after immunoprecipitation (IP) of COUP-TFI, SF-1, Sp1, 
DAX-1 or non-relevant IgG from a total protein extract.  
 
 
Since COUP-TF appears to be part of a multiproteic complex, we now plan to 
investigate the composition of that complex and its modulation under AngII challenge. We 
will perform EMSA and ChIP assays using the various antibodies after challenging bovine 
glomerulosa cells with AngII. Luciferase reporter gene assays using the proximal StAR 
promoter mutated at the SF-1 response element should also yield interesting indications about 
the role of SF-1 in COUP-TF repression. 
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Aldosterone, the major mineralocorticoid, is principally made in the glomerulosa 
cells of the adrenal cortex by a series of enzymatic steps that convert cholesterol into 
aldosterone. Aldosterone production is regulated at two critical enzymatic levels: the initial 
enzymatic step that converts cholesterol into pregnenolone and the late step that converts 
corticosterone into aldosterone by aldosterone synthase (CYP11B2) (Williams GH 2005). 
The octapeptide hormone angiotensin II is one of the most important physiological agonists 
of mineralocorticoid biosynthesis, although aldosterone secretion is also regulated by 
extracellular potassium and the adrenocorticotropic hormone, ACTH. These three agonists 
exert their action, among other mechanisms, by activating the transcription of the StAR gene, 
which facilitates the rate-limiting step of mineralocorticoid biosynthesis, cholesterol transfer 
from the outer to the inner mitochondrial membrane (Clark BJ et al. 1995).  
 
The transcription factor COUP-TF, a member of the steroid hormone receptor 
superfamily, originally known for playing important roles in the regulation of organogenesis, 
neurogenesis, and cellular differentiation during embryonic development (Park JI et al. 2003), 
is, as shown in this work, also implicated in the acute modulation of differentiated cellular 
functions, namely mineralocorticoid biosynthesis in adult bovine adrenal glomerulosa cells..  
 
Recent studies have shown that COUP-TF expression is inversely correlated with 
steroid production in human adrenocortical tumors, such as cortisol-producing adenomas and 
deoxycorticosterone-producing adenomas (Shibata H et al. 2001), suggesting a possible role 
of COUP-TF in steroidogenesis. Because the StAR protein facilitates the rate-limiting step of 
steroidogenesis, we thus hypothesized an effect of COUP-TF at this level. As demonstrated in 
the present work, COUP-TF directly inhibits transcriptional activity of the StAR gene, and its 
expression is repressed by the three agonists of mineralocorticoid biosynthesis, AngII, 
forskolin (a mimetic of ACTH) and potassium, thus suggesting that the signalling pathways 
triggered by these three factors converge at a point upstream of COUP-TF repression.  
 
The intracellular signaling pathway recruited by AngII and leading to COUP-TF 
repression remains to be elucidated. Indeed, the various secondary messengers activated by 
the AngII (AT1) receptors, such as the mitogen-activated protein kinases (MAPK) ERK1/2, 
the p38 MAPK, the protein kinase C (PKC) or intracellular calcium, do not seem to be 
implicated in COUP-TF modulation. Other possible mediators, such as PI3K/Akt or 
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JAK/STAT may be involved in the AngII-induced repression of COUP-TF and have to be 
investigated. 
 
The acute repressing role of COUP-TF in the modulation of the StAR gene 
expression and of aldosterone biosynthesis, has been shown by overexpressing COUP-TF in 
the bovine adrenal glomerulosa cells using a lentiviral system. In order to corroborate this 
discovery, COUP-TF silencing using RNA interference, followed by analysis of StAR gene 
expression and aldosterone production, are planned.  
 
Chromatine immunoprecipitation experiments have shown that COUP-TF 
physically and directly interacts with the proximal promoter of the StAR gene near or on the 
SF-1 response element. The exact localization of that binding site and its sequence must now 
be studied. We plan to induce in vitro site-directed mutations of the StAR promoter at the SF-
1 response element which is crucial for adequate transcription of the StAR gene, in order to 
define the role of SF-1 in COUP-TF repression. Moreover, other putative sites of binding for 
the transcription factor COUP-TF on the StAR promoter can be explored as well. To this end, 
in vivo genomic footprinting will be a good method to investigate the presence of other 
binding sites.  
 
Since SF-1, another transcription factor acting on the StAR promoter, is reported 
to be a competitor of COUP-TF for occupancy of a nuclear receptor half-site (NRHS, 
AGGTCA) on the promoter of the gene coding for aromatase P450 (P450arom) (Zeitoun K et 
al. 1999), it is planned to analyze the possibility of an interaction or a competition between 
COUP-TF and SF-1 on the StAR promoter. Indeed, in view of our unpublished results, we 
believe that COUP-TF directly binds to the proximal StAR promoter on or near the SF-1 
response element, or transrepresses StAR transcriptional activity by binding to SF-1 fixed on 
the promoter (Figure 43). Indeed, we have shown by co-immunoprecipitation that COUP-TF 
interacts with SF-1 in adrenal glomerulosa nuclei, and also with DAX-1 which plays a crucial 
role in preventing adrenal steroid production by blocking StAR gene transcription 
(Zazopoulos E et al. 1997), and with Sp1 which is known to cooperate with SF-1 in 
controlling human StAR promoter activity (Sugawara T et al. 2000). These experiments 
suggest that COUP-TF is part of a larger multifactorial complex. We thus plan to analyze 
whether AngII challenge of glomerulosa cells affects the composition of this complex. 
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Hypothesis 1: 
 
 
 
 
 
 
 
 
 
 
 
Hypothesis 2: 
 
 
 
 
 
 
 
 
 
Figure 43: Molecular mechanism of COUP-TF as repressor of the StAR promoter. The repressive effect of 
COUP-TF on the StAR promoter can be accounted for two different mechanisms: Transrepression (1) or active 
repression (2). 
 
 
Studies of StAR gene expression control should not only involve DNA-
trancription factor interactions, but also chromatin structure. Covalent modifications of 
histones and remodeling of chromatin structure are inextricably linked to transcriptional 
regulation, and recent studies show how chromatin is modified in order to facilitate 
transcription (Adams CC et al. 1993; Paranjape SM et al. 1994; Kornberg RD et al. 1995; 
Felsenfeld G 1996). Moreover, nuclear corepressors like N-CoR (nuclear receptor 
corepressor) or SMRT (silencing mediator of retinoid and thyroid receptor), can repress 
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transcription by recruting histone deacetylases (HDACs), as for example CBP/p300, to 
specific promoters (Doetzlhofer A et al. 1999) and these same corepressors are known to 
interact with COUP-TF (Bailey P et al. 1998). Indeed, active repression by COUP-TFII is 
mediated by the nuclear corepressors (Chen JD et al. 1995). Other data demonstrates that the 
acetylation of histone H3 associated with the proximal region of the StAR promoter is 
associated with the transcriptional activity of that gene (Christenson LK et al. 2001). All 
these results suggest a possible interaction between COUP-TF, the corepressors and HDACs 
on the StAR promoter.  
 
Preliminary results from our laboratory show that the repression of COUP-TF 
protein mediated by AngII is potentiated by treatment of glomerulosa cells with trichostatinA 
(TSA), an HDAC inhibitor. It is widely accepted that HDACs act as repressors of 
transcription while promoting increasing local chromatin condensation. But it is also possible 
that decondensation of chromatin increases accessibility of various negative transcription 
factors or corepressors, resulting in transcriptional inhibition. 
 
As described previously, COUP-TFs are highly expressed at embryonic stages and 
play a key role during embryonic development (Tsai SY et al. 1997; Pereira FA et al. 2000). 
In general, the gene encoding COUP-TFI is more highly expressed in neuronal tissues of the 
central and peripheral nervous systems, whereas the gene encoding COUP-TFII is more 
highly expressed in developing organs (Qiu Y et al. 1994; Pereira FA et al. 1995). Targeted 
disruption of mouse COUP-TFI gene resulted in perinatal death owing to multiple defects in 
central and peripheral nervous system development (Qiu Y et al. 1997). On the other hand, 
COUP-TFII might play a role in the regulation of mesenchymal–epithelial interactions during 
organogenesis, and in development of the cardiovascular system. Consistent with this, 
COUP-TFII-knockout mice die at E10, exhibiting a variety of heart and vascular defects 
(Pereira FA et al. 1999). Thus COUP-TF knockout animal experiments cannot be used for the 
assessment of the role of COUP-TFs in adult organ function. The consequences of COUP-
TFs single nucleotide polymorphism (SNP) or loss-of-function mutations have not been 
described so far. 
 
However, at the functional level and according to our results, we observed an 
inverse relationship between COUP-TF expression and AngII-induced aldosterone output. 
Interestingly, overexpression of COUP-TF did not affect either basal StAR expression or 
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basal aldosterone production. This result may be explained by the robust basal expression of 
endogenous COUP-TFs in bovine glomerulosa cells, as also observed in human 
adrenocortical cells (Shibata H et al. 2001), which certainly already exert a maximal repressor 
effect on these parameters in the resting state. Moreover, COUP-TF is certainly not the sole 
regulator of StAR gene expression. Indeed, other factors such as SF-1, DAX-1 and Sp1 also 
contribute to the transcriptional control of the basal StAR gene expression. 
 
In conclusion, we have shown in this work that COUP-TF is a direct repressor of 
StAR gene expression and of mineralocorticoid biosynthesis in bovine adrenal glomerulosa 
cells and that angiotensin II activates aldosterone synthesis by lifting this repression.This 
finding may bear pathophysiological relevance, both in the field of blood pressure control and 
in the field of steroid secreting adrenal tumors in which COUP-TF levels are known to be 
downregulated. This implication of COUP-TF must be obviously considered as a part of a 
more complex interplay between various factors, and possibly various genes, contributing to 
corticoid biosynthesis. 
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